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Abstract 
Hypertension and type two diabetes mellitus (Type 2 DM) are serious chronic 
illnesses that impact on the lives of millions of people around the world. Various 
epidemiological studies have shown a relationship between early life events such as 
intrauterine growth retardation (IUGR) resulting in low birth weight and the 
development of these chronic illnesses in adult life. To explain the link between these 
two events, it has been suggested that an ‘insult’ at a critical time point of 
development can ‘program’ alterations in gene expression, organ size, and cell 
number. This has been termed “the early life origins of disease’. There is also 
evidence that these programmed effects are not limited to the first generation but can 
also be passed to subsequent generations.  
 
With changes in lifestyle in modern society, the prevalence of obesity is increasing, 
in association with problems such as type 2 DM, hypertension, fatty liver, 
atherosclerosis and the metabolic syndrome. Obesity during pregnancy is linked to 
problems such as gestational diabetes, hypertension and early miscarriage as well as 
a higher risk of congenital malformations. Maternal obesity has also been recognised 
as one of the factors capable of ‘programming’ the offspring, increasing the risk of 
childhood and adult disorders such as obesity and hypertension.  
 
In this thesis I have used two animal models to explore the underlying mechanisms 
of programming and its intergenerational effects: i) a rat model of prenatal 
glucocorticoid over-exposure (the dexamethasone-programmed rat) and ii) a mouse 





Using the dexamethasone-programmed rat, I have shown that prenatal glucocorticoid 
overexposure reduces fetal and placental weight in the first generation (F1) offspring, 
in association with alterations in gene expression in placenta and liver. In addition, I 
have shown effects on fetal and placental weights and gene expression in the second 
generation (F2) offspring. The observed changes in gene expression in the F2 
offspring differ from those in the first generation. Thus, although effects on fetal 
growth are seen in both generations, the underlying mechanisms appear to be 
different. We also observed marked parent of origin effects on fetal and placental 
growth and gene expression in the second generation. 
  
In the mouse model of maternal obesity, birth weight was decreased in the F1 
offspring. At weaning, the offspring of obese mothers were heavier than controls, 
however this difference in weight was not persistent. At three months of age, F1 
female offspring of obese mothers showed altered expression of hepatic genes 
important in lipid regulation and metabolism. More striking changes were seen in the 
F2 generation in which there was an effect of paternal exposure to maternal obesity 
to decrease birth weight. There were also parent of origin effects on organ weights 
and insulin levels at six months of age. 
 
These results provide evidence for the transmission of programming effects to a 
second generation in two different programming models and suggest that the 
mechanisms leading to these effects differ between generations. 
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Since initial studies which were published in the late 20th century, a considerable 
amount of evidence, both from human and animal studies, has demonstrated that an 
‘insult’ occurring at a critical time point in development can have lifelong 
consequences for health, a phenomenon which has been termed ‘the early life origins 
of disease’ (Barker 1990). Although the theory of ‘programming’ effects was 
advanced and popularized by Barker et al. in 1989 in their studies showing a link 
between low birth weight and an increased risk of ischaemic heart disease (Barker et 
al. 1989), studies showing evidence for ‘programming’ date back much further 
(Weismann 1875, Gilbert 2005). In 1875, August Weismann, a German biologist 
discovered that the wing colour of the butterfly Araschnia levana changed depending 
on the season of hatching. He performed an experiment in which he incubated 
caterpillars at different temperatures and successfully bred a spring coloured butterfly 
in summer (Weismann 1875, Gilbert 2005); this was one of the first clues that an 
alteration to the environment during a specific time point of development is able to 
‘programme’ the offspring. Another example of ‘programming’ that occurs in nature 
involves the honey bee. It has been demonstrated that during the first three days of 
larval development, the larvae may either develop into a queen or a worker (Weaver 
1955). Although it is known that the underlying genome is exactly the same between 
a queen and a worker bee; they differ in body size and organ development. The 
queen bee has functional reproductive organs and a larger body size whereas the 
worker bees are smaller and do not have functional reproductive organs (Weaver 
1955). The main determinant of developing in to either a queen or worker is the 
nutritional status of the larvae during their first three days of life (Weaver 1955, 
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Haydak 1970). The queen larvae are fed with more nutritious royal jelly, whereas 
worker larvae are fed with less nutritious food (Weaver 1955, Haydak 1970). With 
this in mind, Weaver et al. conducted an experiment in the mid 1950s in which they 
transferred worker larvae into fresh queen larvae cells and allowed the worker larvae 
to grow in the nutritious royal jelly. They found that worker bee larvae raised in this 
environment grew into adults with queen-like features such as a larger body and 
ovaries (Weaver 1955). These observations give an indication that alterations in the 
environment, here either a change in temperature or nutrition, during a specific time 
point of development can permanently alter future growth and development. 
 
Importantly, such programming effects are not exclusive to any single system or 
organ and studies in animal models and in humans have shown effects on a variety of 
organs, in association with chronic illnesses such as type two diabetes mellitus 
(Hales et al. 1991, Valdez et al. 1994), renal disease (Vikse et al. 2008), hypertension 
(Benediktsson et al. 1993), depression (Meaney 2001), schizophrenia (St Clair et al. 
2005) and muscular hypotrophy (Bayol et al. 2005). Interestingly, the occurrence of 
low birth weight and adult onset chronic illnesses appears to be unrelated to age, 
gender, ethnicity and lifestyle such as smoking and alcohol consumption (Barker et 
al. 1989, Barker et al. 1993, Valdez et al. 1994, Rich-Edwards et al. 1997). 
Mechanisms which may account for these seemingly unrelated events of low birth 
weight and adulthood chronic illnesses include effects on gene expression (Nyirenda 
et al. 1998, Meaney 2001, Drake et al. 2005, Burdge et al. 2007), organ size (Ibanez 
et al. 2000), and cell number (Pladys et al. 2005).  
 





pandemic issue (WHO 2011). Obesity has been ascribed to an over-sufficient food 
supply and lack of exercise (WHO 2011) and has been linked to health related 
problems such as type two diabetes, hypertension, fatty liver, atherosclerosis, and the 
metabolic syndrome (WHO 2011). Obesity in pregnancy is known to be linked to 
problems such as gestational diabetes, hypertension, early miscarriage, as well as a 
higher risk of congenital malformations (Carmichael and Shaw 2000, 
Galtier-Dereure et al. 2000, Watkins et al. 2003, Samuelsson et al. 2008). Maternal 
obesity has also been proposed to be a factor capable of ‘programming’ the offspring, 
leading to an increased risk of childhood and adult obesity, hyperphagia, and 
hypertension (Bayol et al. 2005, Bayol et al. 2007, Samuelsson et al. 2008).  
 
1.2 Programming 
1.2.1 Evidence of programming in humans 
Several retrospective epidemiological studies around the world have provided 
evidence that links early life events with subsequent adulthood diseases. These 
impacts are not restricted to physiological changes in the next generation but also to 
psychological and behavioural changes (Archer and Blackman 1971, 
Hernández-Martínez et al. 2008, Mueller and Bale 2008a). In this section I will 
discuss some of the large scale epidemiological studies providing evidence of 
programming effects in humans from different parts of the world and various 
ethnicities. 
 
 1.2.1.1 Programming of cardiovascular diseases 
In 1944, during the World War II, following the landing of the allied forces on 
Omaha beach in northern France, the war was expected to end rapidly. However, the 
progress of the allied forces soon came to a halt after the failed mission of the 
operation Market Garden to take control over the river Rhine at Arnhem in the 
Netherlands. In order to help the allied forces, the Dutch government stopped all 
railways from functioning to prevent German forces from advancing. The Germans 
responded by discontinuing food supplies to the Dutch. The Netherlands then 
experienced a harsh winter and there was a major food shortage, known as the Dutch 
famine (Roseboom et al. 2001). Retrospective studies on the Dutch famine have 
shown that women who experienced famine during early gestation gave birth to 
offspring who were more prone to develop cardiovascular diseases in adulthood 




In contrast, retrospective studies which followed individuals who experienced a 
similar period during World War II, the siege of Leningrad, which occurred between 
1941 and 1944, did not show a link between maternal malnutrition and offspring 
adulthood coronary heart disease and hypertension (Stanner et al. 1997). Suggestions 
made to explain the differences between the Leningrad and the Dutch famine studies 
include that the duration of famine experienced during the Leningrad siege was about 
four times longer than the Dutch famine (>2 years compared to 6 months); also, the 
time that it took for the resumption of a normal state of food supply was very 
different in that the Dutch food supply quickly returned to normal after the famine 
and it took much longer for Leningrad to resume a normal food supply (Roseboom et 
al. 2000). Thus, the offspring in the Leningrad study were probably exposed to 
famine after birth and with decreased nutrition in- and ex-utero, had ‘adapted’ to the 
environment of under-nutrition. 
 
In another large scale retrospective study which was conducted on a non-war period 
of crop failure in Finland in 1866 – 1868, Kannisto et al. used groups of control 
individuals to compare with a group who were directly exposed to famine, a group 
which was born within five years before the famine started and another group which 
were born within five years after the famine. This study showed that there were no 
differences between survival rates in offspring from age 17 until 80 years in both 
males and females (Kannisto et al. 1997). This study suggests some ‘adaptation’ as in 
the Leningrad study, since both populations suffered from a scarce food supply even 
after the famine period, therefore being exposed to famine in- and ex-utero allowed 




Within the United Kingdom, Barker et al. demonstrated the link between low birth 
weight and an increased risk of developing ischaemic heart disease (Barker et al. 
1989, Barker et al. 1993). Amongst more than 5600 adult males who were born in 
Hertfordshire, England between 1911 – 1930, those with a birth weight below 5.5lb 
were at a three-fold greater risk of developing coronary artery disease in later life 
(Barker et al. 1989). Additionally, a lighter weight at one year of age was also 
strongly linked to adult ischaemic heart disease (Barker et al. 1989), with the highest 
risk in men that had low birth weight and below average weight at one year of age 
(Barker et al. 1989, Osmond et al. 1993). Although this is not in line with other 
studies showing catch up growth (discussed in section 1.2.3) being problematic 
(Eriksson et al. 1999, Ozanne and Hales 2004), it supports the importance of the 
postnatal environment in further moderating programming effects. In another study 
on the Hertfordshire population, Osmond et al. showed that women born with lighter 
birth weight were also at increased risk of cardiovascular diseases; with the highest 
cardiovascular death rate in women who were born lighter but were above average 
weight at one year of age (Osmond et al. 1993). 
 
Other studies from outside of Europe have also provided evidence of a link between 
low birth weight and cardiovascular disease risk in later adulthood. A retrospective 
study involving over 121,000 female nurses in the USA provided further evidence for 
a link between low birth weight and adult coronary artery disease and stroke; a link 
which appeared to be independent of current lifestyle factors such as smoking 
(Rich-Edwards et al. 1997). Another retrospective study also linked low birth weight 
with the development of adulthood hypertension in men (Curhan et al. 1996). 
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 1.2.1.2 Programming of metabolic disorders 
Other than programming of cardiovascular risk, studies have also suggested 
programming effects in other organs leading to an increased risk of obesity and type 
two diabetes. From the same population of the Dutch famine study described in 
section 1.2.1.1, the offspring, particularly young men, were found to be prone to 
obesity (Ravelli et al. 1976) and those experiencing famine in late gestation were 
prone to develop decreased glucose tolerance at age of 50 (Ravelli et al. 1998). In 
contrast again, the offspring exposed to famine during the siege of Leningrad did not 
display glucose intolerance or dyslipidaemia (Stanner et al. 1997). Possible 
explanations for these differences between the two studies have been discussed 
above in section 1.2.1.1. 
 
In the United Kingdom, a large retrospective study conducted on over 600 
individuals from Motherwell, Scotland has suggested that exposure to a high protein, 
low carbohydrate diet during pregnancy leads to programming effects in the 
offspring (Shiell et al. 2001). Between 1952 – 1976, pregnant women attending the 
maternity hospital in Motherwell were advised to consume a diet which was low in 
carbohydrate but extremely high in protein; containing at least one pound (~450 
grams) of red meat and a moderate amount of fish, eggs and cheese per day 
(Reynolds et al. 2007). The idea behind this was to decrease the risk of developing 
preeclampsia. Studies have linked this dietary alteration during pregnancy to 
increased fetal adiposity, increased childhood obesity and increased blood pressure as 
well as other metabolic phenotypes (Shiell et al. 2001, Reynolds et al. 2007). Shiell 
et al. reported that women who had a greater consumption of meat and fish in the 
second half of pregnancy give birth to offspring who developed higher systolic blood 
 
8
pressure in adulthood; and high maternal fish (but not red meat) consumption 
associated with increased offspring diastolic blood pressure (Shiell et al. 2001). It has 
been suggested that a high protein diet can stimulate the maternal 
hypothalamic-pituitary-adrenal (HPA) axis to secrete more cortisol, potentially 
resulting in overexposure of the developing fetus to glucocorticoids (Herrick et al. 
2003). Indeed, studies have shown that offspring exposed to this unbalanced high 
protein diet during pregnancy had increased fasting cortisol levels and increased 
cortisol levels in response to stress in adulthood (Herrick et al. 2003, Reynolds et al. 
2007). 
 
In the United States, studies have also shown a link between low birth weight and 
metabolic risk factors. Rich-Edwards et al. showed that females that had a lower 
birth weight are at increased risk of developing type two diabetes in adulthood 
(Rich-Edwards et al. 1999), while Curhan et al. showed that this link is also present 
in men (Curhan et al. 1996). Furthermore, a heavier birth weight has also been shown 
to be linked to the development of obesity in adulthood (Curhan et al. 1996). 
 
In Asia, during the ‘Great Leap’ of 1959 – 1961, various parts of China were exposed 
to famine. It was reported that during this period of famine, birth rate was 
dramatically decreased (St Clair et al. 2005); a similar observation to that in the siege 
of Leningrad (Antonov 1947). Yang et al. reported a significant increase in body 
mass index (BMI) in women born during the famine compared with control women 





 1.2.1.3 Programming of the brain and behaviour 
Psychiatric disorders have also been shown to have a link with the prenatal 
environment. In the Dutch famine cohort, female offspring exposed to famine during 
early gestation have a relative risk of more than two of developing schizophrenia 
(Susser and Lin 1992).  
 
Studies from the Chinese famine (discussed in section 1.2.1.2) also report a link 
between the intra-uterine environment and psychiatric disorders. Offspring that were 
exposed to the famine in utero were at a significantly greater risk of developing 
schizophrenia (St Clair et al. 2005). However, this study did not report on the gender 
difference that was seen in the Dutch famine study. 
 
Studies of individuals involved in the more recent event of the September 11th  2001 
incident in the United States have also revealed programming effects in the offspring 
(Yehuda et al. 2005). Following the collapse of the World Trade Centre on 9/11 the 
frequency of people developing clinical signs of post-traumatic stress disorder 
(PTSD) rose significantly (Neria et al. 2006). Women who were around the World 
Trade Centre during the 9/11 event who went on to develop PTSD had lower salivary 
cortisol levels (Yehuda et al. 2005). Interestingly, the babies of the mothers who 
developed PTSD from the 9/11 event also had low salivary cortisol levels at one year 
old, a finding which was particularly noted if the mother was exposed to the 9/11 
event during the third trimester of pregnancy (Yehuda et al. 2005). These findings are 
consistent with previous studies looking at the offspring of the survivors from the 
Nazi holocaust which also showed lower cortisol level (Yehuda et al. 2000) as did 





In addition, it has been shown that stress resulting from natural disasters may also 
have programming effects on offspring. A study of women that were pregnant when 
the most costly ice storm in the recent history of Canada struck Québec in 1998 
(Laplante et al. 2008) showed that maternal stress, particularly during early gestation, 
had a clear relationship with the children’s cognitive and language ability at two 
years of age (Laplante et al. 2004) and was associated with lower intelligence 
quotient (IQ) and poorer verbal skills at five years of age (Laplante et al. 2008). 
Species Country/City Stressor Gestation References Primary findings 
Human Amsterdam 
Netherlands 
↓ global nutrient 
intake 
Early (Roseboom et al. 1999) ↑ Blood pressure 
 Amsterdam 
Netherlands 
↓ global nutrient 
intake 
 (Ravelli et al. 1976) ↑ Obesity especially in 
males 
 Netherlands ↓ global nutrient 
intake 




Natural disaster  (Laplante et al. 2008) ↓ Intellectual performance 
 Amsterdam 
Netherlands 
↓ global nutrient 
intake 
















 (Herrick et al. 2003) ↑ Fasting plasma cortisol 
 New York City 
United States 
Post traumatic stress  (Yehuda et al. 2005) ↓ Salivary cortisol 
 Leningrad 
Russia 
↓ global nutrient 
intake 
All (Stanner et al. 1997) No difference between 
intrauterine malnutrition 
and control 
 Finland ↓ global nutrient 
intake 
 (Kannisto et al. 1997) No difference between 
intrauterine malnutrition 
and control 
 China ↓ global nutrient 
intake 
 (Yang et al. 2008) ↑ BMI in female 
 Wuhu 
China 
↓ global nutrient 
intake 
 (St Clair et al. 2005) ↑ Risk of schizophrenia 
 - Post traumatic stress  (Yehuda et al. 2000) ↓ Urinary cortisol 
 Québec 
Canada 
Natural disaster  (Laplante et al. 2008) ↓ Language ability 
 
Table 1.1 Studies showing programming effects in humans 
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1.2.2 Obesity in pregnancy 
The prevalence of obesity is increasing rapidly. Within the UK alone, the prevalence 
of obesity has increased by more than 300% between 1980 and 2002 (Rennie and 
Jebb 2005). Heslehurst et al. reported that in 2004, the prevalence of maternal 
obesity at the beginning of pregnancy was as high as 16% compared to 9.9% in 1999 
(Heslehurst et al. 2007). Heslehurst et al. also predicted that by 2010, 22% of women 
would be obese at the beginning of pregnancy (Heslehurst et al. 2007). In the United 
States, the prevalence of obesity has continued to grow not only in adults, but also in 
adolescents and children (Ogden et al. 2006); Chu et al. reported that between 2004 – 
2005, in 26 states, 23% of women were overweight and 18.7% of women were obese 
during pregnancy (Chu et al. 2009). Globally, the WHO has estimated that more than 
20% of the world population are overweight (WHO 2011). As previously noted, 
obesity predisposes to various serious metabolic illnesses. 
 
Obesity in pregnancy has been linked to programming effects in the offspring. 
Numerous studies from around the world have provided evidence that an increased 
maternal BMI is linked to an increased risk of childhood obesity (Whitaker 2004, 
Gale et al. 2007), increased fat mass (Gale et al. 2007, Reynolds et al. 2010), and 
metabolic illnesses (Catalano et al. 2009, Group 2010) in the offspring. These 
programming effects have been shown to be already apparent at birth (Catalano et al. 
2009). A large scale international study conducted by the HAPO (Hyperglycaemic 
and Adverse Pregnancy Outcome) group on over 23,000 adult participants in nine 
countries has suggested that increased maternal BMI is linked to increased body fat 
in the offspring along with increased fetal hyperinsulinaemia, this appears to be 
independent of maternal glycaemia (Group 2010). 
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Taken together, these large scale retrospective population studies have provided 
convincing evidence for an effect of an altered intrauterine environment and the 
subsequent risk of disease in adulthood. This link is independent of gender, ethnicity, 
lifestyle factors, geographical distribution, and socio-economic status. 
 
1.2.3 The role of post-natal growth 
In the previous sections, the idea that in utero environmental alterations can lead to 
various programming effects has been discussed. However, studies have also 
suggested an important role of the post-natal environment in programming effects.  
 
Programming is thought to reflect the adaptation of the fetus to a poor environment, 
resulting in some organs that are less important in survival to be less developed than 
other organs which may be critical for survival (Hales and Barker 1992). This change 
in organ development may be of critical importance in later development of chronic 
diseases. The highest risks of later diseases appear to be in offspring that had 
restricted growth in utero but had rapid catch up growth during infancy. Some have 
suggested that catch up growth, especially those that occurred within the first two 
years of life are at greater risk (Ong et al. 2000); while others suggested that less 
weight gain before 1 year of age followed by rapid weight gain at increased risk 
(Eriksson et al. 2001). This suggests that retarded fetal growth may be associated 
with effects on organ function and that the subsequent accelerated growth during the 
post-natal period, increasing metabolic demands on these under-functioning organs, 
may lead to an increased risk of diseases (Eriksson et al. 2000).  
 





be important in programming effects. Cardiovascular disease risk and death from 
cardiovascular events are related to reduced birth weight (Barker et al. 1989), with an 
even higher risk in children who displayed catch up growth (Eriksson et al. 1999). 
Children with catch up growth during early infant life have more central fat 
distribution and increased BMI (Ong et al. 2000), increased insulin secretion (Soto et 
al. 2003a), and increased blood pressure (Williams et al. 1992, Launer et al. 1993). In 
mice, restricted intrauterine growth and rapid post natal catch up growth has been 
associated with a shorter life span (Ozanne and Hales 2004) and in the rat, catch up 
growth has been linked to obesity and disruption in insulin and glucose homeostasis 
(Bieswal et al. 2006). Although it has been suggested that the increased cellular 
division and oxidative damage may occur in rodents with accelerated growth during 
early postnatal life leading to shortening of telomeres (Jennings et al. 1999); the 
exact mechanisms underlying the link between early nutritional status and adulthood 
diseases remain to be explored. 
 
1.2.4 Animal models of programming 
Various animal models of alterations in the fetal environment have been developed 
with the ultimate goal of achieving ‘programming’ in the offspring. These models 
facilitate understanding the underlying mechanisms that lead to such effects.  
 
 1.2.4.1 Prenatal glucocorticoid overexposure 
In the past few decades, studies have suggested a connection between glucocorticoid 
exposure and low birth weight both in animal models and in humans (Reinisch et al. 
1978, Nyirenda et al. 1998, French et al. 1999, Bloom et al. 2001, Drake et al. 2005). 
In Edinburgh, the hypothesis that fetal overexposure to glucocorticoids during a 
critical developmental period might underpin the epidemiological association 
between low birth weight and future adulthood disease has been explored 
(Benediktsson et al. 1993). In rodents, prenatal glucocorticoid overexposure has been 
associated with programming effects on the cardiovascular system including 
hypertension and effects on the vasculature (Hadoke et al. 2006, Tang et al. 2011), 
glucose-insulin homeostasis and behaviour (Nyirenda et al. 1998, Welberg et al. 2001, 
O'Regan et al. 2004). Similar programming effects of prenatal glucocorticoids have 
been shown in other species including sheep (Tangalakis et al. 1992) and non-human 
primates (Clarke et al. 1994, Koenen et al. 2002, de Vries et al. 2007). 
 
 1.2.4.1.1 Glucocorticoid actions 
Glucocorticoids are steroid hormones that are synthesized in the adrenal cortex under 
the tight control of the HPA axis (Figure 1.1). Glucocorticoids exert their actions on 
nearly every tissue in the body, with many functions including roles in metabolism 





regulation (Simpson et al. 1974). Glucocorticoids exert their effects by binding to the 
glucocorticoid receptor (GR) and regulate gene expression, homeostasis, and cell 
signalling (Lu and Cidlowski 2004). Glucocorticoids also bind with high affinity to 
the mineralocorticoid receptor (MR) (Funder 1993, Seckl and Chapman 1997).  
 
Glucocorticoids are used clinically as an anti-inflammatory agent for patients who 
suffer chronic illnesses such as asthma or rheumatoid arthritis and have long been 
used in pregnancy to promote acceleration of fetal lung maturation if preterm 
delivery is expected, as well as for the treatment of fetuses at risk of congenital 
adrenal hyperplasia (Seckl and Meaney 2004). Other then promoting lung maturation, 
glucocorticoid administration has also been shown to reduce the incidence of 
periventricular haemorrhage and necrotizing enterocolitis in preterm infants thereby 
increasing survival (Crowley et al. 1990). The role of glucocorticoids in epigenetic 





Figure 1.1 Hypothalamic pituitary adrenal (HPA) axis schematic 
Red arrows = stimulatory effects; blue arrows = negative feedback; CRH = Corticotropin-releasing 
hormone; ACTH = Adrenocorticotropic hormone 
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1.2.4.1.2 11β-hydroxysteroid dehydrogenase 
Under normal physiological conditions, maternal glucocorticoids do not readily cross 
the placenta into the fetal circulation (Seckl and Chapman 1997). This is due to the 
enzyme 11β-hydroxysteroid dehydrogenase type II (11β-HSD2), a NAD+ dependent 
enzyme that is expressed mainly in MR rich tissues such as the kidneys (Roland and 
Funder 1996), colon (Whorwood et al. 1994), and salivary glands (Roland and 
Funder 1996), where it acts to restrict inappropriate activation of MR by 
glucocorticoids (Stewart et al. 1988, Roland and Funder 1996, Seckl and Chapman 
1997, Deuchar et al. 2011). This enzyme also appears to be present in some 
non-mineralocorticoid receptor rich tissues such as blood vessels (Christy et al. 2003) 
and the placenta (Seckl and Chapman 1997) where it is relatively abundant in the 
trophoblast cells in humans (Krozowski et al. 1995, Stewart et al. 1995, Pepe et al. 
1999), baboons (Pepe et al. 1999), sheep (Yang 1995, Clarke et al. 2002), rabbit 
(Hundertmark et al. 2001), rat (Waddell et al. 1998), and mouse (Brown et al. 1996). 
The enzyme acts to convert active cortisol into inactive cortisone in humans and 
from active corticosterone to the inactive 11-dehydrocorticosterone in rodents 
(Edwards et al. 1996, Seckl and Meaney 2004) (Figure 1.2).  
 
In the placenta, the enzyme 11β-HSD2 acts as a barrier to prevent the fetus from 
overexposure to excess maternal glucocorticoid (Staud et al. 2006). This enzymatic 
barrier does not completely inactivate all glucocorticoid however, and it has been 
suggested that about 20% of glucocorticoids pass from the mother to the fetus 
unaltered (Benediktsson et al. 1997). In humans, it has been reported that reduced 
birth weight is associated with deficient level of placental 11β-HSD2 (Shams et al. 





preventing fetal glucocorticoid overexposure. 
 
In animal models, fetal glucocorticoid overexposure can be achieved by, i) 
administration of a synthetic glucocorticoid such as dexamethasone (Dex), which is a 
poor substrate for the 11β-HSD2 enzyme in the placenta (Benediktsson et al. 1993, 
Nyirenda et al. 1998, Drake et al. 2005), ii) administering an agent which inhibits 
11β-HSD2 (e.g. carbenoxolone) (Edwards et al. 1996, Lindsay et al. 1996), iii) using 
a 11β-HSD2 genetic knockout model (Wyrwoll et al. 2009), and iv) exposing the 
pregnant mother to stressful events which increase natural maternal circulatory 
glucocorticoids and swamp the placental 11β-HSD2 barrier (Barbazanges et al. 
1996). 
 
In summary, glucocorticoids have diverse actions on multiple organs. Despite the 
important role of glucocorticoids in fetal growth and organ maturation, evidence 
suggests a role for fetal glucocorticoid overexposure in programming, and this has 




Figure 1.2 Glucocorticoid activation and reduction in human and rodents 
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 1.2.4.2 The role of maternal nutrition 
Evidence from the various large scale human cohort studies discussed previously, 
highlights the importance of the nutritional status of the mother during pregnancy. 
Similar programming effects are also seen as a consequence of early life nutritional 
alterations in animal models. 
 
1.2.4.2.1 Maternal undernutrition 
Various methods have been implemented to achieve the goal of undernutrition in 
animal models and to induce programming effects (Harding 2001). Programming 
effects on blood pressure (Langley Evans and Jackson 1994) and glucose tolerance 
(Langley et al. 1994, Jimenez-Chillaron et al. 2009) have been shown by restricting 
dietary protein in rats. In a rat model, the introduction of a low protein diet two 
weeks before pregnancy was associated with a significant decrease in birth weight as 
well as lowered placental 11β-HSD activity (Langley Evans and Jackson 1994, 
Langley-Evans et al. 1996) and the offspring subsequently developed hypertension. 
Other models of undernutrition including those in mice (Peixoto-Silva et al. 2011), 
guinea pigs (Persson and Jansson 1992) and sheep (Gardner et al. 2005) have also 
shown similar programming effects in offspring. 
 
1.2.4.2.2 Maternal overnutrition 
Animal models of dietary induced obesity (DIO) have been developed to explore the 
mechanisms by which maternal obesity in pregnancy causes programming effects in 
the offspring (Carmichael and Shaw 2000, Gale et al. 2007, Catalano et al. 2009). 
Various dietary content combinations have been used to achieve obesity; including 
high fat content alone, high sugar content alone, or a combination of both (Surwit et 
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al. 1988, Surwit et al. 1995a, Bayol et al. 2005, Sumiyoshi et al. 2006, Samuelsson et 
al. 2008, Surve 2008, Chechi et al. 2010). Studies using females exposed to an 
obesogenic diet prior to pregnancy, throughout pregnancy, and during lactation 
(Khan et al. 2003, Bayol et al. 2005, Samuelsson et al. 2008) have shown 
programming effects on offspring metabolic function, with offspring of obese 
mothers developing a metabolic and cardiovascular phenotype such as insulin 
resistance/hyperglycaemia (Han et al. 2005, Liang et al. 2009, Shankar et al. 2010), 
hypercholesterolaemia (Elahi et al. 2009), steatohepatitis (Bruce et al. 2009), 
hypertension (Khan et al. 2003, Samuelsson et al. 2008, Liang et al. 2009) or a 
change in the regulation of appetite and satiety in the hypothalamus (McMillen et al. 
2005, Taylor and Poston 2007) therefore making them prone to develop obesity in 
adulthood (Bayol et al. 2005, Bayol et al. 2007, Bayol et al. 2008, Akyol et al. 2009). 
Unlike the glucocorticoid over-exposure model, in most DIO programming models 
the offspring are exposed to an already obese or over-nourished mother and it is 
difficult to determine the critical window of developmental programming (Drake and 
Reynolds 2010), however some studies have attempted to address the importance of 
timing. In one study, Shankar et al. showed that the offspring of obese female rats 
maintained on a standard chow diet during pregnancy still showed programming 
effects, suggesting that maternal obesity at conception is able to programme the 
offspring (Shankar et al. 2008). Some studies have shown that exposure to high fat 
diet for 7 – 10 days prior to conception and during pregnancy is sufficient to cause 
programming effects on blood pressure, insulin sensitivity, fat deposition and 
metabolism in the offspring (Guo and Jen 1995, Khan et al. 2005, Taylor et al. 2005). 
Finally, feeding a pregnant mother a ‘junk food’ diet from the day of conception till 





well as a differential preference for ‘junk food’ (Bayol et al. 2007, Bayol et al. 2008). 
 
Other than programming by ‘in utero’ exposure to an obesogenic environment, 
post-natal events (discussed in section 1.2.3) can also programme the animals 
(Francis et al. 1999, Meaney 2001). The role of early postnatal overfeeding has been 
explored using the “pup in a cup” model pioneered by Hall et al. (Hall 1975) which 
allows studies of the effects of overnutrition during the suckling period (Patel and 
Srinivasan 2002). Modifying milk constituents using this model can permanently 
alter the metabolism of these animals leading to hyperinsulinaemia and subsequent 
diabetes (Patel and Srinivasan 2002) suggesting the importance of early postnatal 
feeding in mediating programming effects. A summary of the proposed mechanisms 





Figure 1.3 Proposed mechanisms of programming effects 
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1.2.5 Importance of timing of insult exposure 
The timing of exposure to an insult appears to be a critical factor influencing 
programming outcome. In the Dutch Famine cohort, exposure to famine during early 
gestation shifts programming effects toward developing cardiovascular diseases 
(Roseboom et al. 2000), whereas exposure in late gestation leads to programming 
effects on metabolic phenotype in which decreased glucose tolerance is more evident 
(Ravelli et al. 1998). Similarly, women exposed to the 9/11 event during their third 
trimester of pregnancy have offspring that showed lower salivary cortisol level 
(Yehuda et al. 2005). Studies in animal models have also indicated the importance of 
the timing of exposure to an insult (Table 1.2). Excess glucocorticoid exposure 
during the last week of pregnancy in the rat leads to reduced birth weight, glucose 
intolerance (Nyirenda et al. 1998), hypertension (Levitt et al. 1996), whereas if the 
exposure to excess glucocorticoid was during the first or second week of gestation no 
effects were seen on glucose and insulin responses (Nyirenda et al. 1998). A further 
study suggests that two days of glucocorticoid excess during the last week of 
pregnancy was sufficient to alter renal development leading to hypertension (Singh et 
al. 2007). The timing of exposure is also important in determining programming 
effects on behaviour. Glucocorticoid exposure throughout the whole gestation, is 
associated with programming of anxiety-like behaviour and increased GR and MR 
mRNA expression in the amygdala (Welberg et al. 2001), whereas exposure during 
the last week of gestation in rodents has been linked to decreased cognitive function, 
increased stress responsiveness (Brabham et al. 2000) and alterations in GR and MR 
mRNA expression in the hippocampus (Levitt et al. 1996, Shoener et al. 2006). 
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Species GC Timing Dose References Primary findings 




(Koenen et al. 2002) ↑ blood pressure 
  E134 IM 
87.5μg/kg 
(Antonow-Schlorke et al. 
2003) 
Structural alteration of neuronal 
cytoskeleton 
Sheep CORT E127-E143 
(term E145-150) 
IV 
4μg/hr for 5hr 
(Wood et al. 1987) ↓ heart rate 
↓ blood volume 
↑ arterial pressure 




(Moss et al. 2001) ↓ insulin sensitivity 
↓ arterial pressure at 3 months 
  E104, 111, 118 IM 
500μg/kg 
(Jobe et al. 1998b) ↓ birth and organ weight 




(Huang et al. 1999) Retards fetal brain growth 




(Welberg et al. 2001) ↑ anxiety 
↑ GR/MR expression in amygdala 




(Hadoke et al. 2006) ↑ blood pressure 
↑ mesenteric artery but not aortic 
contraction 









  E8, 10, 12 IM 
100μg/kg 
(Dahlgren et al. 2001) ↓ glucose tolerance 
↑ fat depots 
  E15-delivery SC 
100μg/kg 
(Levitt et al. 1996) ↑ blood pressure 
↑ basal CORT 
  E14-21 SC 
100μg/kg 
(O'Regan et al. 2004) ↑ hepatic PEPCK mRNA 
Hypertension 
Gender specific changes 
  E14-21 SC 
100μg/kg 
(Holson et al. 1995) ↓ sexual performance 
Altered sexual differentiation 
  E15-E21 SC 
100μg/kg 
(O'Regan et al. 2008) Basal hypotension 
Hypertension to stress 
 
 





  E15-21 SC 
100μg/kg 
(Drake et al. 2005) Intergenerational effects in F2 and ↑ 
PEPCK activity 
  E15-delivery DW 
2.5μg/ml 
(Brabham et al. 2000) ↓ cognitive function 
↑ stress response 
↑ hippocampal GR mRNA 
  E17-19 SC 
50, 200, 
800μg/kg 






(Emgård et al. 2007) ↓ cognitive function 
 BET E15-21 SC 
50, 100, 200, 
400, 600μg/kg 
(McDonald et al. 2003) Except lowest dose of 50μg/kg, all 
doses reduce birth weight 
No change in blood pressure 
  E19-20 IM 
200μg/kg 
(Murthy and Moya 
1994) 
Transient decrease in cellular 
immunity 
  E20 SC 
170μg/kg 
Twice in 4 hr 
(Scheepens et al. 2003) Somatic growth retardation 
No difference in postnatal CORT 
level 
 CORT E14-15 IP 
800μg/kg 
Twice daily 
(Singh et al. 2007) ↓ nephron number 
↑ arterial pressure 
  E14-21 SC 
7000μg/kg 
(Holson et al. 1995) Altered sexual differentiation 
 HC E17-19 SC 
1500μg/kg 
(Piffer and Pereira 2004) Disturbed oestrous cycle and 
fertility in adulthood 
Mouse DEX E20-delivery OP 
125μg/kg 
(Dickinson et al. 2007) ↑ expression of genes involved in 
branching of tubules in the kidneys 
↓ nephron number 
 
Table 1.2 Animal models of excess glucocorticoid 
Phenotypes presented are of mix ages and some may emerge only with ageing 
GC = Glucocorticoids; E = Embryonic day; BET = Betamethasone; DEX = Dexamethasone; CORT = 
Corticosterone; HC = Hydrocortisone; GR = Glucocorticoid receptor; MR = Mineralocorticoid 
receptor; PEPCK = Phosphoenolpyruvate carboxykinase; mRNA = messenger ribonucleic acid; F2 = 
Second generation; SC = Subcutaneous; IM = Intramuscular; IV = Intravenous; IP = Intraperitoneal; 
OP = Osmotic pump; DW = Drinking water 
1.2.6 The role of epigenetics in programming 
There has been much recent interest in the role of epigenetic modifications as a 
mechanism for programming effects. The term “epigenetic” was first used by the 
Jewish Italian philosopher, Eugenio Rignano, in his ‘centroepigenetic hypothesis’ 
(Rignano 1911); however, it was the British developmental biologist, Conrad Hal 
Waddington (Waddington 1957), Professor of Animal Genetics at the University of 
Edinburgh who popularised this term. Professor Waddington first used this term to 
describe how a certain genotype may give rise to phenotypes (Waddington 1957). 
Now, the word “epigenetic” is most commonly defined as changes which alter the 
expression of a gene that cannot be accounted for by genetic variations (Richards 
2006). This can be achieved by several mechanisms: a) DNA methylation, a 
phenomenon where a methyl group is attached to the DNA (on the 5’-position of the 
cytosine nucleotide on a CpG dinucleotide) to either allow transcription (e.g. Igf2) 
(Szabo et al. 2004) or silencing (e.g. CDKn1c) (Beatty et al. 2006) gene expression. 
The patterns of such methylation (5-methylcytosine/5-mC) are preserved relatively 
accurate through mitosis through the actions of DNA methyltransferases (DNMTs) 
(Bestor 2000, Dahl et al. 2011). Recently, interest has centred on an alternative type 
of DNA methylation, the hydroxylated form of 5mC, 5-hydroxymethylcytosine 
(5-hmC). The first discovery of 5hmC in mammalian cells dates back to 1972 when 
Penn et al. reported its presence in brain tissues of several species (Penn et al. 1972). 
Recently, 5-hmC has been detected in various mouse tissues including kidney, lung, 
muscle, heart, brain (Kriaucionis and Heintz 2009) and at lower levels in bladder, 
liver, and endocrine glands (Globisch et al. 2010). 5-hmC may be involved in active 
DNA demethylation pathways and DNA repair (Tahiliani et al. 2009); b) non-coding 
RNAs (ncRNA) which can impact on gene expression and are of particular 
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importance in the transcriptional silencing of retrotransposons (Chu and Rana 2007, 
Rana 2007). ncRNAs have a wide range of functions including RNA editing, splicing, 
and inhibition of gene translation (Mattick and Makunin 2006). Additionally, 
emerging evidence has linked these ncRNAs with epigenetic regulation through 
effects on chromatin and transcriptional silencing of genes (Bernstein and Allis 2005, 
Mattick and Makunin 2006). Lastly, c) histone modifications (including acetylation, 
methylation, ubiquitination and SUMOylation) can affect chromatin accessibility and 
impact on DNA transcription (Delcuve et al. 2009). As histones are condensed as a 
consequence of hypoacetylation, access of binding proteins to DNA for transcription 
is restricted; in contrast, hyperacetylation of histones can lead to chromatin 
decondensation allowing accessibility (Wang et al. 2001, Kouzarides 2002, Delcuve 
et al. 2009). Methylation status of histones has also been associated with activation 
(Noma et al. 2001, Kouzarides 2002) or silencing (Tachibana et al. 2008) of 
transcription depending on the site of methylation. 
 
Various studies have suggested a role for epigenetic modifications as an underlying 
mechanism in programming. For example, Waterland et al. showed that with 
maternal dietary methyl donor supplementation in mice, an epigenetic modification 
(increased DNA methylation) occurred at the Agouti gene in the offspring, leading to 
a change in coat colour and metabolic phenotype (Waterland and Jirtle 2003). 
Similarly, Lillycrop et al. showed that offspring of rats fed a protein restricted diet 
during pregnancy had alterations in DNA methylation at the promoters of the hepatic 
glucocorticoid receptor and peroxisomal proliferator-activated receptor α (PPARα) in 
association with altered gene expression (Lillycrop et al. 2005); these alterations in 
methylation status affected specific CpG dinucleotides (Lillycrop et al. 2008). 
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Prenatal exposure to protein restriction has also been shown to alter histone 
configuration on the GR 110 promoter by increasing acetylation (at H3K9 and H4K9) 
and methylation (at H3K4) which facilitated transcription (Lillycrop et al. 2007). 
Another recent report has also shown that a protein restricted diet given to rats during 
pregnancy alters epigenetic regulation of the hepatic nuclear factor 4α (Hnf4α) gene 
in the islets of the pancreas (Sandovici et al. 2011). Maternal behaviour has also been 
shown to lead to differences in the pattern of DNA methylation; offspring of mothers 
with higher rate of grooming and nursing of pups had decreased methylation at the 
glucocorticoid receptor promoter (Weaver et al. 2004). In addition, a model which 
uses uterine arterial ligation has also shown decreased expression of Pdx1, a gene 
important in pancreatic β cell growth regulation, by epigenetic modifications leading 
to alteration in glucose homeostasis (Park et al. 2008). Thus, epigenetic 
modifications may play an important role in programming of the offspring. 
 
1.2.7 Glucocorticoids and the epigenome 
Glucocorticoids may affect the epigenome. Glucocorticoids are known to affect the 
expression of epigenetically regulated imprinted genes such as Igf2 (Li et al. 1998) 
and glucocorticoid treatment of cultured fetal hepatocytes was associated with DNA 
demethylation, a phenomenon which persisted even after withdrawal of 
glucocorticoids, providing a ‘memory’ of the event (Thomassin et al. 2001). One 
recent report has shown that glucocorticoid overexposure during the last week of 
gestation is associated with decreased DNA methylation at one of the differentially 
methylated regions controlling the expression of Igf2 in the fetal liver (Drake et al. 






1.2.8 Transmission of programming effects to subsequent generations 
Increasing evidence suggests that programmed effects may be transmitted to 
subsequent generations (Anway et al. 2005, Drake et al. 2005, Anway et al. 2006a, 
Benyshek et al. 2006, Godfrey et al. 2007, Inawaka et al. 2009). In this thesis the 
terminology proposed by Skinner will be used (Skinner 2008). The term 
“multigenerational” will be used when the insult might affect several generations at 
once e.g. in situations where the pregnant F0 females are exposed to an insult, 
programming effects may be seen in F1 fetus(es) due to direct exposure to this insult. 
However the germ cells which will go on to form the F2 generation are already 
present in the developing gonad and are therefore potentially also exposed to the 
same insult (Figure 1.4) (Drake and Liu 2010). The term “transgenerational” will be 
used only when programming effects are seen in a non-exposed generation, such as 
the presence of programmed effects in a third (F3) generation (Skinner 2008).  
 
Studies in humans have also suggested that programmed effects can be transmitted to 
subsequent generations, such as the Dutch Famine cohort study(Lumey 1992, 
Roseboom et al. 2000, Painter et al. 2005). Additionally, studies in Sweden linked the 
nutritional status of grandparents to the risk of adulthood diseases and longevity in 
grand-offspring (Kaati et al. 2002, Kaati et al. 2007). This study suggested that the 
male proband had a higher mortality rate if their grandfather had good nutritional 
supply during his prepubertal slow growth period, thus suggesting a 
transgenerational response down the male lineage, possibly through sperm (Kaati et 
al. 2007). Therefore, evidence from animal and human studies suggest programmed 
effects can be passed down through maternal (Emanuel et al. 1992, Drake et al. 2005) 




Figure 1.4 Model showing mechanisms of transmission of programming effects 
across generations 
The initial insult may have direct programming effects on both the F1 and F2 
generations, but at different stages of development. Meanwhile, ongoing 




1.3 Mechanisms to explain the transmission of programming effects 
1.3.1 Maternal physiology 
 1.3.1.1 Maternal size 
There is much evidence that maternal size correlates with offspring birth size. One 
classic example of this comes from the studies of Walton et al in which large Shire 
horses were crossed with smaller Shetland ponies. He concluded that size at birth is 
in direct correlation with maternal size rather than genotype (Walton and Hammond 
1938). These findings have been replicated in other species such as horses (Allen et 
al. 2002), sheep (Hunter 1956), pigs (Gama and Johnson 1993), mice (Cowley et al. 
1989), and humans (Ibanez et al. 2000). In humans, the height of the mother 
correlates strongly with the size of the uterus (Cogswell and Yip 1995). It has also 
been shown in ovum donation studies that infant birth weight correlates with the 
recipient mother’s BMI rather than the donor’s BMI (Brooks et al. 1995), stressing 
the importance of maternal factors in determining offspring birth weight. Therefore, 
these studies indicate the possibility that a smaller mother might give birth to a 
smaller baby, which may grow up to become a smaller mother and continue a cycle 
of lower birth weight. 
 
 1.3.1.2 Maternal health 
It has also been suggested that maternal illnesses may cause programming effects in 
the offspring. For example, pregnant women with diabetes are prone to deliver babies 
that are large for gestational age (Ehrenberg et al. 2004). These offspring are thus 
more prone to develop obesity and metabolic syndrome in adulthood. Similarly, 
women with hypertension tend to have offspring that are small for gestational age 
(McCowan et al. 1996), thus more prone to cardiovascular disease risk in adulthood. 
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Similar effects have been demonstrated in animal studies (Aerts et al. 1990, Gauguier 
et al. 1990, Wichi et al. 2005). For example, reports suggested that diabetes in rats 
can lead to increased offspring blood pressure (Wichi et al. 2005) and higher blood 
pressure in pregnancy associates with lower offspring birth weight (Fang et al. 1999, 
Odell et al. 2006), thus potentially leading to cycle of multigenerational 
programming. 
 
 1.3.1.3 Maternal behaviour 
Interestingly, maternal behaviour has programming effects. In humans, parental 
behaviour such as neglect, sexual and physical abuse associates with adulthood 
obesity (Lissau and Sorensen 1994), depression (Bifulco et al. 1991), anxiety 
(McCauley et al. 1997), diabetes and heart disease (Felitti et al. 1998), and also 
violence and aggression in the offspring (Doumas et al. 1994). In animals, similar 
results have been shown, for example in studies showing that postnatal handling of 
the young infant and separation from maternal care from birth decreases the 
physiological and psychological reaction to stress in adulthood (Levine et al. 1967). 
Also, differences in normal maternal care behaviour in rodents (licking/grooming 
and arched back nursing (LG-ABN)) in the first week post delivery  has been 
related to neonatal neural development (Francis et al. 1999); where mothers who 
show high rates of LG-ABN have offspring that are less fearful and show milder 
HPA response to stress (Francis et al. 1999, Weaver et al. 2004). These effects are 
transmissible to future generations since female offspring of mothers who showed 
high rate of LG-ABN also display high rate of LG-ABN towards their offspring 




 1.3.1.4 Maternal exposure to drugs 
In animal models, the use of certain drugs, such as vinclozolin (an antifungal drug) 
has been shown to have programming effects on the offspring. Effects have been 
demonstrated on reproductive organs such as the testis (Anway et al. 2005), blood 
chemistry and red blood cell numbers (Nilsson et al. 2008), and behaviour (Skinner 
et al. 2008). It has been reported in some studies that programming effects induced 
by vinclozolin may be transmissible to subsequent generations through the male 
germline as far as the F4 generation (Anway et al. 2005, Anway et al. 2006a) and to 
the F3 generation through female germline (Nilsson et al. 2008). These findings were 
not recapitulated in a similar study (Inawaka et al. 2009) and it has been suggested 
that it may be due to different strain of animals used (Dolinoy et al. 2006).  
  
1.3.2 Epigenetics and the transmission of programming effects 
An increasing amount of evidence suggests that epigenetic marks may be passed to 
subsequent generations (Anway et al. 2005, Cropley et al. 2006, Burdge et al. 2007, 
Stouder and Paoloni-Giacobino 2010). In a rat model of maternal protein restriction, 
methylation in the promoter region of hepatic PPARα and GR110 was decreased in 
F2 as well as F1 males (Burdge et al. 2007). Similar multigenerational effects have 
been reported with methyl donor diet supplementation, in which the methylation of 
the agouti viable yellow (Avy) gene was increased in both F1 and F2 offspring 
(Cropley et al. 2006).  
 
Emerging evidence suggests changes in DNA methylation patterns (Anway et al. 
2005, Franklin et al. 2010) and small non-coding RNAs (Rassoulzadegan et al. 2006, 
Lalancette et al. 2008) may be transmissible through the germline. Additionally, 
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histone modifications may be transmissible in sperm (Hammoud et al. 2009); about 
5 – 15% of DNA in sperm is organised by histone packaging, and many of these are 
sperm variant specific (Zalensky et al. 2002, Hammoud et al. 2009, Oliva and Mateo 
2011). The remainder of the sperm DNA is tightly packed around protamines (Oliva 
and Dixon 1991). Importantly, studies have suggested that packaging of genes either 
by histones or protamines is not random (Oliva and Dixon 1991, Wykes and Krawetz 
2003, Hammoud et al. 2009) suggesting a crucial role for histone modifications in 
sperm. Prenatal vinclozolin exposure may disrupt the methylation pattern of 
imprinted genes in sperm (Oliva and Dixon 1991, Wykes and Krawetz 2003, 
Hammoud et al. 2009), which may explain the transmission of epigenetic changes 
through the male germline.  
 
It is important to note that in mouse, epigenetic marks such as DNA methylation are 
reset during development at two developmental stages: i) erasure: which occurs at 
around embryonic day 12 – 13 and, ii) re-establishment: which occurs only after sex 
determination of the offspring. In males, the re-establishment of epigenetic marks 
occurs during late fetal development whereas in females, it occurs predominantly 
after birth (Kafri et al. 1992, Szabó and Mann 1995, Reik and Walter 2001, Lee et al. 
2002, Sasaki and Matsui 2008). There is a further wave of epigenetic reprogramming 
which occurs after fertilisation, when the paternal and maternal genomes both 
undergo a process of epigenetic reprogramming. In the paternal genome, this process 
has been shown to occur within 6 – 8 hours following fertilization, whereas that in 
the female genome occurs after several cleavage divisions (Mayer et al. 2000b). 
Importantly, epigenetic marks at imprinted loci escape this period of epigenetic 
reprogramming following fertilisation. In humans, the exact time of epigenetic marks 
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being erased and reset is currently unknown, but one recent study has suggest it to be 
different from that of rodents and also to differ between genders (Wermann et al. 
2010). 
 
Nonetheless, it has been shown that under certain conditions, such as vinclozolin 
exposure during pregnancy, defective epigenetic marks may not be re-set, but may be 
carried through to subsequent generations (Anway et al. 2005, Stouder et al. 2009, 
Stouder and Paoloni-Giacobino 2010). The exact mechanisms of such resistance to 
reprogramming remains to be discovered (Youngson and Whitelaw 2008, Stouder 
and Paoloni-Giacobino 2010).  
 
1.3.3 Genomic imprinting 
Genomic imprinting is an epigenetic mechanism in which one allele of a gene is 
inactivated in a parent-of-origin specific manner. Imprinting of a gene is tissue 
specific, developmentally regulated, time point specific, and species specific 
(Fowden et al. 2006a). For example, the paternally expressed gene Igf2, is imprinted 
in most fetal tissue in mice and humans, but is bi-allelically expressed in brain 
(Tycko and Morison 2002); Igf2 has also been shown to be silenced in all somatic 
tissues in rodents by the time of weaning (Fowden 2003). Also, a maternally 
expressed organic cation transporter, Slc22a3, is imprinted in mice at embryonic day 
11.5 in the placenta, but loses its imprinted status by day E15.5 (Zwart et al. 2001).  
 
An interesting and unique feature of imprinted genes is that they are not randomly 
distributed across the genome, but are usually found in clusters (Reik and Walter 
2001). For example, the two imprinted genes, CDKn1c and Phlda2 (discussed in 
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section 1.3.4.3 and 1.3.4.4 respectively) are both located on human chromosome 
11p15 (mouse chromosome 7; rat chromosome 1) in the same locus as a number of 
other imprinted genes (Salas et al. 2004, Beatty et al. 2006). Each cluster of 
imprinted genes is regulated by a cis-element called the imprinting control region 
(ICR), which may itself be modulated by other elements (Edwards and 
Ferguson-Smith 2007). 
 
Many imprinted genes are important in growth, either in the placenta or fetus or both 
(Moore and Haig 1991, Reik et al. 2002, Coan et al. 2005). According to the 
‘parental conflict’ hypothesis (sometimes referred to as Haig’s hypothesis or the 
kinship theory of imprinting), paternally expressed imprinted genes act to extract 
more nutrients from the mother to promote fetal growth (thus decreased expression 
of these may lead to IUGR); whilst maternally expressed genes act to restrict fetal 
growth, thus limiting nutrient supply to the fetus to protect the mother’s own 
well-being (Moore and Haig 1991, Reik and Walter 2001). This theory has been 
backed up by evolutionary explanations (Haig 1993) suggesting that failure to 
regulate the distribution of the nutrient resources between the maternal needs and 
those of the fetus may have severe consequences for either, especially during periods 
when food is scarce. More nutrients taken by the fetus will result in a better chance 
of fetal survival, but this could cause harm to the mother; in contrast, if the mother 
preserves all the nutrients for herself, the chance of survival of the fetus decreases. 
However, the father in this case will not be harmed in either situation, therefore it is 
in the best interest of the father to promote growth of the fetus to increase the chance 
of fetal survival so that it can pass on the paternal genome (Haig 1993, Haig 2000). 
This theory has also been supported by the distribution of imprinted genes in specific 
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branches of the phylogenetic tree (Reik et al. 2002). It appears that genes that have 
been found to be imprinted in mammals are not imprinted in egg laying animals 
(monotremes and birds) (Reik et al. 2002). Further support for this theory can be 
derived from data showing that the disruption of the key paternally expressed 
imprinted gene insulin-like growth factor 2 (Igf2) causes growth deficiency 
(DeChiara et al. 1991, Constância et al. 2002), whereas disruption of the maternally 
expressed gene Igf2r (which sequesters Igf2) results in fetal overgrowth (Lau et al. 
1994). Examples of some imprinted genes important in fetal and placental growth are 
discussed in detail below. 
 
1.3.4 Imprinted genes important in growth: 
 1.3.4.1 Insulin-like growth factor 2 (Igf2) 
Insulin-like growth factors (Igf) are probably the most well characterised genes in the 
development of the placenta and fetus. There are two main forms of Igf, namely Igf1 
(which is not imprinted) and Igf2. Igf2 in particular plays an important role in 
placental and fetal development. It is a maternally imprinted gene that is expressed 
from the paternal allele in most fetal tissues and placenta, but is bi-allelically 
expressed in the brain (Tycko and Morison 2002). Igf2 is known to be imprinted 
during fetal life and gradually loses its imprinting status during ageing into adulthood. 
There are four promoters regulating the tissue-specificity of Igf2 expression (P0, P1, 
P2, and P3), with the P0 promoter being most important in the placental labyrinth 
(Moore et al. 1997, Constância et al. 2002). Decreased Igf2 expression results in 
placental and fetal growth restriction (Baker et al. 1993, Constância et al. 2002, 
Fowden et al. 2006a). Notably, the Igf2 gene in ovine liver has a glucocorticoid 
response element (GRE) on one of the promoter regions, suggesting that 
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glucocorticoids may regulate Igf2 transcription (Li et al. 1998).  
 1.3.4.2 Grb10 
Grb10 (growth receptor bound protein 10) encodes a protein which interacts with 
receptor tyrosine kinases. Grb10 is a maternally expressed gene in most tissues 
including the placenta, however, it has been shown to be paternally expressed in the 
brain (Monk et al. 2009). The exact function of this gene is not clearly characterised, 
but it has been shown to cause placental and fetal overgrowth when disrupted, 
suggesting it has a role as a growth suppressant (Charalambous et al. 2003).  
 
 1.3.4.3 Cyclin dependent kinase inhibitor (CDKn) 
Cyclin dependent kinase inhibitor 1c (CDKn1c) or p57kip2 is a tumour suppressor 
gene that is maternally expressed. It is a cell cycle regulator and is known to arrest 
cells in the G1 phase when over expressed. In humans, CDKn1c disruption has been 
linked to various tumours and is also thought to be important in 
Beckwith-Wiedemann syndrome, a condition associated with prenatal overgrowth 
(Takahashi et al. 2000). CDKn1c deficient mice develop placentomegaly (Hatada et 
al. 1996), confirming its importance in the control of development of the placenta. A 
GRE is located about 5kb upstream of the promoter region of CDKn1c gene in 
humans (Fitzpatrick et al. 2002). 
 
 1.3.4.4 Pleckstrin homology-like domain family A (Phlda) 
Phlda member 2 (Phlda2 or IPL = “imprinted in placenta and liver”) is a tumour 
suppressor gene expressed maternally in a region along with various other tumour 
suppressor genes (including CDKn1c). The expression of Phlda2 along with 





KvDMR1 is an imprinting control region and methylation on the maternal allele is 
associated with expression of CDKn1c and Phlda2 from the maternal allele 
(Fitzpatrick et al. 2007, Shin et al. 2008). 
Deletion of the Phlda2 gene has been shown to lead to the development of 
placentomegaly with specific enlargement of the junctional zone (Frank et al. 2002, 
Salas et al. 2004) and recent data suggests it has an important function in the 
regulation of glycogen storage in the junctional zone of the placenta (Tunster et al. 
2010). Phlda2 over-expression is associated with a significant reduction in glycogen 
storage and a reduction in the size of the junctional zone (Tunster et al. 2010). 
 
 1.3.4.5 Mesoderm specific transcript homolog (Mest/PEG1) 
Mest is a maternally imprinted gene (paternally expressed) that is abundantly 
expressed in mesodermal derivatives. The function of this gene is unknown, however, 
sequence similarities with the α/β-hydrolase fold family suggest an enzymatic role 
(Kaneko-Ishino et al. 1995). Although its function is largely unknown, studies have 
suggested a role for Mest in fetal growth (Lefebvre et al. 1998) and angiogenesis in 
the placenta (Mayer et al. 2000a). 
 
1.4 The placenta 
1.4.1 The role of the placenta in early life programming 
The placenta connects the mother to the fetus, thereby providing the fetus with 
oxygen and nutrients, removing waste products, and acting as an immunological 
barrier between the mother and the fetus. Complications in placental development 
can lead to pregnancy loss and other pregnancy related problems such as 
preeclampsia (Kaufmann et al. 2003), as well as future offspring developmental 
problems (Soares et al. 1996, Fowden et al. 2006a). Birth weight is closely related to 
the morphology of and nutrient transport across the placenta (Fowden and Forhead 
2004). Since low birth weight is linked to various adulthood diseases as discussed 
previously this highlights a potentially important role of the placenta during 
development.  
 
The rodent placenta, like the human placenta, is hemochorial in formation (Figure 
1.5) (Ain et al. 2006), meaning the fetal chorion is bathed in maternal blood by direct 
contact (Rossant and Cross 2001). It is formed by the fusion of two tissues, the 
allantois derived from extra embryonic mesoderm and the extra embryonic chorion 
(Rinkenberger and Werb 2000). Shortly after the fusion of these two tissues, blood 
vessels grow in from the allantois to form the fetal compartment of the placental 
vascular network (Rossant and Cross 2001). Thereafter, the trophoblast invades and 
further branching of the fetal blood vessels occurs, forming the labyrinth zone; this 
formation helps increase the area of contact with maternal blood (Peel and Bulmer 
1977). This is similar to the chorionic villi in humans (Rinkenberger and Werb 2000). 
Although there are some similarities between human and rodent placentas, some 





syncytial layer plus a trophoblast stem cell layer; compared to the three trophoblast 
cell layers (trichorial) of the rodent placenta (Rossant and Cross 2001).  
 
As described above, the rodent placenta is divided grossly into two layers, namely 
the junctional zone (also known as the spongiotrophoblast layer) on the maternal 
facing surface, and the labyrinth layer on the fetal facing surface. The labyrinth layer 
contains numerous important nutrient transporters, including the system A amino 
acid (e.g. Slc38a1, Slc38a2, Slc38a4) and glucose transporters (e.g. Glut1/Slc2a1, 
Glut3/Slc2a3). The precise function of the junctional zone is largely unknown, 
although it is involved in invasion (Soares et al. 1996), hormone secretion (such as 
prolactin-like hormones and placental lactogen), the production of cytokines which 
help maintain the secretion of progesterone by the corpus luteum (Coan et al. 2006, 
Tunster et al. 2010) and glycogen storage by glycogen cells (Tunster et al. 2010). 
 
The placenta appears to play a critical role in programming. Examples of its 
importance include studies in sheep which show different programming effects of 
glucocorticoids depending on whether they are administered to the mother or the 
fetus (Jobe et al. 1998a). Because of the close link between placental wellbeing and 
fetal health and growth, much recent interest has focused on the role of placental 




Figure 1.5 Schematic of rodent and human placenta 




1.4.2 Nutrient transporters 
Nutrients transported across the placenta are directly related to the growth of the 
fetus. As pregnancy progresses towards the end of gestation, the fetus grows at a rate 
much faster than the placenta (Sands and Dobbing 1985), therefore, it is reasonable 
to assume that the nutrient transporting mechanisms may be up-regulated towards the 
end of pregnancy (Desforges and Sibley 2010). The majority of nutrients pass 
through the placenta by passive diffusion, which is broadly divided into the lipophilic 
route by which lipid soluble molecules cross the placenta and the hydrophilic route 
by which lipid insoluble molecules cross the placenta (Desforges and Sibley 2010). 
Because hydrophilic molecules do not pass easily through the lipid bilayer (Dobson 
and Kell 2008), hydrophilic molecules are also transported through specialised 
membrane transporters. These transporters may transfer nutrients across the plasma 
membrane by means of passive diffusion or against the concentration gradient 
(Desforges and Sibley 2010). However, it should be noted that other determinants 
such as blood flow, contact surface area of placenta and maternal blood spaces, 
hormones, pH, and oxygen tension are also important in the regulation of nutrient 
transport (Jones et al. 2007, Desforges and Sibley 2010).  
 
 1.4.2.1 Glucose transporters (Glut) 
Glucose oxidation is a major source of energy in living organisms. Glucose is 
transported into a cell by one of two ways: down the concentration gradient or 
against the concentration gradient by Na+- dependent transporters (such as the Gluts), 
a number of which have been identified. Glut1 is mainly found at the blood-tissue 
barrier such as the blood-brain-barrier (Kalaria et al. 1988) or the placental barrier 
(Takata et al. 1992) but numerous studies have identified its presence in different 
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tissues (Gould and Holman 1993). Glut3 has been suggested to be found mostly in 
tissues with a large glucose demand, such as the brain, but it is also present in the 
placenta (Gould and Holman 1993). In the rodent placenta, immunohistochemistry 
studies have shown the presence of both Glut1 and Glut3 in the placental labyrinth 
(Takata et al. 1994, Shin et al. 1997), but only Glut1 in the junctional layer (Shin et al. 
1997). In the human placenta, Glut1 is seen mainly in syncytiotrophoblast cells at 
term and Glut3 is present at lower amounts in both syncytiotrophoblast cells and 
non-syncytial cells (Jansson et al. 1995). Although both Glut1 and Glut3 act as 
glucose transporters, their action seems to differ in the placenta. Zhou et al. showed 
that in the placenta, Glut1 acts mainly to provide glucose to the placenta itself from 
the maternal circulation as fuel, whereas Glut3 acts mainly to provide glucose to the 
fetus from the placenta (Zhou and Bondy 1993).  
 
Interestingly, despite the known importance of Gluts in glucose transport, the 
expression and activity of Gluts are unaltered in human placenta from growth 
restricted fetuses (Jansson et al. 1993, Jansson et al. 2002, Desforges and Sibley 
2010). In contrast, in human fetal overgrowth, transport of glucose is shown to be 
increased in the basement membrane but unchanged in the microvillous membrane 
(Jansson 2001, Desforges and Sibley 2010). 
 
In rodent models of glucocorticoid exposure, Dex treatment in late gestation 
increases the expression of Glut1 and 3 (Langdown and Sugden 2001), whereas, 
treatment by triamcinolone leads to decreased expression (Hahn et al. 1999). In a 
model of maternal high fat feeding and obesity the activity of the glucose 
transporters was found to be significantly enhanced (Jones et al. 2009). 
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 1.4.2.2 System A amino acid transporters (Slc38) 
Amino acids are essential for the growing fetus, in which they help in laying down 
protein as well as being a major source for energy (Battaglia and Meschia 1978). The 
system A amino acid transporters are also known as Na+- dependent neutral amino 
acids transporters (SNAT). The main purpose of these transporters is the transport of 
non-essential neutral amino acids such as alanine, glycine, and glutamine (Jansson et 
al. 2002, Desforges and Sibley 2010). mRNA encoding the three SNATs (Slc38a1, 
Slc38a2, and Slc38a4) has been shown to be present in the rodent placenta and 
immunohistochemistry studies have shown both Slc38a1 and Slc38a2 to be present 
in the placental labyrinth in the final third of gestation (Novak et al. 2006). Studies in 
rats have shown that fetuses of mothers fed protein restricted diets have a decreased 
fetal concentration of amino acids despite normal levels of amino acid in the mother, 
suggesting a decrease in the amino acid transport through the placenta (Malandro et 
al. 1996). Whilst some studies in humans have shown reduced expression of SNATs 
in the placenta of small for gestational age and IUGR babies (Jansson et al. 2002, 
Shibata et al. 2008); studies in mice suggest that expression is up-regulated in 
smaller placentas, suggesting that the placenta can enhance its nutritional transfer 
capability to meet fetal demands (Coan et al. 2008a). In the 11β-HSD2 knockout 
mouse, which has decreased fetal and placental size, expression of SNATs was also 
found to be up-regulated (Wyrwoll et al. 2009). In vitro studies suggest that Dex 
exposure in human placental villous tissues does not increase the mRNA expression 
of SNATs but does result in increased function along with syncytiotrophoblast 
differentiation and maturation (Audette et al. 2010). In mice, Dex treatment at 
midgestation had no effect on SNAT mRNA expression in placental labyrinth, but 





In a rodent model of high fat feeding leading to maternal obesity, SNAT transport 
capacity was found to be increased (Jones et al. 2009). These studies suggest the 
importance of SNATs in the placenta and fetal development and demonstrate that 
manipulation of the prenatal environment can impact on placental amino acid 
transport. One of the SNATs, Slc38a4, has been shown to be imprinted and paternally 
expressed in mice. 
 
1.5 The Insulin-like Growth Factor pathway 
Insulin-like growth factors 1 and 2 play crucial roles in promoting fetal and placental 
growth and may have a role in programming effects. Insulin-like growth factors 1 
and 2 are single chain polypeptides which can be found normally in circulating 
plasma and at a slightly reduced level in tissues (Humbel 1990). It has been 
suggested that most of the circulating Igfs are produced from the liver, whereas Igfs 
found in the tissues are suggested to be paracrine/autocrine in action (Humbel 1990, 
DeChiara et al. 1991). Throughout development, growth hormone (GH), Igf1 and 
Igf2 play crucial role in growth, from the fetus to adulthood. Igf2 is produced at a 
higher levels during fetal life, these levels gradually decrease postnatally; in contrast, 
Igf1 is produced in a much lower level during fetal life and gradually increases 
postnatally (DeChiara et al. 1991). During fetal life, GH may have very little 
influence on fetal growth (Randhawa and Cohen 2005).  
 
The actions of both Igf1 and Igf2 are exerted by binding to the insulin-like growth 
factor 1 receptor (Igf1r) (Forbes and Westwood 2008). Thereafter, signalling through 
a cascade of downstream proteins results in cellular growth, translation of genes, and 
inhibition of apoptosis (Figure 1.6). Igf1 binds exclusively to Igf1r (a cellular 
membrane tyrosine kinase receptor) whereas Igf2 binds to both Igf1r and the 
insulin-like growth factor 2 receptor (Igf2r), binding with greater affinity to the latter. 
Once bound to Igf2r, Igf2 is thought to be inactivated (Louvi et al. 1997, Randhawa 
and Cohen 2005) although studies have also shown that when Igf2 binds to Igf2r, it 
can exert its effects on trophoblast cells to stimulate migration and invasion 
(McKinnon et al. 2001) and on blood vessels to stimulate angiogenesis and vascular 





act in part through the insulin receptor (IR) and therefore exert its effect to promote 
growth (Louvi et al. 1997). Although both Igf1 and Igf2 interact with Igf1r to exert 
their effects, these effects may differ. Igf1 infusions in pregnant rodents resulted in an 
increase in fetal growth but no difference in placental growth (Gluckman et al. 1992). 
As Igf1 does not cross the placenta (Davenport et al. 1990), it has been suggested 
that Igf1 exerts its effect on the nutrient transport across the placenta and affects the 
fetus indirectly. In contrast, Igf2 given to guinea pigs during early to mid-gestation 
increased placental size, thereby providing more nutrition to the developing fetus and 




Figure 1.6 Diagrammatic representation of the Igf signalling pathway  
Igf1 = Insulin-like growth factor 1; Igf2 = Insulin-like growth factor 2; Igf1r = Igf1 receptor; Igf2r = 
Igf2 receptor; P = Phospholation; IR = Insulin receptor; IRS1 = Insulin receptor substrate 1; pIRS1 = 
Phosphorylated IRS1; Pi3k = Phosphoinositide 3-kinase; pPi3k = Phosphorylated Pi3k; GSK3β = 
Glycogen synthase kinase-3β; pGSK3β = Phosphorylated GSK3β; mTOR = Mammalian target of 
rapamycin; pmTOR = Phosphorylated mTOR; GS = Glycogen synthase; pGS = Phosphorylated GS 
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Circulating Igfs are mostly bound to insulin-like growth factor binding proteins 
(IgfBP). There are six known IgfBPs (IgfBP1 – IgfBP6) which have higher affinity 
for the Igfs than Igf1r (Hwa et al. 1999, Forbes and Westwood 2008). When Igfs are 
bound to IgfBPs, their effects may either be inhibited or enhanced depending on the 
role of IgfBP in the tissue as well as its molecular status (eg. phosphorylated vs 
non-phosphorylated) (Firth and Baxter 2002). IgfBPs serve not only to transport Igfs 
in the circulation, but also prolong Igf half-life (Forbes and Westwood 2008). 
 
1.5.1 Insulin receptor substrate – 1 (IRS1) 
After Igf1 or Igf2 binds to Igf1r, or following stimulation of the insulin receptor by 
insulin, a tyrosine phosphorylation reaction occurs at the IRS1 protein leading to its 
activation. IRS1 is a protein with a size of about 165 – 185kDa which has at least ten 
potential tyrosine phosphorylation sites (Sun et al. 1991, Saad et al. 1992). IRS1 acts 
primarily as a docking protein between the receptor and a variety of Src homology-2 
(SH2) containing proteins, such as phosphoinositide 3-kinase (Pi3K) and growth 
factor receptor bound protein 2 (Grb2) (Saad et al. 1992). However, only specific site 
(Tyr612) phosphorylation on the IRS1 protein can lead to Pi3K activation and 
growth (Esposito et al. 2001).  
 
1.5.2 Phosphoinositide 3-Kinase (Pi3k) 
After activation of IRS1, Pi3k catalyses the production of 
phosphatidylinositol-3,4,5-triphosphate (PIP3) which functions to co-ordinate cellular 
growth and survival (Cantley 2002). The Pi3K protein consists of two subunits; the 
regulatory subunit at the p85 position and the catalytic subunit at the p110 position 
(Carpenter et al. 1990, Backer et al. 1992). The activation of Pi3k by phosphorylation 
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results in the stimulation of downstream proteins, such as Akt and PDK1 through 
PIP3 to stimulate cellular growth, protein synthesis and survival (Cantley 2002).  
 
1.5.3 Akt 
Akt (which is also referred to as protein kinase B (PKB)) is homologous to the PKA 
and PKC family of protein kinases (Franke et al. 1997). Akt plays a central role in 
the regulation of growth, inhibition of apoptosis, and protein synthesis in part 
through the factors that activate Pi3K (Franke et al. 1995, Andjelković et al. 1996). 
There are two main residues where Akt can be phosphorylated, namely: threonine 
308 (Thr308) and serine 473 (Ser473) (Alessi et al. 1996). When phosphorylation of 
either of the residues occurs, the protein becomes activated (Alessi et al. 1996). 
There are debates as to whether the phosphorylation of one of the residues is more 
important than the other (Sarbassov et al. 2005); but evidence suggests that Ser473 
phosphorylation may be more important that Thr308 phosphorylation (Scheid et al. 
2002, Sarbassov et al. 2005).  
 
1.5.4 Mammalian target of rapamycin (mTOR) 
Mammalian target of rapamycin (mTOR) is a Ser/Thr protein kinase which is 
important in protein synthesis, nutrient and energy sensing (Dennis et al. 1999, 
Dennis et al. 2001). Two phosphorylation sites have been identified on mTOR which 
can be triggered by the Pi3K/Akt pathway activation: threonine 2446 (Thr2446) and 
serine 2448 (Ser2448) (Navé et al. 1999, Hay and Sonenberg 2004); as well as a site 
of autophosphorylation at serine 2481 (Ser2481) (Navé et al. 1999). Studies have 
suggested a role for placental mTOR in the regulation of nutrient transporters 
(Edinger 2007, Roos et al. 2009, Rosario et al. 2011). In fact, mTOR activity in the 
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placenta has been shown to be reduced in human IUGR (Roos et al. 2007, Yung et al. 
2008), suggesting the importance of this protein in fetal growth. 
 
1.5.5 Glycogen Synthase Kinase-3β (GSK3β) 
Glycogen synthase kinase 3 (GSK3) has been known for decades to be involved in 
the synthesis of glycogen via its action on glycogen synthase (GS), the rate limiting 
enzyme of glycogen biosynthesis (Welsh et al. 1996). Unlike most other kinases, 
when GSK3 is phosphorylated, it becomes inactive (Welsh et al. 1996). Under 
normal conditions, non-phosphorylated GSK3 acts to inhibit GS by phosphorylation; 
however, under certain conditions such as increased insulin levels, GS may be 
dephosphorylated leading to synthesis of glycogen (Parker et al. 1983). This may 
either be a direct effect of insulin on GS or may be through an effect of insulin to 
inhibit GSK3 through phosphorylation of the serine residue at position 9 (Ser9) 








1.6 Hypothesis and aims: 
In the dexamethasone-programmed rat model: 
I hypothesise that overexposure to glucocorticoids in utero during the last week of 
gestation will induce programming effects in the developing offspring and that these 
programming effects may be passed down to the second generation but that the 
mechanisms of programming underlying the phenotype in the two generations will 
be different. I will therefore explore the effects of prenatal glucocorticoid 
overexposure on fetal and placental growth as well as on the expression of genes 
known to be important in fetal and placental growth in both F1 and F2 offspring. I 
will concentrate particularly on the expression of imprinted and various growth 
related genes as well as the developing placenta. I will also explore the Igf pathway 
in F1 placenta and liver. 
 
In the maternal obesity mouse model: 
I hypothesise that maternal obesity will program the offspring and grand offspring 
and that the programming effects will be generation and gender specific. I will 
describe programming effects on the F1 and F2 offspring, and explore the expression 
of genes that are important in metabolism. 
 
This study will be aimed at exploring the transmission of programming effects to 













Materials and methods 
 
2.1 Materials 
Unless otherwise stated, all general chemicals and solutions were purchased from 
Sigma-Aldrich Company Ltd, Dorset, UK. 
Room temperature (RT°) is defined as 18-22°C. 
 
2.1.1 General chemicals/solutions/kits 
VWR International, Leicestershire, UK Ethanol 
 Methanol 
Sigma-Aldrich Ltd., Dorset, UK Neutral Buffered Formalin (10%) 
 Harris Haemotoxylin 
 Eosin-Y 
 Ponceau-S solution 
Promega Ltd., Southampton, UK Reverse transcription enzymes 
 Bovine serum albumin 
Thermo Fisher Scientific, Leicestershire, UK Infinity™ glucose hexokinase  
 Infinity™ triglyceride reagents  
 Infinity™ cholesterol reagents 
 Ammonia solution 
 Xylene 
Starstedt, Leicester, UK Microvette® CB-300 EDTA tubes 
Alpha Laboratories, Hampshire, UK NEFA kit 
Crystal Chem Inc., Illinois, USA Insulin ELISA kit 
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2.1.2 Molecular biology 
 2.1.2.1 Ribonucleic Acid 
Qiagen, West Sussex, UK RNeasy® mini kit 
 QIAzol® lysis reagent 
 RNase-free DNase set 
Invitrogen, Paisley, UK Primers 
Applied Biosystems, Warrington, UK TaqMan™ primers and probes 
Promega Ltd., Southampton, UK 1kb DNA ladder 
 PCR Master Mix 
Roche Diagnostics Ltd., West Sussex, UK SYBR® Green I Master 
LightCycler® 480 probes master 
Lonza, Maine, USA Agarose powder 
Biotium Inc., California, USA Gel-Red™ nucleic acid stain 
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 2.1.2.2 Western blotting 
Roche Diagnostics Ltd., West Sussex, UK Protease inhibitor cocktail tablet 
Bio-Rad, Hertfordshire, UK Protein assay solutions 
 Kaleidoscope™ protein ladder 
 Blotting grade blocker non fat dry milk
GE Healthcare, Buckinghamshire, UK Hybond™-C Extra nitrocellulose 
membrane, 0.45μm 
Whatman Ltd, Kent, UK Filter paper, 3mm 
Invitrogen, Paisley, UK NuPAGE® Novex 4-12% Bis-Tris gel 
 NuPAGE® MOPS SDS running buffer 
(20x) 
 NuPAGE® transfer buffer (20x) 
 NuPAGE® sample reducing agent 
(10x) 
 NuPAGE® LDS sample buffer (4x) 
 NuPAGE® antioxidant 
 Alexa Fluor® 680 goat anti-rabbit IgG
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2.1.3 Equipment 
Thermo Fisher Scientific, Leicestershire, UK ND1000 Nanodrop quantification 
spectrophotometer 
 Microtome blade MB35 
UVItec, Cambridge, UK DBT-08 gel documentation system 
Molecular Devices Ltd., Berkshire, UK OPTImax plate reader 
Eppendorf, Cambridge, UK 5810R Bench centrifuge for 
microplates 
 5415D Bench centrifuge for RT° 
 5415R Bench centrifuge for other 
temperatures 
Biochrom Ltd., Cambridge, UK Microplate washer 
Grant Instruments Ltd., Cambridge, UK SS40-2 Shaking water bath 
PRO Scientific, Connecticut, USA PRO200 Homogeniser 
Electrothermal, Essex, UK Paraffin section mounting bath 
Leica Microsystems Ltd., Buck, UK Rotary microtome 
Invitrogen, Paisley, UK XCell Surelock™ western blot tank
Photometrics Ltd., Buckinghamshire, UK CoolSNAP CCD camera 
CRi, Massachusetts, USA Micro*Color RGB crystal filter 
LI-COR Biosciences LTd., Cambridge, UK Odyssey® Infrared Imaging system
G-Storm Ltd., Somerset, UK GS1 Thermocycler 




2.1.4 Statistical analysis 
The data were analysed using SPSS® (IBM Ltd., New York, USA) and GraphPad® 
(GraphPad Software, California, USA). A Student’s t-test was used when the data is 
normally distributed and has one variable. A Mann-Whitney u-test was used when 
the data has one variable but not normally distributed as tested by skewness. A 
two-way ANOVA was used when two individual variables were present. A 
Chi-square test was used to determine the statistical significance of an expected and 
observed outcome. A Pearson’s correlation was used when determining the statistical 
correlation between two variables. Results were considered significant if p<0.05. 
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2.2 Buffers and solutions 
10x TBE Buffer: Tris base (108g), boric acid (55g), and 40ml of 0.5M EDTA were 
dissolved in 800ml of Milli-Q water. pH was adjusted to 8.0 by adding 10M KOH 
and thereafter, the volume was adjusted to 1L with Milli-Q water. The buffer was 
autoclaved and kept at RT°. 
 
0.5x TBE Buffer: 50ml of 10x TBE was diluted in 950ml of Milli-Q water and 
stored at RT°. 
 
10x TBS Buffer: Tris base (30g), KCl (2g), and NaCl (88g) were dissolved in 800ml 
of Milli-Q water. The pH was adjusted to 7.4 with 37% HCl, thereafter, volumes 
were adjusted to 1L with Milli-Q water and stored at RT°. 
 
1x TBS Buffer: 10ml of 10x TBS buffer was diluted with 90ml of Milli-Q water and 
stored at RT°. 
 
1x TBST Buffer: 100ml of 10x TBS was diluted in 900ml of Milli-Q water and 1ml 
Tween-20 was added, the solution was mixed gently and stored at RT°. 
 
2x Protein lysis buffer: 50ml of 1M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES), NaCl (8g), CaCl2 (0.15g), MgCl2 (0.2g), NaF (0.42g), EDTA (0.37g) 
and sodium pyrophosphate (Na2H2P2O7, 2.29g) were dissolved in 1L of Milli-Q 





1x Protein lysis buffer: 5ml of 2x protein lysis buffer, 1ml NP40 (10% v/v), 1ml 
glycerol, 0.2ml NaVO4 (100mM), 1 protease inhibitor cocktail tablet were dissolved 
in 2.8ml of Milli-Q water. This buffer was prepared immediately prior to use. 
 
5% Blocking milk: 2.5g of blotting-grade blocker, non-fat, dry milk powder were 
dissolved in 50ml of 1x TBST and stored at 4°C. This was prepared immediately 
prior to use. 
 
5% BSA: 0.5g of bovine serum albumin (BSA, Fraction V) was dissolved in 10ml of 
1x TBST and stored at 4°C. This was prepared immediately prior to use. 
 
1x Running Buffer: 50ml of 20x NuPAGE® MOPS-SDS running buffer was diluted 
in 950ml of Milli-Q water. 
 
1x Transfer Buffer:  
For 1 gel transfer: 25ml of 20x NuPAGE® transfer buffer were diluted in 425ml of 
Milli-Q water and 50ml of methanol. 500μl of NuPAGE® Antioxidant was added 
prior to use. 
 
For 2 gel transfer: 25ml of 20x NuPAGE® transfer buffer was diluted in 375ml of 
Milli-Q water and 100ml of methanol. 500μl of NuPAGE® Antioxidant was added 
prior to use. 
 
Alkaline tap water: 3 drops of ammonia were added to 400ml of tap water. 
2.3 Animal maintenance 
All animal procedures were carried out under the Project License number 60/3962 
and personal licence number 60/12181 under the terms of the Animals (Scientific 
Procedures) Act 1986. William Mungall and Jon Hendersson were responsible for the 
daily maintenance of rats and mice respectively in the BRF Little France facility; Ian 
McCall, David Read, and Bill Smith were responsible for the daily maintenance of 
mice in the BRF Western General Hospital facility. Animals were maintained in a 
controlled environment with set humidity (55%), temperature (22°C), and light/dark 
cycle (lights on 12 hours per day from 07:00 to 19:00) in both units. Animals were 
kept at a maximum of five per cage and cages were cleaned weekly. 
 
2.3.1 Rats 
Female Wistar rats were bought from Harlan, UK Ltd. Female rats were purchased 
for mating at a weight of 200-250g; in house male rats of equivalent age were used 
for mating. Standard BRF laboratory diets, CRM, were used and were supplied by 
Special Diet Services (Witham, Essex, UK). Filter water was used and animals were 
allowed ad libitum access to food and water. 
 
2.3.2 Mice 
In house wild type C57Bl/6 mice were used, and were maintained on standard BRF 
laboratory diets, RM1, unless otherwise stated. The standard laboratory diets were 
supplied by Special Diet Services. Experimental control (CON) and diet-induced 
obesogenic (DIO) diets were purchased from Research Diets (New Brunswick, NJ, 




2.4.1 F1 offspring production 
Females were allowed to acclimatize for two weeks after arrival at the BRF. At 
mating, a female was singly housed with a wild type male of the similar age. The day 
when the expelled vaginal plugs was noted was designated as embryonic day zero of 
the pregnancy (E0). From this day on, Pregnant females were group housed with 
animals from the same group at a maximum of five animals per cage until last week 
of pregnancy after which females were singly housed. Between E15 and E21, 
pregnant females were weighed daily in the morning before 09:30 and given a 
subcutaneous injection of either 100μg/kg of dexamethasone mixed in 4% ethanol 
and 0.9% normal saline (Dex) or an equivalent volume of 4% ethanol mixed with 
0.9% normal saline (Veh).  
 
Groups of pregnant females were killed at E20 or left to litter naturally which 
occurred between days E21 – E23.  At E20, females were sacrificed by carbon 
dioxide asphyxiation followed by cervical dislocation in the morning (between 
09:20 – 12:00) at least one hour after the final injection. Food and water were not 
withdrawn prior to sacrificing. Fetal and placental tissues were dissected, weighed 
and snap frozen on dry ice immediately and were stored at -80°C until use. Some 
placentas were randomly selected from each litter to be placed in a glass bijou with 
10% neutral buffered formalin (Sigma-Aldrich). The placentas were stored at 4°C 
overnight and were transferred into 70% ethanol and kept at RT˚ until use. Trunk 
blood was collected via the inferior vena cava or cardiac puncture with a 2ml syringe 
rinsed with 0.5mM EDTA, and then transferred to an Eppendorf™ tube and placed 
on wet ice. Fetal blood was collected using EDTA coated collection tubes 
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Microvette® CB-300 (Sarstedt) after decapitation. The collected blood was placed 
on wet ice and centrifuged as soon as possible at 5000rpm for 10 minutes at 4°C, the 
supernatant plasma was then transferred into a new Eppendorf™ tube and stored at 
-20°C. 
 
For females which littered naturally, pups were weighed, sexed and culled back to 
eight per litter on the day of delivery with a similar number of males and females 
kept for each litter. Pups were reared by their mother until three weeks of age and 
were then weaned. Pups were then housed randomly with littermates of a same age 
from the same treatment group. Animals were selected at random and from as many 
different litters as possible for subsequent experiments.  
 
2.4.2 F2 offspring production 
At three months of age, F1 animals were mated in all combinations (Veh female x 
Veh male, Dex female x Dex male, Dex female x Veh male and Veh female x Dex 
male) to give four groups of F2 litters (VV, DD, DV and VD) (Figure 2.1). Pregnant 
females were group housed with animals from the same group at a maximum of five 
animals per cage until last week of pregnancy after which females were singly 
housed. Females were killed and tissues collected at E20. The animals were 
sacrificed using the same method as described above for F1 animals. Tissues were 













2.5.1 Production of F1 offspring 
In house C57Bl/6 wild type mice were reared by their biological mothers on standard 
laboratory chow (RM1) and were weaned at three weeks of age onto standard 
laboratory chow. At five weeks of age, these F0 females were randomly assigned to 
either CON or DIO diets for 12 weeks. At 17 weeks of age, F0 CON and DIO 
females were singly housed with a stud male in the afternoon, remaining on their 
assigned diet. Vaginal plugs were checked in the morning, and when found, the male 
was removed from cage and the day was designated as E0 of pregnancy. Pregnant 
females were singly housed until delivery which occurred between E19 and E21 and 
were weighed at E10 and E18. Females were maintained on their designated diets 
through pregnancy and lactation. At delivery, F1 CON and F1 DIO pups were 
weighed, sexed, and culled back to five per litter with similar numbers of male and 
female kept in each litter. F1 offspring were weaned onto standard laboratory chow at 
three weeks of age. 
 
2.5.2 Production of F2 offspring 
F1 males and females were allowed to grow until three months of age, and then 
mated in all combinations (F1 CON female x F1 CON male, F1 DIO female x F1 
DIO male, F1 DIO female x F1 CON male and F1 CON female x F1 DIO male) 
Pregnant females were singly housed until delivery which occurred between E19 and 
E21 and were weighed at E10 and E18. At delivery, F2 pups (designated CC, DD, 
DC and CD) were weighed, sexed, and culled back to five per litter with two males 







Figure 2.2 Schematic diagram showing the duration of exposure to experimental diets 




2.6 Biochemical assays 
2.6.1 Measurement of plasma insulin concentrations 
Plasma insulin concentrations were measured using the ultra sensitive rat insulin 
ELISA kit for rat and ultra sensitive mouse insulin ELISA kit for mice (Crystal Chem 
Inc., Illinois, USA). The manufacturer reports 100% reactivity to rat and mouse 
insulin as well as an intra- and inter-assay coefficient of variation (CV) of ≤10%. The 
manufacturer’s instructions for the low range assay (able to measure insulin levels 
between 0.1 – 6.4 ng/ml) were followed accordingly for both rats and mice. Samples 
were loaded as 5μl per well in singlicate and standard in duplicates along with 95μl 
of sample diluent. Each well was pre-coated with primary guinea pig anti-insulin 
antibody. For the blank negative, sample diluent was used. The plate was then 
incubated at 4°C for 2 hours followed by five washes with supplied wash buffer to 
remove excess insulin not bound to the plate. This was then followed by the addition 
of 100μl of horse-radish peroxidase conjugated anti-insulin antibody and incubated at 
RT° for 30 minutes. The plate was washed again seven times with wash buffer to 
remove excess anti-insulin antibody. 100μl of enzyme substrate containing 
tetramethylbenzidine was then added to each well and incubated in the dark for 40 
minutes at RT°. This was then followed by the addition of 100μl of reaction enzyme 
stop solution. The plate was then read using a plate reader (Molecular Devices, 
Berkshire, UK) and the difference between the absorbances at 630nm and 450nm 




2.6.2 Measurement of plasma glucose 
The measurement of plasma glucose level was achieved by using Infinity™ glucose 
hexokinase reagent. Hexokinase acts to catalyse the phosphorylation of glucose by 
removing a phosphate from adeno-triphosphate (ATP) to form glucose-6-phosphate 
(G6P) and adeno-diphosphate (ADP). Glucose-6-phosphate then oxidises to become 
6-phosphogluconate (6-PG) while reducing nicotinamide adenine dinucleotide from 
its oxidised form NAD+ to NADH with the help of glucose-6-phosphate 
dehydrogenase (G6PDH) (Carroll et al. 1970). The amount of NADH formed is thus 
in direct proportion to the concentration of glucose in the plasma.  
 
Glucose ATP   G6P ADP 
G6P NAD  
G PDH
 6‐PG NADH  H  
 
Therefore, by measuring the absorbance of NADH at 340nm, it is possible to 
calculate the concentration of glucose. The concentration of glucose in each 
individual sample was calculated by setting a glucose standard (Thermo Fisher 
Scientific) of 0-400mg/dl in duplicate on each 96-well plate. 2μl of each plasma 
sample was used for the experiment. After the standard and sample had been loaded 
on the plate, 200μl of glucose hexokinase reagent were added to each well and 
incubated for 10 minutes at room temperature. Thereafter, by reading the UV 
absorbance of the standard glucose and sample, the concentration of each sample was 
calculated. The manufacturer reported an intra- and inter-assay CV of 1.6%. 
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2.6.3 Measurement of plasma triglyceride 
Plasma triglyceride concentrations were measured by using the Infinity™ 
triglyceride liquid stable reagent. The mechanisms of the reaction are as follow: The 
hydrolysis of triglyceride molecules by specific lipases results in glycerol and free 
fatty acid production. Glycerol is then phosphorylated by ATP into 
glycerol-3-phosphate and ADP by glycerol kinase (GK). Glycerol-3-phosphate is 
then oxidised to form dihydroxyacetone phosphate (DAP) and hydrogen peroxide 
(H2O2) by glycerolphosphate (GPO). The reaction of H2O2 with 4-aminoantipyrine 
(4-AAP) and 3,5-dichloro-2-hydroxybenzene sulfonate (3,5 DHBS) with peroxidase 
(POD) as catalyst produces a red coloured dye (Fossati and Prencipe 1982, 
McGowan et al. 1983). The absorbance of this dye correlates to the triglyceride level 









 DAP 2H O  
H O  4‐AAP 3,5 DHBS 
POD
 Quinoneimine dye 2H O 
 
Standard curves were generated by serial dilution (0.565 – 7.91mmol/l) of 
triglyceride standard solution and Milli-Q water. Fasted plasma samples were loaded 
in singlicate at 2μl per well and standards in duplicate on a 96 well plate. 200μl of 
triglyceride reagent was added to each well and the plate incubated in dark at 37°C 
for 5 minutes. The difference between absorbance at 500nm and 600nm were 
calculated. A standard curve R2 > 0.98 was deemed satisfactory. The manufacturer 
reported an intra- and inter-assay CV were reported of 2.1%. 
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2.6.4 Measurement of plasma cholesterol 
Plasma cholesterol concentration was measured by using Infinity™ total cholesterol 
reagent. The mechanism of reactions is similar to that of the measurement of plasma 
triglyceride. Cholesterol esters were hydrolyzed to cholesterol and fatty acids by the 
action of cholesterol ester hydrolase (CEH). Free cholesterols were then oxidised by 
cholesterol oxidase (CO) to cholest-4-en-3-one and hydrogen peroxide (H2O2). 
Hydrogen peroxide then combines with hydroxybenzonic acid (HBA) and 
4-aminoantipyrine (4-AAP) to form a red coloured dye by the catalyst action of 







 Cholest‐4‐en‐3‐one  H O  
2H O  HBA 4‐AAP 
POD
 Quinoneimine dye 4H O 
 
Standard curves were generated by serial dilution (0.97 – 27.16mmol/l) of 
cholesterol standard solution and Milli-Q water. Samples were loaded in singlicate at 
2μl per well and standards in duplicate on a 96 well plate. 200μl of cholesterol 
reagent was added to each well and the plate incubated in dark at 37°C for 5 minutes. 
The difference between absorbance at 500nm and 600nm were calculated. A standard 
curve R2 > 0.98 was deemed satisfactory. The manufacturer reported an intra- and 






2.6.5 Measurement of glycogen in tissue 
The measurement of tissue glycogen level was performed using Infinity™ glucose 
hexokinase reagent. Tissues were cut and weighed (40 – 50mg for placental labyrinth; 
20 – 35mg for the placental junctional layer). Tissues were placed in a glass bijou 
and 500μl of 2N HCl were added. Glass bijous were then put in a 50ml BD Falcon™ 
tube with 5ml of 95°C water. The Falcon™ tubes were incubated in a water bath at 
95°C for 2 hours with gentle shaking. After the incubation, 500μl of sodium 
hydroxide (NaOH) was added to each sample. Each sample was adjusted with a pH 
4.5 – 10 strip (Sigma-Aldrich, Dorset, UK) with either 2N HCl or 2N NaOH until the 
pH was close to 7.0; the volume added and removed for each sample was recorded 
for later calculation of glycogen levels. The samples were left on ice after pH 
adjustment and were transferred into a new 2ml Eppendorf™ tube. Samples were 
then centrifuged at 2000rpm at 4°C for 4 minutes. The supernatant was then removed 
into a new 2ml Eppendorf™ tube and analysed using the Infinity™ glucose 
hexokinase reagent (section 2.6.2). Samples were loaded on a 96 well plate in 
duplicate. A protein assay was performed on each sample for accurate calculation of 
glycogen levels. The quantification of protein in samples is described in 2.7.7.1. The 









2.7 Molecular procedures 
2.7.1 Extraction of total RNA from tissues 
Snap frozen liver and placental tissues were used. Total RNA was extracted by using 
the RNeasy® mini kit (Qiagen, West Sussex, UK) and the manufacturer’s 
instructions were followed. Approximately 30-50mg of tissue was used for the 
extraction of RNA. An on-column DNase treatment step was performed on liver and 
placental RNA according to the manufacturer’s instructions. 
 
2.7.2 Extraction of total RNA from adipose tissue 
The same procedures were followed for the extraction of RNA from adipose tissue 
except for the homogenisation step. About 60mg of snap frozen adipose tissue was 
added to 1ml of QIAzol® for homogenisation. 300μl of chloroform was added and 
mixed by shaking vigorously; the mixture was then left at RT° for five minutes. 
Samples were centrifuged at 13,000rpm for 15 minutes at 4°C. The clear aqueous 
supernatant was removed into a new Eppendorf™ and mixed with equal volume of 
70% ethanol. The samples were then transferred to the RNeasy® spin columns and 
the remainder of the steps were followed as described in section 2.7.1. 
 
2.7.3 RNA quantification and agarose gel electrophoresis 
Approximately 2μl of RNA extracted was used undiluted for quantification using the 
NanoDrop ND-1000 quantification system. The RNA concentration was recorded 
and the ultraviolet absorbance at 260nm/280nm and 260nm/230nm was also 
recorded as an indication of purity of the RNA extracted. A value between 1.8 – 2.1 
was considered satisfactory.  
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To ensure extracted RNA was intact, all RNA samples underwent an agarose gel 
electrophoresis step on a 1% TBE agarose gel (section 2.2) containing 1:10 
GelRed™ (for nucleic acid fluorescent under ultraviolet light exposure). 
Approximately 0.8 – 1.2μg of RNA was mixed with 2μl of loading buffer (Orange G). 
A 1kb DNA ladder was loaded along with samples to estimate size and to act as 
control. The gel was run at 100 volts for 45 – 60 minutes and viewed using a Gel-doc 
system at 240nm. The presence of a thick 28S and a thinner 18S ribosomal RNA 
bands (at about 2:1 ratio) indicates intact RNA and was considered satisfactory. 
 
2.7.4 Reverse transcription of RNA 
The synthesis of cDNA from RNA (~1μg for liver and placenta, ~0.5μg for adipose) 
was performed by using the reverse transcription system from Promega®. After 
normalisation of all samples to a similar concentration and volume (10.7μl), a final 
quantification step was performed using the NanoDrop system (as described in 2.7.3). 
The samples were then denatured in 70°C for 10 minutes, then immediately placed 
on ice. A master mix was made consisting of: MgCl2 (4μl), 10x reverse transcription 
buffer (2μl), dNTP (2μl), RNasin inhibitor (0.5μl), AMV reverse transciptase (0.6μl), 
Oligo-dT (0.2μl) per sample. After the addition of this master mix, samples were 
reverse transcribed at 42°C for 15 minutes followed by 95°C for 5 minutes then 
gradually cooled down to 4°C in a G-Storm thermal cycler. A –RT (no reverse 
transcriptase) sample was made; the sample underwent all the procedures mentioned 
above except that nuclease free water was added in place of AMV reverse 
transcriptase. This acts as a negative control to ensure no genomic DNA 




2.7.5 Real-time polymerase chain reaction 
The quantity of mRNA was measured using a LightCycler® 480. Either a Taqman® 
primer-probe mix or self designed primers were used for specific gene amplification. 
Self designed intron spanning assays were designed using the Universal 
ProbeLibrary™ (UPL) system (Roche Diagnostics Ltd., West Sussex, UK). A 
standard curve was made by pooling cDNA from all the samples for the experiment 
and serially diluted in nuclease free water (1:4, 1:8, 1:16, 1:32, 1:64, 1:128). 
Individual samples of cDNA were diluted to 1:20 in nuclease free water. 2μl of 
samples and standard curve were loaded into the bottom of a 384 well plate in 
triplicate, followed by a master mix containing primers, probe and Roche® probes 
master (Table 2.1). 
 
Plates were centrifuged for 2 minutes at 2000rpm and then loaded into the 
LightCycler® 480. The reaction conditions comprised rapid heating to 95°C for 5 
minutes for denaturation followed by 50 cycles of a denaturation step at 95°C for 10 
seconds, annealing at 60°C for 30 seconds, and elongation at 72°C for 1 second. The 
samples were then cooled to 40°C for 30 seconds for completion. Acceptable assays 
had a reaction efficiency value between 1.7 – 2.1 and  slope between -3.1 - -3.6. 
Data were analysed with the Roche LightCycler® software (ver. 1.5.0 SP1). All 









cDNA (1:20) 2μl 2μl 
Roche Probes Master 5μl 5μl 
Taqman® probe 0.5μl - 
Forward primer - 0.02μl (100μM) 
Reverse primer - 0.02μl (100μM) 
Corresponding UPL probe - 0.1μl (10μM) 
Nuclease free water 2.5μl 2.7μl 
 
Table 2.1 Recipe for real time PCR using either Taqman® primer-probe mix or self 






 2.7.5.1 Rat self designed primers (UPL) 
 




Akt1 ENSRNOT00000031164.2 aacgacgtagccattgtgaa ccatcattcttgaggaggaagt 71 95 
IRS1 NM_012969.1 tggacgtcacaggcagaat gggatgcatcgtaccatctac 69 142 
Igf1 NM_178866.4 tgacatgcccaagactcaga cgtggcattttctgttcctc 63 114 
Igf1r NM_052807.1 gcctccaactttgtctttgc cactgggccaggaatgtc 68 66 
Phlda2 XM_001065824.1 gcgctgatcgactaccaga ctactcccgtgggtctctga 25 69 
GAPDH M17701.1 agctggtcatcaatgggaaa atttgatgttagcgggatcg 9 83 
11β-HSD1 NM_017080.2 tctacaaatgaagagttcagaccag gccccagtgacaatcacttt 1 62 
Grb10 NM_00110903.1 caaccaagaagccaaccag tccacggatgagttaatatcgtt 117 74 
IgfBP2 NM_013122.2 gcgggtacctgtgaaaagag tccctccgagtggtcatc 112 78 
IgfBP3 NM_012588.1 cacactgaatcatctgaagttcct tttggaagggcgacactg 95 109 
Igf2r ENSRNOT00000021840.3 gcaacaaaaccgcaggtc tgcagtccacctcacctgt 55 63 
TATA box binding protein 
(TBP) 
NM_001004198.1 cccaccagcagttcagtagc caattctgggtttgatcattctg 129 75 







 2.7.5.2 Rat Taqman® primer-probe set 
 
Primer Accession Number Reference Sequence Amplicon (nt)
Cyclophilin-A (PPiA) RN00690933_m1 NM_017101.1 149 
Actin β (ActB) RN00667869_m1 NM_031144.2 91 
Igf2 RN01454518_m1  74 
Igf2r RN01636937_m1 NM_012756.1 82 
GR (Nr3c1) RN01405584_m1 NM_012576.2 75 
Mest RN01500324_m1 NM_001009617.1 101 
CDKn1c RN00711097_m1  70 
11βHSD2 RN00492539_m1 NM_017081.1 100 
Slc2a1 (Glut1) RN01417099_m1 NM_138827.1 73 
Slc2a3 (Glut3) RN00567331_m1 NM_017102.2 99 
Slc38a1 RN00593696_m1 NM_138832.1 95 
Slc38a2 RN00710421_m1 NM_181090.2 57 




 2.7.5.3 Mouse self designed primers (UPL) 
 




11β-HSD1  tctacaaatgaagagttcagaccag gccccagtgacaatcacttt 1 62 
Lipoprotein lipase 
(LPL) 
NM_008509.2 ctcgctctcagatgccctac aggcctggttgtgttgctt 95 90 
Hormone sensitive 
lipase (HSL) 
ENSMUST00000054301.6 gcgctggaggagtgttttt ccgctctccagttgaacc 3 75 
Fatty acid synthase 
(FAS) 
NM_007988.3 ccaaatccaacatgggaca tgctccagggataacagca 34 76 
PPAR α ENSMUST00000109423.1 ccttccctgtgaactgacg caccatgttggatggatgtg 5 107 
PPAR γ ENSMUST00000000450.3 gctgttatgggtgaaactctgg tctgtgtcaaccatggtaatttct 2 110 
5α Reductase NM_175283.3 gggaaactggatacaaaataccc ccacgagctccccaaaata 41 78 
5β Reductase NM_145364.2 gaaaagatagcagaagggaaggt gggacatgctctgtattccataa 103 77 
PEPCK ENSMUST00000029017.4 gatgacattgcctggatgaa cgttttctgggttgatagcc 105 64 
GR ENSMUST00000115567.1 tgacgtgtggaagctgtaaagt catttcttccagcacaaaggt 56 78 
FTO NM_011936.2 cacagcctcggtttagttcc aatccaaggtgcctgttgag 53 60 
TATA box binding 
protein 






 2.7.5.4 Mouse Taqman® primer-probe set 
 
Primer Accession Number Reference Sequence Amplicon (nt)
Cyclophilin-A (PPiA) Mm02342430_g1 NM_008907.1 148 




2.7.6 Detection and quantification of Igf2 promoter transcripts 
 2.7.6.1 SYBR® Green quantification of Igf2 promoter transcripts 
SYBR® green is a cyanine dye that is widely used in various type of nucleic acid 
analysis (Zipper et al. 2004). Intron-spanning primers were designed by Dr. Amanda 
J. Drake (Table 2.3); with the reverse primers situated in exon 4 (code: 4R in this 
experiment) of the rat Igf2 gene. cDNA was diluted 1:20 with a standard curve 
generated as previously described in section 2.7.5.  
 
Samples were loaded in triplicate along with primers and SYBR® Green (Table 2.2) 
on to a 384 well real-time plate which was centrifuged for 2 minutes at 2000rpm. 
Using a LightCycler® 480 real time machine, the samples were rapidly heated to 
95°C for 5 minutes for denaturation then underwent 50 cycles of amplification 
process. Each cycle of amplification consists of a denaturation step at 95°C for 10 
seconds, annealing at 60°C for 20 seconds, and elongation at 72°C for 30 second. 
After the amplification, the samples underwent one cycle of melting curve formation 
at 95°C for 5 seconds, 65°C for 1 minute, a rise of temperature to 97°C and rapid 
cooling to 40°C for 10 seconds for completion. The presence of a single peak on the 
melt curve indicated a single product was formed. This was confirmed by gel 
electrophoresis. Data were analysed with the Roche LightCycler® software (ver. 







Volume per well 
cDNA (1:20) 2.5μl 
Roche SYBR® Green I 5μl 
Forward primer 0.05μl (100μM) 
Reverse primer 0.05μl (100μM) 
Nuclease free water 2.4μl 
 







Rat Igf2 promoter Primer Sequence Amplicon (nt)
P0 (Forward primer) cctgaggcaaaaccagagaa 151 
P1 (Forward primer) acttcagcagctcccacttc 123 
P2 (Forward primer) ccgctgttcggtttgcatac 102 
P3 (Forward primer) cggcctccttatccaacttc 64 
4R (Reverse primer) agcacaacatcgacttccc  
 






 2.7.6.2 Standard polymerase chain reaction for rat Igf2 promoters 
A standard PCR was done to confirm the presence or absence of transcripts from the 
different Igf2 promoters in rat fetal liver and placental labyrinth. Primers used in this 
experiment were same as for the SYBR® green experiment listed in table 2.3. Two 
random cDNA sample from each treatment group: Veh and Dex, were chosen and 
mixed together for this experiment. PCR mix was added to the cDNA mix along with 
nuclease free water, forward and reverse primers (Table 2.4) and the PCR reaction 
was performed in a G-Storm thermal cycler. Samples were rapidly heated to 95°C for 
5 minutes for denaturation then underwent 30 cycles of amplification process. Each 
cycle consists of a denaturation step at 95°C for 30 seconds, annealing at 60°C for 30 
seconds, and elongation at 72°C for 30 second. The samples were then left at 72°C 






 Volume per well 
cDNA (1:20) 0.5μl 
Promega Master PCR mix 5μl 
Forward primer 0.5μl (20μM) 
Reverse primer 0.5μl (20μM) 
Nuclease free water 3.5μl 
  




2.7.7 Western blotting 
 2.7.7.1 Protein extraction and quantification 
Approximately 50mg of fetal liver and placental labyrinth were used for protein 
extraction. Tissues were homogenised in 500μl protein lysis buffer (section 2.2) with 
protease inhibited water and NaVO4 for phosphorylated protein examination. Tissue 
homogenates were centrifuged at 14,000rpm for 15 minutes at 4°C. The supernatant 
was then transferred into a new Eppendorf™ tube and a protein quantification assay 
was performed. 
 
Protein concentration assays were performed using the Bio-Rad® protein assay kit 
using 5μl of samples. BSA standards were used at a serial dilution (10, 8, 6, 4, 2, 1, 
0.5, 0 mg/ml) to determine the concentration of individual samples. 20μl of Reagent 
S was added to each millilitre of Reagent A before use. 25μl of Reagent A and 200μl 
of Reagent B was added to each sample in duplicate in a 96-well plate. The plate was 
covered and incubated at room temperature for 15 minutes. The plate was then 
measured with a plate reader at an absorbance of 750nm. Individual sample 
concentrations were recorded. A standard curve R2>0.98 was considered satisfactory. 
 
 2.7.7.2 Protein gel electrophoresis 
Protein samples (50μg) were reconstituted with 1x NuPAGE® LDS sample loading 
buffer and 1x NuPAGE® sample reducing agent to equal volume not exceeding a 
total of 20μl. Samples were mixed gently, centrifuged briefly and incubated at 70°C 
for 10 minutes to denature protein. Samples were then loaded on to a NuPAGE® 
Novex 4 – 12 % Bis-Tris gel along with a Kaleidoscope™ protein ladder for 
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separation. A XCell Surelock™ Mini-Cell was used for this process. The central 
chamber of the XCell tank was filled with 200ml of 1x running buffer (section 2.2) 
and 1ml antioxidant solution, added immediately before use. The outer chamber was 
filled with 1x running buffer (section 2.2). The gel was run at 200V for 1 hour at RT° 
(or longer if required).  
 
 2.7.7.3 Gel transfer 
Hybond™-C extra nitrocellulose membrane with 0.45μm pores were used for the 
transfer of protein. XCell Surelock™ tank were used for this procedure. A gel 
sandwich was prepared within the cassette provided for XCell, depending on the 
amount of gel to be transferred a different gel sandwich configuration was used 
(Figure 2.3). The gel cassette was placed in the XCell tank and was filled with 1x 
transfer buffer (section 2.2) with 500μl of antioxidant solution. The outer chamber 




Figure 2.3 Gel sandwich configuration for one or two gel transfer 
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 2.7.7.4 Protein immunoblotting 
After the transfer of protein to the nitrocellulose membrane, the membrane was 
stained quickly with Ponceau-S solution to confirm successful transfer. The 
membrane was then washed with Milli-Q water to remove excess Ponceau-S and 
blocked with 5% milk (section 2.2) for 1hour. The membrane was then washed three 
times (5 minutes each) with TBST (section 2.2), then incubated with primary 
antibody (Table 2.5) at a concentration of 1:1,000 in 5% BSA solution (section 2.2) 
overnight at 4°C on a rocker. The membrane was then washed three times (5 minutes 
each) in TBST prior to secondary antibody incubation. Secondary antibody was 
made in 5% milk at a concentration of 1:10,000. The membrane was incubated on a 
rocker for 1 hour at RT°. Lastly the membrane was washed again with TBST twice (5 
minutes each) and was kept in 1x TBS (section 2.2) solution. 
 
 2.7.7.5 Blot reading 
Membranes were visualised using the Odyssey® Infrared Imaging System. A 
scanned image of the membrane was taken using the infrared imaging system and the 
density of the band measured using the Odyssey® imaging system software. 
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Primary antibody Phosphorylation site Size (kDa) Company 
IRS1 - 165 Millipore 
Phospho-IRS1 Tyr612 165 Invitrogen 
Pi3k - 85 Cell Signaling 
Phospho-Pi3k Tyr458 85 Cell Signaling 
AKT1 - 60 Cell Signaling 
Phospho-AKT1 Ser473 60 Cell Signaling 
GSK3β - 46 Cell Signaling 
Phospho-GSK3β Ser9 46 Cell Signaling 
mTOR - 289 Cell Signaling 
Phospho-mTOR Ser2448 289 Cell Signaling 
β-tubulin - 55 Invitrogen 
 
Table 2.5 Primary antibodies for immunoblotting of protein 
IRS1 = Insulin receptor substrate 1; Pi3k = Phosphoinositide 3-kinase; GSK3β = Glycogen synthase 





2.8 Histological procedures: 
2.8.1 Tissue collection: 
Rat placentas were collected at embryonic day 20 (E20), fixed in 10% neutral 
buffered formalin and kept at 4°C overnight, then transferred into 70% ethanol and 
kept at RT˚ until embedding in paraffin. Before embedding, placentas were weighed 
and halved mid-sagittally. The placentas were orientated with the cut surface facing 
up and embedded in paraffin.  
 
2.8.2 Tissue sectioning 
Embedded samples were sectioned at 7-μm thickness with a rotary microtome 
machine and MB35 blades (Thermo Fisher Scientific, Leicestershire, UK). The tissue 
were cut into a 10 section ribbon each time and laid out on a platform in sequential 
series. After the tissue has been exhaustively sectioned, a systematic random 
sampling (Gundersen and Jensen 1987) approach was used to select sections without 
bias. A total of seven sections were chosen from each sample. The selected sections 
were carefully dissected from the ribbon and placed in a water bath heated to 45°C 
then transferred to a glass slide. Slides were dried and incubated overnight at 37°C; 
the slides were then kept at RT˚ until use. 
 
2.8.3 Histological staining: 
For examination of the sections, a standard haematoxylin and eosin stain approach 
was used. Haematoxylin stains the nuclei of the cells blue and eosin counter-stains 




The slides were first de-waxed by immersing in xylene and rehydrated through a 
series of diluted ethanol. The slides were then rinsed in distilled water to remove 
excess ethanol before staining in Harris’ haematoxylin. The slides were then washed 
under running tap water and checked under a microscope for sufficient staining. The 
slides were then neutralised in alkaline tap water (section 2.2) followed by washing 
under running tap water. The slides were stain with Eosin-Y, washed under running 
tap water and dehydrated using a series of concentrated ethanol solutions. Lastly, the 
sections were then cleared with xylene. The complete procedures were outlined in 
table 2.6. Glass coverslips (VWR International, Leicestershire, UK) were mounted 
with dystyrene plasticiser and xylene (DPX) (Thermo Fisher Scientific, 





Xylene 10 minutes (x2) 
100% Ethanol 2 minutes (x2) 
95% Ethanol 2 minutes 
70% Ethanol 2 minutes 
50% Ethanol 2 minutes 
30% Ethanol 2 minutes 
Distilled water 5 minutes 
Harris’ haematoxylin 1 – 2 minutes 
Running tap water 3 minutes 
Alkaline tap water 1 minute 
Running tap water 3 minutes 
Eosin-Y (Alcoholic) 30 seconds 
30% Ethanol 10 seconds 
50% Ethanol 10 seconds 
70% Ethanol 10 seconds 
95% Ethanol 10 seconds 
100% Ethanol 2 minutes 
Xylene 5 minutes (2x) 
 




2.8.4 Slides analysis: 
In order to analyse the sections, the histologically stained tissues were visualised 
under a photographic CoolSNAP CCD camera and microscope system with liquid 
crystal RGB filter at 1.25x magnification for a full view of the placenta. Areas of the 
different zones of the placenta were measured using the software MCID Basic 7.0 
software (InterFocus Imaging Ltd., Cambridge, UK). The absolute volume was 
calculated by applying the Cavalieri principle and an estimated volume was 
established by using the following equations. The measurements and calculations 




V A   T 
 
Equation 2: 





Where in equation 1: Vi is the volume of the section; Ax is the area of the section; T 
is the thickness of the section (in this case, T = 7, as a constant number as all sections 
were cut at 7μm). 
 
Where in equation 2: V(est) is the estimated placental volume; Vi is the volume of the 
section (calculated by equation 1); Vi+1 being the volume of next section and so forth; 




2.9 Experimental diet constituents: 
Diets were purchased from Research Diets Inc., New Brunswick, New Jersey, USA 
 
 Control diet (CON) 
D12328 
Obesogenic diet (DIO) 
D12331 
 gm% kcal% gm% kcal% 
Protein 16.8 16.4 23.0 16.4 
Carbohydrate 74.3 73.1 35.5 25.5 
Fat 4.8 10.5 35.8 58.0 
Total kcal/gm 4.07  5.56  
Casein, 80 Mesh 228 912 228 912 
DL-Methionine 2 0 2 0 
Maltodextrin 10 170 680 170 680 
Corn starch 835 3340 0 0 
Sucrose 0 0 175 700 
Soybean oil 25 225 25 225 
Coconut oil (hydrogenated) 40 360 333.5 3001.5 
Mineral mix (S10001) 40 0 40 0 
Sodium bicarbonate 10.5 0 10.5 0 
Potassium citrate, 1 H2O 4 0 4 0 
Vitamin mix (V10001) 10 40 10 40 
Choline bitartrate 2 0 2 0 
Colour dye 0.1 0 0.1 0 
Total 1366.6 5557 1000.1 5558.5 
 
These two diets were chosen because the micro- and macronutrient constituents of 
the two diets were identical; the only difference being the fat, carbohydrate content, 
















Programming effects on placenta and liver 





Numerous studies in humans (Barker et al. 1989, Rich-Edwards et al. 1997) and 
animals have suggested that exposure of the fetus to an insult during a specific period 
of development may lead to programming effects on many organ systems including 
the cardiovascular system (Koenen et al. 2002, O'Regan et al. 2004, Hadoke et al. 
2006), liver and pancreas (Nyirenda et al. 1998, Dahlgren et al. 2001, Moss et al. 
2001, Drake et al. 2005), and the brain (Brabham et al. 2000, Welberg et al. 2001, 
Emgård et al. 2007). One mechanism leading to these effects may be prenatal 
exposure to excess glucocorticoid.  
 
The placenta plays a central role in modulating the transfer of nutrients, waste and 
hormones between the maternal and fetal circulation and may be a key target for 
programming effects (Langley-Evans et al. 1996, Ain et al. 2005, Fowden et al. 
2006b). Studies have suggested that nutrient transport across the placenta correlates 
with fetal growth (Fowden and Forhead 2004) supporting a potential role for this 
organ in mediating programming effects. Exposure to excess glucocorticoid during 
pregnancy has been suggested to have effects on the placenta by changing hormone 
secretion (Ain et al. 2005), nutrient transport (Hahn et al. 1999, Langdown and 
Sugden 2001, Audette et al. 2011), placental growth (Benediktsson et al. 1993, 
Ozmen et al. 2011) and placental vascular development (Hewitt et al. 2006). 
Interestingly, studies have shown that whilst administration of synthetic 
glucocorticoids to a pregnant mother causes growth restriction in the offspring, direct 
glucocorticoid administration to the fetus does not necessarily decrease birth weight 
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(Jobe et al. 1998a), suggesting an important role for the placenta in 
glucocorticoid-induced programming effects. 
 
As discussed in chapter one, Igf1 and Igf2 are two potent growth factors that are 
important in promoting fetal and placental growth and may have a role in 
programming effects. During fetal life, Igf2 has a more important role than Igf1 
(DeChiara et al. 1991). Both of these growth factors exhibit their effect by binding to 
the Igf1r and thereafter signalling a cascade of proteins downstream in the Igf 
pathway (Figure 1.6). Glucocorticoids may have direct effect on Igf2 expression 
suggesting a role for Igf2 in the glucocorticoid programmed rat (Li et al. 1998). In 
addition, it has been suggested that Igf2 may act as a ‘call for help’ signalling from 
the fetus to the placenta to increase placental nutrient transport capacity (Langdown 
and Sugden 2001, Constância et al. 2005). Therefore the Igf system may play an 
important role in programming.  
 
3.1.2 Hypothesis 
1. Overexposure to glucocorticoids in utero during the last week of gestation induces 
programming effects in the developing offspring; these programming effects may in 
part be modulated by the placenta. 





The aim of this study is to explore the possible underlying mechanisms of 
glucocorticoid programming. I will study the effects of prenatal glucocorticoid 
overexposure on gene expression in placenta and fetal liver, placental volume and 




3.2.1 Animal maintenance, treatment and tissue collection 
Female Wistar rats were time-mated at a weight of around 250g. Cages were checked 
for the presence of a vaginal plug daily each morning. Females were singly housed 
after a vaginal plug was found (denoted as E0) and were left undisturbed with ad 
libitum access to food and water. Pregnant female rats were randomly assigned to 
dexamethasone (Dex) or vehicle (Veh) treatment. Between E15 and E20 inclusive, 
pregnant females were given a subcutaneous injection each morning of either Dex in 
0.9% saline and 4% ethanol (100μg/kg body weight) or the equivalent volume of Veh 
(4% ethanol saline) (n= Veh: 9; Dex: 8).  
 
At E20, at least one hour after the final injection, pregnant females were killed by 
carbon dioxide asphyxiation. Maternal blood was collected by cardiac puncture into 
a 0.5M EDTA rinsed 2ml syringe. Fetal blood was collected into Microvette® 
CB-300 tubes after decapitation. Blood was placed on wet ice until centrifugation 
(5000 rpm, 10 mins, 4°C) and plasma removed and frozen at -20°C. Fetuses and 
placentas were dissected and weighed. Placentas were either fixed in 10% neutral 
buffered formalin, stored overnight in 4°C and transferred into 70% ethanol and kept 
at RT° until embedding in paraffin or dissected into labyrinth and junctional layers. 





3.2.2 Metabolic experiments 
Fetal plasma was pooled from all fetuses within a litter. Non-fasting plasma glucose 
was measured using an enzymatic (hexokinase) method (Thermo Fisher Scientific); 
plasma insulin was measured using an ELISA kit (Crystal Chem Inc.). 
 
3.2.3 Molecular experiments 
Total mRNA was extracted from fetal liver and placental labyrinth using RNeasy® 
mini kit (Qiagen) and reverse transcribed (Promega) to produce cDNA. Quantitative 
real-time PCR was used to examine gene expression by TaqMan™ (Applied 
Biosystems) or self designed UPL (Roche) primers with the addition of MasterMix 
(Roche). The expression levels of different Igf2 transcripts was examined by 
quantitative real-time PCR using SYBR® green and primers designed by Dr. 
Amanda J. Drake. The presence of different Igf2 transcripts in fetal liver and 
placenta was assessed by gel electrophoresis (2% TBE agarose gel with 1kb DNA 
ladder at 100V for 1 hour) following PCR. Expression of genes was normalised to 
the average of two reference genes Cyclophilin-A and Tata box binding protein (TBP) 
in placental labyrinth and to Cyclophilin-A in the fetal liver. 
 
Fetal liver and placental labyrinth were both weighed and protein extracted for 
Western Blot analysis of protein levels. In particular, proteins involved in the Igf 
pathway were explored. Total protein is expressed relative to the control protein: 




3.2.4 Placental stereology procedures 
Paraffin embedded placentas were thoroughly sectioned at 7μm per section. Sections 
were then fixed on glass slides, stained with haematoxylin and counter-stained with 
eosin. Stained sections were examined under a microscope with a CCD camera at 
1.25x magnification. Areas of the two different zones, labyrinth and junctional, were 
measured by MCID Basic 7.0 software (InterFocus Imaging Ltd., Cambridge, UK), 
and volumes calculated. Ratio of volumes were in relation to total placental volume 
measured. Part of this work was performed by Ms. Fiona E. Graham, as part of an 
Honours project for the University of Edinburgh. This experiment was with the 
assessor blinded as to prenatal exposure. 
 
3.2.5 Glycogen measurement in the placenta 
Placental labyrinth and junctional zones were weighed and glycogen levels measured 
using the colourimetric method used for measuring plasma glucose. Glycogen levels 
are expressed relative to the amount of protein per gram of placenta. 
 
3.2.6 Statistical analysis 
Data were analysed using SPSS® and GraphPad®. Statistical significance was 
calculated using Student’s t-test or Mann-Whitney u-test when the distribution of 
data was non-parametric. Data are expressed as mean ± SEM unless otherwise stated. 






3.3.1 Mother (F0) and F1 offspring 
Pregnant females exposed to Dex gained less weight compared to Veh exposed 
females; at E20, F0 Dex mothers were lighter than F0 Veh mothers (Figure 3.1), this 
is in line with previous findings (Simpson et al. 1974, LaBorde et al. 1992). 
 
Offspring of mothers treated with Dex (F1 Dex, n=113 from 8 litters) were 
significantly lighter than mothers treated with Veh (F1 Veh, n=119 from 9 litters) at 
E20 (Figure 3.2). The placentas of F1 Dex offspring (n=112) were also significantly 
lighter compared to F1 Veh offspring (n=119) (Figure 3.2). These results are in 
agreement with previous studies of prenatal glucocorticoid over-exposure 
(Langdown and Sugden 2001, Ain et al. 2005, Ozmen et al. 2011). There was no 
difference in the number of pups per litter between the two treatment groups (Figure 
3.2).  
 
There was no difference in maternal non-fasted plasma glucose levels, however, Dex 
increased maternal non-fasted plasma insulin levels (Figure 3.3a). In contrast, Dex 
exposure was associated with decreased fetal insulin levels in the absence of any 















































Figure 3.1 Maternal weight gain during pregnancy and maternal weights at E20 
Dex exposure decreased A) maternal weight gain during the last week of gestation so 
that B) Dex treated F0 females were lighter at E20 
Data are mean ± SEM, analysed by Student’s t-test 
n = Veh: 8, Dex: 9 
* = p<0.05, **= p<0.01 
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Figure 3.2 F1 offspring fetal and placental weights and litter size 
Prenatal Dex exposure decreased A) pup weight and B) placental weight at E20. C) 
There was no difference in litter size 
Data are mean ± SEM, analysed by Student’s t-test 
n = Fetus Veh: 79, Dex: 74 
Placenta Veh: 79, Dex: 73 
Litter Veh: 9, Dex: 8 





















































































Figure 3.3 Maternal and fetal glucose and insulin levels at E20 
There were A) no differences in F0 maternal plasma glucose but increased maternal 
insulin levels in Dex exposed animals at E20. B) In the fetuses, there were no 
differences in fetal glucose but decreased fetal insulin levels in Dex exposed animals 
at E20 
Data are mean ± SEM, glucose analysed by Students t test and insulin by 
Mann-Whitney u-test as it was not normally distributed 
n = Maternal  Veh: 9, Dex: 8 
 Fetal  Veh: 9, Dex: 8 




3.3.2 F1 fetal liver gene expression 
Dex exposure resulted in increased Igf2 gene expression in fetal liver (Figure 3.4a). 
This reflected an increase in the expression of mRNA transcripts from the three Igf2 
promoters: P1, P2, and P3 (Figure 3.5). There appeared to be no transcripts from the 
P0 promoter in fetal liver (Figure 3.8). Dex also resulted in increased mRNA 
expression of IRS1 and AKT1 (Figure 3.4a). 
 
Expression of IgfBP2 was also increased in Dex exposed offspring (Figure 3.4a) 
although there were no differences in the expression of Igf1, Igf1r, Igf2r and IgfBP3 
(Figure 3.4a). The expression of the potent growth inhibitors CDKn1c and Grb10 
were both increased in liver of offspring exposed to Dex. No difference was seen in 






























































































Figure 3.4 Gene expression in F1 fetal liver at E20 
Dex exposure was associated with A) increased expression of genes in the Igf 
pathway: Igf2, IgfBP2, IRS1, AKT1 and with B) increased expression of the 
imprinted genes CDKn1c, and Grb10 in fetal liver at E20 
Data are mean ± SEM, all data analysed by Student’s t-test except Igf1 and CDKn1c 
which were analysed by Mann-Whitney u-test 
n = Veh: 12, Dex: 12 































Figure 3.5 Expression of transcripts from Igf2 promoters in fetal liver 
Dex exposure increased expression of transcripts from Igf2 promoters P1, P2, and P3 
in fetal liver at E20 
Data are mean ± SEM, analysed by Student’s t-test 
n = Veh: 12, Dex: 12 




3.3.3 F1 placental labyrinth gene expression 
In contrast to the pattern of gene expression in fetal liver, the expression of Igf2 was 
decreased in Dex exposed offspring placenta (Figure 3.6a); this reflected a decrease 
in expression of transcripts from the P0 (exclusively expressed in placenta) 
(Nyirenda et al. 1998, Langdown and Sugden 2001, Constância et al. 2002, Drake et 
al. 2005), P1, and P2 promoters (Figure 3.8). No difference was seen in transcript 
levels from the P3 promoter (Figure 3.8). The presence of transcripts from the P0 
promoter in placental labyrinth was confirmed on gel electrophoresis (Figure 3.9). 
Dex exposure was associated with an increase in the expression of IRS1 but not in 
the expression of AKT1 (Figure 3.6a). 
 
Despite the reduction in the size of the placenta, Dex exposure was associated with 
an increase in the mRNA expression of the system A amino acid transporters: 
Slc38a2 and Slc38a4 as well as increased expression of the glucose transporters: 
Glut1 and Glut3 (Figure 3.7). There was a trend to an increase in the expression of 
the amino acid transporter Slc38a1 (p=0.057) in Dex exposed placentas (Figure 3.7). 
There were no differences in the mRNA expression of the organic cation transporters: 
Slc22a1 and Slc22a3 (Figure 3.7) or in the expression of the imprinted genes Igf2r, 


























































































Figure 3.6 Expression of genes in E20 placental labyrinth 
Dex exposure was associated with A) increased expression of genes in the Igf 
signalling pathway: Igf1r and IRS1 and with decreased expression of Igf2 in 
placental labyrinth at E20. B) No differences were found in the expression of a 
number of imprinted genes important in growth 
Data are mean ± SEM, analysed by Student’s t-test 
n = Veh: 12, Dex: 12 






















































Figure 3.7 Expression of nutrient transporters in E20 placental labyrinth 
Dex exposure increased expression in Slc38a2, Slc38a4, Glut1, Glut3 and was 
associated with a trend for an increased expression of Slc38a1 in placental labyrinth 
at E20 
Data are mean ± SEM, analysed by Student’s t-test 
n = Veh: 12, Dex: 12 






























Figure 3.8 Expression of transcripts from Igf2 promoters in placental labyrinth 
Dex exposure decreased expression of transcripts from Igf2 promoters P0, P1, and 
P2 in placental labyrinth at E20 
Data are mean ± SEM, analysed by Student’s t-test 
n = Veh: 12, Dex: 12 








Figure 3.9 Gel electrophoresis of Igf2 transcripts from P1, P2, P3, and P0 promoters in 
E20 fetal liver and placental labyrinth 




3.3.4 F1-E20 placental stereology 
Despite the Dex-induced reduction in placental size (Figure 3.2b), the area, and thus 
the volume of the placental labyrinth (Figure 3.10a) and junctional zone (Figure 










































Figure 3.10 Ratio of the volume of labyrinth and junctional zones in placenta at E20 
There was no difference in the ratio of volume of A) labyrinth and B) junctional 
zones between groups in relation to total placental volume 
Data are mean ± SEM, analysed by Student’s t-test 
n = Veh: 11, Dex: 16 




3.3.5 F1 placental glycogen 
No differences were seen in the amount of glycogen in placental labyrinth or 















































Figure 3.11 Glycogen levels in placental labyrinth and junctional zones at E20 
There was no difference in glycogen level in A) labyrinth and B) junctional zones 
between groups 
Data are mean ± SEM, analysed by Student’s t-test 
n = Labyrinth  Veh: 7, Dex: 8 




3.3.6 Western blot analysis of proteins involved in the Igf2 signalling 
pathway in placental labyrinth 
Protein levels of pIRS1 and pmTOR were both elevated in placental labyrinth with 
Dex exposure. In contrast, prenatal Dex exposure was associated with a reduction in 























































Figure 3.12 Placental labyrinth Igf2 pathway proteins 
Increased protein level of pIRS1, pmTOR and decreased level of pAKT1 and 
pGSK3β were found in placental labyrinth of Dex exposed animals at E20 
Data are mean ± SEM, all genes analysed by Student’s t-test except pIRS1 which 
was analysed by Mann-Whitney u-test 
n = Veh: 7, Dex: 7 





Figure 3.13 Representative blots of placental labyrinth Igf2 pathway proteins 
IRS1 = Insulin receptor substrate 1; pIRS1 = Phosphorylated IRS1 (Tyr612); Pi3k = Phosphoinositide 
3-kinase; pPi3k = Phosphorylated Pi3k (Tyr458); pAKT1 = Phosphorylated AKT1 (Ser473); GSK3β = 
Glycogen synthase kinase 3β; pGSK3β = Phosphorylated GSK3β (Ser9); mTOR = Mammalian target 
of rapamycin; pmTOR = Phosphorylated mTOR (Ser2448) 
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3.3.7 Western blot analysis of proteins involved in the Igf2 signalling 
pathway in fetal liver 
Phosphorylated GSK3β protein levels were increased with Dex exposure. No 
difference was seen in phosphorylated AKT1 (Figure 3.14 and 3.15). Protein levels 





































Figure 3.14 Fetal liver Igf2 pathway proteins 
Dex exposure increased protein levels of pGSK3β in fetal liver at E20 
Data are mean ± SEM, analysed by Student’s t-test 
n = Labyrinth Veh: 7, Dex: 7 






Figure 3.15 Representative blots of fetal liver Igf2 pathway proteins 
IRS1 = Insulin receptor substrate 1; pIRS1 = Phosphorylated IRS1 (Tyr612); Pi3k = Phosphoinositide 
3-kinase; pPi3k = Phosphorylated Pi3k (Tyr458); pAKT1 = Phosphorylated AKT1 (Ser473); GSK3β = 
Glycogen synthase kinase 3β; pGSK3β = Phosphorylated GSK3β (Ser9); mTOR = Mammalian target 





These results demonstrate that prenatal Dex exposure is associated with effects on 
both fetus and placenta. The reduction in fetal and placental weights with Dex 
exposure are consistent with previous reports (Langdown and Sugden 2001, Ain et al. 
2005). These results suggest that the programming effects of prenatal glucocorticoid 
overexposure may, at least in part, be due to alterations in placental growth and 
function. 
 
Decreased maternal weight gain during the last week of pregnancy was also observed 
and is consistent with previous reports (Ain et al. 2005). This reduction in maternal 
weight gain is not due to a reduction in litter size as no difference was seen in pup 
number. One possible explanation for this could be the direct effect of Dex on eating 
behaviour. It has been shown previously that a single dose of Dex treatment in rats 
can result in anorexic behaviour within 24 hours and reduce weight gain (Simpson et 
al. 1974). This is an important finding as lower gestational weight gain has been 
linked to an increased risk of giving birth to small for gestational age babies (Nohr et 
al. 2008, Margerison Zilko et al. 2010). 
 
An increase in plasma insulin levels was noted in non-fasted plasma of Dex exposed 
mothers. An increase in insulin levels is a known effect of chronic glucocorticoid 
treatment and has been observed in both animals and humans (Lenzen and Bailey 
1984). In contrast, a reduction in fetal insulin levels was seen with Dex exposure. 
Previous studies have suggested that fetal overexposure to glucocorticoid may impair 




pancreas (Blondeau et al. 2001). Insulin has long been linked to fetal growth as 
pregnant women with diabetes are at risk of giving birth to babies that are larger in 
size (Ehrenberg et al. 2004). This increase in fetal growth appears to be related to the 
level of maternal blood glucose which stimulates fetal insulin production (Tallarigo 
et al. 1986, Farmer et al. 1988). In this study, the finding of reduced fetal insulin in 
Dex exposed animals may contribute to the decreased weight in offspring exposed to 
Dex in utero. 
 
Igf2 has been suggested to be one of the most important growth factors during fetal 
life (Randhawa and Cohen 2005). In the Igf2 knockout mouse, fetal growth was 
reduced by 40 – 50% and placental growth by about 60% (DeChiara et al. 1990, 
Coan et al. 2008b). In this study, I have shown that despite a reduced weight at E20 
in offspring exposed to Dex, there was an increase in Igf2 mRNA expression in the 
fetal liver. However, there was also an increase in the expression of IgfBP2, which 
primarily acts to inhibit the actions of Igfs particularly Igf2 (Jones and Clemmons 
1995, Firth and Baxter 2002). Studies in pigs have shown that despite an increase in 
hepatic Igf2 mRNA expression in IUGR piglets in utero, IgfBP2 mRNA expression 
is also increased (Kampman et al. 1993) and previous studies in rodents have 
reported increased Igf2 and IgfBP2 gene expression in Dex exposed fetal liver (Price 
et al. 1992). Along with the increase in IgfBP2 which may counteract the actions of 
Igf2, I also found an increase in the expression of the potent growth inhibitors 
CDKn1c and Grb10 in Dex exposed fetal liver. CDKn1c has been suggested to be the 
major regulator of fetal growth within its domain which contains other imprinted 




proliferation and when over-expressed, has been linked to a reduction in growth 
(Andrews et al. 2007). Interestingly, CDKn1c has a glucocorticoid response element 
5kb upstream of its promoter site, suggesting that glucocorticoids may regulate the 
expression of this gene directly (Alheim et al. 2003). Grb10 is able to interact with 
receptor tyrosine kinases and may also play an important role in fetal and placental 
growth. Loss of function of Grb10 results in fetal and placental overgrowth, 
suggesting a role for this gene as a growth suppressor (Charalambous et al. 2003). 
Thus, the effects of Dex exposure on fetal growth may reflect a complex interaction 
between the expression of genes promoting and repressing fetal growth. The 
interaction between the imprinted genes in the fetal liver also mirrors the parental 
conflict hypothesis, which suggests that maternally expressed genes act to restrict 
growth, whereas paternally expressed genes act to enhance growth (Moore and Haig 
1991). In this study, there was an increase in the expression of the maternally 
expressed genes, CDKn1c and Grb10 which may act to suppress growth and the 
paternally expressed gene, Igf2 which would be predicted to enhance growth. The 
increased expression of Igf2 may reflect an attempt to compensate for the growth 
retardation caused by CDKn1c and Grb10 (Caspary et al. 1999, Grandjean et al. 
2000).  
 
In the placental labyrinth, the expression of mRNA encoding several nutrient and 
glucose transporters important in growth was increased with Dex exposure, including 
Slc38a2, Slc38a4, Glut1, and Glut3. This is consistent with previous reports of the 
effects of glucocorticoid overexposure on the expression of nutrient transporters 




of Dex exposure on the mRNA expression of these nutrient transporters after Dex 
exposure, but found increased nutrient transport (Audette et al. 2011). The 
discrepancy reported between this last study and the others could be a consequence 
of the time-point of glucocorticoid exposure, since studies that showed a difference 
in mRNA expression involved exposure of the mother to glucocorticoids during the 
last week of gestation, whereas Audette et al. performed the study at mid-gestation.  
 
It has been proposed that smaller placentas may be more efficient in providing 
nutrients to the fetus (Coan et al. 2008a) and may be able to adapt to the increasing 
fetal demands by up-regulating the nutrient transfer capability (Constância et al. 
2005). Indeed, it has also been proposed that an increase in fetal Igf2 expression may 
be a “call for help” from the fetus, signalling to the placenta to increase nutrient 
supply from the mother (Constância et al. 2005, Coan et al. 2008a). Thus, the 
increased expression of the nutrient and glucose transporters Slc38a2, Slc38a4, Glut1 
and Glut3 in the Dex exposed placentas may reflect this increased demand from the 
fetus in Dex exposed animals mediated by Igf2. In contrast to the findings in fetal 
liver, the expression of Igf2 was decreased in the placental labyrinth. The levels of 
transcripts from three of the four promoters: P0, P1, and P2 of Igf2 was also 
decreased in placental labyrinth. The P0 promoter of the Igf2 gene has been shown to 
be placenta specific and acts as a major modulator of placental and fetal growth 
(Constância et al. 2002).  
 
The exact function of glycogen stored in the placenta remains to be determined. 




placenta’s own needs (Barash and Shafrir 1990), whilst others have suggested that it 
may be used for fetal growth and survival (Selye and McKeown 1935, Bouillot et al. 
2006, Leonce et al. 2006, Esquiliano et al. 2009). The majority of the glycogen in the 
placenta is stored in the cytoplasm of the glycogen cells, which migrate to the 
junctional zone close to the end of pregnancy (Tunster et al. 2010). In the current 
study, no difference was seen in glycogen levels between Dex and Veh in either the 
placental labyrinth or the junctional zone. It has been suggested recently that Phlda2 
may be a major regulator of glycogen storage in the placenta (Tunster et al. 2010) so 
that the lack of change in glycogen levels are consistent with the lack of change in 
Phlda2 gene expression. 
 
Due to the important role of Igf2 in fetal and placental growth, I measured the 
protein levels of important components of the Igf2 signalling pathway which play an 
important role in cellular growth and protein synthesis. In the placental labyrinth, 
pIRS1 and pmTOR were both increased with Dex exposure, whereas pAKT1 and 
pGSK3β were decreased and no difference was seen in pPi3k. Upon insulin 
stimulation, IRS1 is phosphorylated and activates downstream Pi3k/AKT pathways 
(Esposito et al. 2001, Gual et al. 2005). Thus, the rise in pIRS1 level seen in 
placental labyrinth with Dex exposure may be due to a direct effect of increased 
maternal circulating insulin. Although activation of IRS1 through phosphorylation 
would be expected to increase placental growth, Dex exposed placentas were smaller. 
One mechanism for this may be the decrease in the level of activated phosphorylated 
AKT1 and the lack of change in activation of Pi3k through phosphorylation. GSK3β 




associated with activation of this protein (Welsh and Proud 1993, Welsh et al. 1996). 
The activation of GSK3β would result in deactivation of glycogen synthase and 
therefore reduced glycogen synthesis. The increased phosphorylation of mTOR may 
be a consequence of the increase in nutrient transport which would be predicted to 
occur in Dex exposed placentas, since it has been suggested that mTOR can be 
regulated by the presence of nutrients, especially amino acids (Roos et al. 2009). 
Therefore, the observed change in mTOR could be independent of Igf signalling. In 
the fetal liver, no difference was seen in pAKT1 but an increase was seen in pGSK3β 
in offspring exposed to Dex. IRS1 and mTOR protein was present at very low levels. 
The phosphorylation, and therefore activation, of these two proteins was also seen at 
very low levels and phosphorylation of Pi3k was not seen. Previous work has 
demonstrated that these proteins are indeed present at extremely low levels in fetal 
liver (Anand et al. 2002, Khamzina et al. 2003).  
 
From this study, it is clear that exposure to Dex during the last week of gestation in 
rats is associated with tissue-specific effects on both fetus and placenta. One 
explanation for these tissue-specific effects is that during the last week of gestation, 
the growth of the fetus and the fetal liver is at its maximal rate; whereas the lifespan 
of the placenta is coming to an ‘end’, therefore, it is likely that the fetus and the 
placenta were ‘insulted’ by Dex at different points in the lifespan of the organ leading 
to different outcomes. Additionally, glucocorticoids may act to induce epigenetic 
changes directly by modifying DNA methylation patterns (Thomassin et al. 2001) 
and changing chromatin conformation (Fryer and Archer 1998). The patterns of DNA 




glucocorticoid induced effects on DNA methylation may result in tissue-specific 
effects. 
 
In conclusion, this study has demonstrated that glucocorticoid overexposure during 
the final week of pregnancy in the rat results in effects on fetal weight, placental 
weight, placental gene expression and function, and fetal liver gene expression. The 
precise mechanisms underlying these effects remain to be determined but may 

















Intergenerational programming in the  





Previous studies from our group and others have provided evidence that 
programming effects may be transmissible to a second generation (F2) in the absence 
of a direct exposure to an insult. As discussed in chapter 1, this phenomenon has 
been reported in both humans and animals. Epidemiological studies in humans have 
provided evidence for intergenerational effects on birth weight (Klebanoff et al. 1984, 
Emanuel et al. 1992, Collins et al. 2003) and obesity (Labayen et al. 2010), 
cardiovascular (Davey Smith et al. 1997, Walker et al. 1998, Kuznetsova et al. 2003, 
Bunt et al. 2005, Labayen et al. 2010) and type 2 diabetes risk (Dabelea et al. 2000, 
Hyppönen et al. 2003, Dabelea et al. 2008). Similar results have been reported in 
animal studies with a number of studies showing evidence for multigenerational 
effects occurring as a consequence of prenatal exposure to a low protein diet, 
including effects on birth weight (Snoeck et al. 1990, Benyshek et al. 2008), the 
pancreas (Snoeck et al. 1990), brain development (Stewart et al. 1975, Hoet and 
Hanson 1999), nephrogenesis and renal function (Langley-Evans et al. 1999, Watkins 
et al. 2010), blood pressure (Langley Evans and Jackson 1994, Harrison and 
Langley-Evans 2009), and glucose homeostasis (Benyshek et al. 2006). Early 
postnatal exposure to dietary manipulations has also been shown to have 
multigenerational effects on pancreatic function, insulin secretion, and insulin 
sensitivity (Laychock et al. 1995, Srinivasan et al. 2003, Benyshek et al. 2004). In 
most of these studies, similar phenotypes were observed in both F1 and F2 
generations even though the F2 offspring were not directly exposed to the ‘insult’. 
Additionally, in a number of these ‘across generation’ studies, effects have been 
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demonstrated to be passed through either the maternal (Drake et al. 2005, Zambrano 
et al. 2005, Burdge et al. 2007, Skinner et al. 2008) or paternal (Anway et al. 2005, 
Drake et al. 2005, Kaati et al. 2007) lines. 
 
We have previously shown multigenerational effects on birth weight and glucose 
homeostasis in the Dex programmed rat (Drake et al. 2005). In the previous chapter, 
I showed effects in the placenta and fetus in F1 offspring directly exposed to Dex 
treatment during the last week of gestation. Here I have explored effects on the 
placenta and fetal liver in a second (F2) generation. 
 
4.1.2 Hypothesis 
I hypothesise that overexposure to glucocorticoids during the last week of gestation 
may induce programming effects not only in the developing offspring but also in the 
grand offspring. I also hypothesise that the underlying mechanisms of programming 
between the two generations are different, as the exposure to glucocorticoids occurs 
at different stages of development. 
 
4.1.3 Aims 
The aim of this study was to explore whether the effects of prenatal glucocorticoid 
overexposure differ in the F1 and F2 generations. This will be achieved by studying 
fetal and placental size and gene expression in the F2 generation at the same time 





4.2.1 Animal maintenance, treatment, tissue collection, and offspring 
production 
Female Wistar rats were time mated with a stud Wistar male when they weighed 
around 250g. The presence of a vaginal plug was checked daily in the morning. The 
females were singly housed after a vaginal plug was found (denoted as E0) and were 
left undisturbed with ad libitum access to food and water. Pregnant female rats were 
randomly assigned to Dex or Veh treatment. On E15, pregnant females were given a 
subcutaneous injection of either Dex in 0.9% saline and 4% ethanol (100μg/kg body 
weight) or an equivalent volume of Veh (1ml/kg). The injection was given every day 
in the morning from E15 to E21 inclusive after weighing the animals.  
 
Litters (F1 Veh and F1 Dex) were weighed at birth and culled back to eight per group. 
Pups were reared by their biological mother until three weeks of age and were then 
weaned and housed with animals from the same treatment group. When F1 females 
weighed around 250g, they were housed singly with an F1 male from a different 
litter of either the same or a different treatment group. This lead to the production of 
four different groups: F1 Veh female x F1 Veh male (VV), F1 Veh female x F1 Dex 
male (VD), F1 Dex female x F1 Veh male (DV), and F1 Dex female x F1 Dex male 
(DD) (Figure 2.1). 
 
At E20, F1 pregnant females were killed by carbon dioxide asphyxiation. Maternal 
blood was collected by cardiac puncture into a 0.5M EDTA rinsed 2ml syringe. Fetal 
blood was collected into Microvette® CB-300 tubes after decapitation. Blood was 
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placed on wet ice until centrifugation (5000 rpm, 10 mins, 4°C) and plasma removed 
and frozen at -20°C. Fetuses and placentas were dissected and weighed. Placentas 
were either fixed in 10% neutral buffered formalin, stored overnight in 4°C and 
transferred into 70% ethanol and kept at RT° until embedding in paraffin or dissected 
into labyrinth and junctional layers. Fetal liver was dissected. Dissected tissues were 
snap frozen on dry ice and stored at -80°C. 
 
4.2.2 Metabolic experiments 
Fetal plasma was pooled from all fetuses within a litter. Non-fasting plasma glucose 
was measured using an enzymatic (hexokinase) method (Thermo Fisher Scientific); 
plasma insulin was measured using an ELISA kit (Crystal Chem Inc.). 
 
4.2.3 Molecular experiments 
Total mRNA was extracted from fetal liver and placental labyrinth using the 
RNeasy® mini kit (Qiagen) and reverse transcribed (Promega) to produce cDNA. 
Quantitative real-time PCR was used to examine gene expression by TaqMan™ 
(Applied Biosystems) or self designed UPL (Roche) primers with the addition of 
MasterMix (Roche). The expression levels of different Igf2 transcripts was examined 
by quantitative real-time PCR using SYBR® green and primers designed by Dr. 
Amanda J. Drake. The presence of different Igf2 transcripts in fetal liver and 
placenta was assessed by gel electrophoresis (2% TBE agarose gel with 1kb DNA 
ladder at 100V for 1 hour) following PCR. Expression of all genes examined in 
placental labyrinth were normalised to the average of two reference genes 
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Cyclophilin-A and Tata box binding protein (TBP) and to Cyclophilin-A in the fetal 
liver. 
4.2.4 Placental stereology procedures 
Paraffin embedded placentas were thoroughly sectioned at 7μm per section. Sections 
were then fixed on glass slides, stained with haematoxylin and counter-stained with 
eosin. Stained sections were examined under a microscope with a CCD camera at 
1.25x magnification. The areas of the two different zones, labyrinth and junctional, 
were measured by MCID Basic 7.0 software (InterFocus Imaging Ltd., Cambridge, 
UK), and volumes calculated. Ratio of volumes were in relation to total placental 
volume were measured. This experiment was performed with the assessor blinded to 
experimental groups. 
 
4.2.5 Statistical analysis 
Data were analysed by using SPSS® and GraphPad®. Statistical significance was 
calculated using Student’s t-test, two-way ANOVA, Chi-Square test, or Pearson’s 
correlation and is expressed as mean ± SEM unless otherwise stated. Results were 






4.3.1 F1 cohort 
No difference was seen in length of gestation or litter size between females receiving 
Dex (F0 Dex) or Veh (F0 Veh) (Table 4.1). Offspring of Dex treated mothers (F1 Dex) 
were lighter than Veh (F1 Veh). At weaning, both F1 Dex males (Table 4.2) and F1 
Dex females (Table 4.2) were lighter than Veh males and females respectively. 
 
4.3.2 F2 cohort 
Difficulties were encountered when setting up F1 Dex females to plug with F1 Veh 
males (DV) as well as F1 Veh females to plug with F1 Dex males (VD). Both these 
groups took longer to mate and had higher rate of failed pregnancy after confirmation 
of the presence of vaginal plug (Table 4.3). Possible reasons for this are discussed 
below in section 4.4. At E20, analysis by two‐way ANOVA showed an effect of 
maternal prenatal Dex exposure to increase fetal weight (p<0.001; F=16.67) and 
paternal prenatal Dex exposure to decrease fetal weight (p<0.05; F=4.09) (Figure 
4.1a). For the placenta, maternal prenatal Dex exposure was associated with 
increased placental weight (p<0.001; F=11.25), and paternal prenatal Dex exposure 
with decreased placental weight (p<0.001; F=13.55) (Figure 4.1b). At birth, weight 
was decreased in DD, DV and VD offspring, with the VD group having the lowest 
weight (Figure 4.1c). No difference was seen in the number of pups per litter across 
the four groups (Table 4.3). There were no differences in glucose and insulin levels 
in non-fasted plasma from the F1 mothers at E20 (Figure 4.2a). There were also no 




Table 4.1 F0 maternal cohort 
No difference in gestation length and litter size 
Data are mean ± SEM, analysed by Student’s t-test 
n = Gestation length Veh: 8, Dex: 9 






 F1 Veh F1 Dex p value 
Birth weight (g)    
     Male 6.761 ± 0.09 5.897 ± 0.11 < 0.0001 
     Female 6.434 ± 0.09 5.541 ± 0.08 < 0.0001 
Wean weight (g)    
     Male 68.08 ± 1.56 61.42 ± 1.21 < 0.01 
     Female 64.30 ± 1.44 60.37 ± 1.08 < 0.05 
 
Table 4.2 F1 cohort for 8 litters per group 
Offspring exposed to Dex were significantly lighter at birth and at weaning 
Data are mean ± SEM, analysed by Student’s t-test 
 
 
 F0 Veh F0 Dex p value 
Gestation length (days) 22.50 ± 0.18 22.67 ± 0.16 0.51 




Table 4.3 F2 cohort – pregnancy setup 
Chi-Square analysis of observed versus expected plugs: Chi-square 12.79; p<0.05 
and Chi-square analysis of observed versus expected pregnancies following 
successful plugging: Chi-square 2.13; p=0.5 
Data for litter size were mean ± SEM, analysed by two-way ANOVA 
 
 
 VV DD DV VD 
Setup to plug 14 13 21 22 
Successful plug 9 10 10 12 
Plug percentage 64.28% 76.92% 47.61% 54.54% 
Successful pregnancy 9 8 8 8 
Pregnancy percentage 100.00% 80.00% 80.00% 66.66% 
Litters with reabsorption sites 0 0 1 3 
Litter size 14.1 ± 0.9 13.1 ± 1.5 11.7 ± 0.8 13.4 ± 2.0
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Figure 4.1 F2 weights of A) fetus, B) placenta, and C) at birth 
There was an effect of maternal prenatal Dex exposure to increase fetal and placental 
weight at E20; an effect of paternal prenatal Dex exposure effect to reduce fetal and 
placental weight at E20 and weight at birth; and an interaction between parental 
prenatal Dex exposure to reduce weight at birth 
Data are mean ± SEM, analysed by two-way ANOVA 
n = Fetuses  VV: 127, DD: 91, DV: 94, VD: 106 
 Placentas  VV: 126, DD: 91, DV: 94, VD: 106 
 Pups  VV: 109, DD: 110, DV: 109, VD: 84 
a = Maternal prenatal Dex exposure effect to increase, b = Paternal prenatal Dex 
exposure effect to decrease, c = Interaction between parental prenatal Dex exposure 

































































Figure 4.2 Maternal and fetal glucose and insulin at E20 
There was A) no difference in F1 maternal plasma glucose and insulin levels in all 
four groups at E20 and B) no difference in F2 fetal plasma glucose and insulin levels 
in all four groups at E20 
Data are mean ± SEM, analysed by two-way ANOVA 
n = Maternal and fetal glucose 6 per group 





4.3.3 F2-E20 fetal liver gene expression 
At E20, there was an interaction between maternal and paternal prenatal Dex 
exposure to decrease the mRNA expression of Igf2 (p<0.05; F=5.66) and Phlda2 
(p<0.05; F=6.62); an interaction between maternal and paternal prenatal Dex 
exposure to increase IgfBP2 (p<0.05; F=6.15) mRNA expression; and an effect of 
paternal prenatal Dex exposure to decrease IgfBP3 (p<0.05; F=4.62) mRNA 
expression (Figure 4.3). No difference was seen in the expression of Igf1, CDKn1c, 
Grb10 (Figure 4.3), or in the mRNA expression levels of transcripts from the three 
promoters of Igf2 (P1, P2, P3) (Figure 4.4a). There was a significant correlation 
between the expression of the three Igf2 promoters and total Igf2 (Figure 4.4b). No 
expression of a transcript from the P0 promoter of Igf2 was seen in fetal liver as 
expected. 
 
4.3.4 F2-E20 placental labyrinth gene expression 
In the placental labyrinth, there was an effect of prenatal maternal Dex exposure to 
increase the expression of IgfBP2 (p<0.01; F=6.85), Mest (p<0.05; F=6.33), Slc38a4 
(p<0.05; F=5.33), Glut1 (p<0.01; F=10.11), and Slc22a3 (p<0.01; F=7.78); and a 
trend for an increase in the expression of Slc38a1 (p=0.058; F=3.89) (Figure 4.5a, b 
and 4.6). There was an effect of paternal prenatal Dex exposure effect to increase 
mRNA expression of CDKn1c (p<0.05; F=6.41), Phlda2 (p<0.05; F=6.08), and 
Slc22a1 (p<0.05; F=6.28) (Figure 4.5b and 4.6). No differences were seen in the 
expression of Slc38a2, Igf2, Igf2r, IgfBP3, Grb10 (Figure 4.5a, b and 4.6), or in the 
transcripts from all four Igf2 promoters (P0, P1, P2, P3) (Figure 4.7a). There was a 
significant correlation between the expression of all four Igf2 promoters and total 






















































Figure 4.3 F2-E20 fetal liver gene expression 
There was an interaction between parental prenatal Dex exposure effect to reduce 
expression of Igf2 and Phlda2; an interaction between parental prenatal Dex 
exposure effect to increase expression of IgfBP2; and a paternal prenatal Dex 
exposure effect to decrease expression of IgfBP3 
Data are mean ± SEM, analysed by two-way ANOVA 
n = VV: 9, DD: 7, DV: 8, VD: 8 
a = Parental interaction of prenatal Dex exposure to decrease, b = Parental interaction 
































  B) 























Figure 4.4 F2 fetal liver Igf2 promoter transcript levels and correlation 
There was A) no difference in the level of mRNA transcripts of all three promoters in 
fetal liver at E20 but B) there is a positive correlation between total Igf2 expression 
and all three promoter transcripts. The significance of the correlation between total 
Igf2 expression and all three promoter transcripts (P1, P2, P3) was p<0.001 
Data are mean ± SEM, analysed by two-way ANOVA and Pearson’s correlation 
n = VV: 9, DD: 7, DV: 8, VD: 8 
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Figure 4.5 F2 placental labyrinth Igf pathway and imprinted gene expression 
There was a paternal prenatal Dex exposure effect to increase expression of CDKn1c 
and Phlda2; and a maternal prenatal Dex exposure effect to increase expression of 
Mest and IgfBP2 
Data are mean ± SEM, analysed by two-way ANOVA 
n = VV: 9, DD: 7, DV: 8, VD: 8 
d = Paternal prenatal Dex exposure effect to increase, e = Maternal prenatal Dex 
























































Figure 4.6 F2-E20 placental labyrinth nutrient transporter gene expression 
There was a paternal prenatal Dex exposure effect to increase expression of Slc22a1; 
and a maternal prenatal Dex exposure effect to increase expression of Slc38a4, Glut1, 
and Slc22a3 
Data are mean ± SEM, analysed by two-way ANOVA 
n = VV: 9, DD: 7, DV: 8, VD: 8 
d = Paternal Dex exposure effect to increase, e = Maternal Dex exposure effect to 
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Figure 4.7 F2 placental labyrinth Igf2 promoters’ transcription level and correlation 
There was A) no difference in the level of mRNA transcripts of all four promoters in 
labyrinth at E20 but B) there is a positive correlation between total Igf2 expression 
and all four promoter transcripts. The significance of the correlation between total 
Igf2 expression and all four promoter transcripts (P0, P1, P2, P3) was p<0.001 
Data are mean ± SEM, analysed by two-way ANOVA and Pearson’s correlation 
n = VV: 9, DD: 7, DV: 8, VD: 8 
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4.3.5 F2-E20 placental stereology 
There were no differences in the volume of placental labyrinth between the four 
groups (Figure 4.8a); however there was an effect of paternal prenatal Dex exposure 
to decrease the volume of the junctional zone (Figure 4.8b). Data presented are in 
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Figure 4.8 Ratio of the volume of F2 placental labyrinth and junctional zones 
There was A) no difference between the volume of placental labyrinth in all four 
groups but B) there is a paternal prenatal Dex exposure effect to decrease the volume 
of the junctional zone in relation to total placental volume 
Data are mean ± SEM, analysed by two-way ANOVA 
n = 6 per group 






Figure 4.9 Representative pictures of H&E stained placentas from each group 
Picture shows the decreased junctional zone in DD and VD groups 




These results demonstrate programming effects of parental prenatal Dex exposure on 
placental and fetal development in the F2 generation. Previous reports have 
suggested that the transmission of programming effects across generations results in 
similar phenotypes being reproduced in the subsequent generations (Drake et al. 
2005, Harrison and Langley-Evans 2009, Jimenez-Chillaron et al. 2009). These 
results confirm that prenatal Dex exposure is associated with effects on fetal and 
placental growth and gene expression in the F2 generation but suggests that despite 
similar phenotypes in both F1 and F2 offspring, the mechanisms underlying the 
programming effects on growth in the two generations may be different. 
 
In this study, difficulties were encountered when mating DV and VD groups. These 
two groups took longer to mate and there were a number of resorption sites in the 
litters of the VD group. It is not clear at what point in gestation this resorption of 
embryos occurred and whether this was a result of failed implantation or as a 
consequence of maternal physiological error. Although the cause of the resorption 
sites in the VD group is not clear, but one explanation could be that this occurred as a 
consequence of altered gene expression, since many of the genes that showed 
changes in expression in this study, in particular imprinted genes, are important in 
growth and fetal survival (Walsh et al. 1994, Barton et al. 2005). Alterations in the 
expression of these genes may lead to unfavourable pregnancy outcome (Walsh et al. 
1994, Dean et al. 1998). Indeed, some studies have previously shown that disruption 
in the expression of some imprinted genes leads to post-implantation embryo loss 
(Walsh et al. 1994, Pathak et al. 2010) and others studies using a chemotherapeutic 
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agent, cyclophosphamide, have shown increased resorption sites associated with 
epigenetic changes (Hales et al. 1992, Barton et al. 2005). Possible explanations for 
the increase in the length of time to plug may be the altered sexual behaviour in F1 
Dex males. Previous studies have suggested that prenatal exposure to glucocorticoids 
can alter sexual preference and behaviour in male rats (Holson et al. 1995, Piffer et al. 
2009). Additionally, studies have shown that prenatal overexposure to stress or 
glucocorticoids may impact on females; altering the oestrous cycle, increasing 
avoidance behaviour during mating, increasing spontaneous abortions during 
pregnancy, and altering fertility in female offspring (Herrenkohl 1979, Frye and 
Orecki 2002, Piffer and Pereira 2004). 
 
In the second generation, I found parent-of-origin effects on placental and fetal 
weight at E20 and on birth weight. The parental conflict hypothesis suggests that the 
influence of the father promotes growth enhancement, whereas the influence of the 
mother is to restrict the growth of the developing fetus (Moore and Haig 1991). My 
results showing a maternal effect to increase and a paternal effect to reduce fetal and 
placental growth in combination with maternal and paternal effects on placental gene 
expression appear to be in opposition to this hypothesis. However, an alternative way 
to look at this would be that the normal mechanisms by which the mother acts to 
restrain growth and by which the father acts to promote growth have failed as a 
consequence of prenatal Dex exposure, thus agreeing with the parental conflict 
hypothesis. 
 
In the F2 fetal liver, gene expression studies showed an interaction between parental 
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prenatal Dex exposure effects to decrease the expression of Igf2. There was also an 
interaction between parental prenatal Dex exposure to decrease the expression of the 
imprinted gene Phlda2. In opposition to the findings in F1, but in agreement with the 
observed effects on fetal growth, the lowest expression of Igf2 and Phlda2 was found 
in the smallest offspring, VD. The reduction in Igf2 may be the reason for the small 
offspring in VD group since Phlda2 has been shown to have its primary function in 
the placenta (Tunster et al. 2010). In contrast, there was an interaction between 
parental prenatal Dex exposure to increase the expression of IgfBP2. As discussed in 
chapter 3, IgfBP2 acts primarily to inhibit Igf2 action (Jones and Clemmons 1995). 
The reduction in Igf2 expression together with an increase in IgfBP2 expression, 
would be predicted to reduce fetal growth. Although a marked change in hepatic 
CDKn1c expression was observed in the F1 Dex offspring, CDKn1c expression was 
unchanged in the F2 generation. This gives additional support to the possibility that 
mechanisms underlying programming effects are different between the F1 and F2 
generations. 
 
In the placental labyrinth, we found a paternal effect to increase the expression of the 
maternally expressed genes CDKn1c and Phlda2. In transgenic mouse models, 
knockout of CDKn1c results in placentomegaly with abnormalities of the labyrinth 
(Takahashi et al. 2000); and deletion of Phlda2 gene leads to placentomegaly with 
expansion of both labyrinth and junctional layers (Frank et al. 2002, Salas et al. 
2004). In contrast, over‐expression of Phlda2 leads to a reduction in the growth of the 
placenta (especially the junctional zone), in association with a significant reduction 
in glycogen storage (Tunster et al. 2010). In this study, there was an effect of 
 
  149
paternal prenatal Dex exposure to decrease the area of the placental junctional zone 
This is consistent with the pattern of Phlda2 gene expression, since we found an 
effect of paternal prenatal Dex exposure to increase its expression. The expression of 
Mest, a paternally expressed imprinted gene known to be related to placental and 
fetal growth (Lefebvre et al. 1998, McMinn et al. 2006) is increased in placental 
labyrinth by maternal prenatal Dex exposure. The increased expression of Mest 
would be expected to result in increased fetal and placental growth; and indeed 
analysis by two-way ANOVA showed an effect of maternal Dex to increase fetal 
growth, although placental growth was only increased in the DV group. One reason 
for the differences seen between this model and the models using 
knockouts/overexpression of single genes might be that the effects of the original 
glucocorticoid overexposure result in the altered expression of multiple genes that 
play a role in fetal and placental growth and it is the balance of changes which 
determines the patterns of growth that were observed in this study. 
 
Although the mechanisms that underlie all of the programming effects in the 
glucocorticoid programmed rat remain undefined, epigenetic modifications have 
been suggested as a likely mechanism. Previous reports have shown 
multigenerational epigenetic changes as a consequence of maternal dietary 
manipulation (Morgan et al. 1999) as well as exposure to an endocrine disruptor 
which induced epigenetic changes in multiple generations that were not exposed 
(Anway et al. 2005, Stouder and Paoloni-Giacobino 2010). A recent report has shown 
that the multigenerational epigenetic effects induced by endocrine disruptors can 
specifically affect imprinted genes in the germline (Stouder and Paoloni-Giacobino 
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2011), therefore suggesting the potential for these epigenetic marks to be transmitted 
to subsequent generations. In our recent report, fetal overexposure to glucocorticoids 
led to changes in methylation pattern of Igf2 in F1 and F2 fetal liver (Drake et al. 
2011), thus giving further support to the concept that epigenetic modifications are a 
possible mechanism in multigenerational programming. 
 
In this study, I have shown that the gene expression changes in F2 placental labyrinth 
and fetal liver are dependent on parental prenatal Dex exposure. This is best 
exemplified by the expression of a number of imprinted genes which are important in 
both fetal and placental growth. This suggests that in the glucocorticoid 
overexposure model, the transmission of programming effects to the second 
generation may occur as a consequence of epigenetic changes, since imprinted genes 
are epigenetically regulated. The erasing of imprinted marks in the developing germ 
line occurs at around embryonic day 12 – 13 (Reik and Walter 2001, Hajkova et al. 
2002) and there is re-establishment of DNA methylation at imprinted genes later in 
fetal development, at least in the male germ line (Kafri et al. 1992, Tada et al. 1998, 
Reik and Walter 2001) (Figure 4.10). Thus, the germ cells which will go on to form 
the F2 generation are exposed to Dex during the period in which DNA methylation is 
re-established. If this process was disrupted and the effects preserved following 
fertilisation, this could result in the transmission of effects to the F2 generation. 
Indeed, previous reports using endocrine disruptors have shown epigenetic 
programming effects in the male germ line (Anway et al. 2006b, Stouder and 
Paoloni-Giacobino 2010, Stouder and Paoloni-Giacobino 2011) which appear to 
escape the epigenetic reprogramming that occurs following fertilisation (Anway et al. 
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2005, Stouder et al. 2009). Although the exact mechanism of such resistance to 
resetting of epigenetic marks remains to be explored (Youngson and Whitelaw 2008), 
it has been proposed that under the effect of these ‘external agents’, alterations in 
DNA methylation or the induction of new differentially methylated regions can 
persist through generations (Anway et al. 2005, Guerrero‐Bosagna et al. 2005, 
Skinner et al. 2010). Other than DNA methylation, emerging evidence suggests that 
changes in histone marks (Fu et al. 2004, Park et al. 2008, Fu et al. 2009, Hammoud 
et al. 2011) and non-coding RNAs (Rassoulzadegan et al. 2006, Lalancette et al. 









Figure 4.10 DNA methylation in germ cells of females and males 
Diagrammatic representation of methylation levels in germ cells showing the erasure 





The timing of exposure to excess glucocorticoids may also lead to generation 
specific programming effects. In the F1, the programming effects may be due to 
direct exposure to glucocorticoids during late gestation; whereas in the F2, the 
exposure to excess glucocorticoids may occur at the level of the germ cell in the 
developing F1 gonad so that the changes seen in F1 and F2 may be different due to 
the effects of Dex at different time points of development. 
 
Another possible factor that may play a role in the transmission of programming 
effects specifically through the maternal line could be alterations in maternal 
physiology and behaviour. As previously discussed, maternal size has been linked to 
birth weight in horses (Walton and Hammond 1938), pigs (Gama and Johnson 1993), 
mice (Cowley et al. 1989), and humans (Ibanez et al. 2000). In this study, F1 female 
exposed to Dex were lighter, and previous data has shown that despite slight catch up 
growth in Dex exposed females, this reduced weight at birth can continue till 6 
months of age (Cleasby et al. 2003, Drake 2004). Smaller F1 Dex females may give 
birth to offspring that are lighter at birth as was seen in DD and DV groups. Also, 
Dex exposure has been reported to cause altered behaviour in animals which are 
directly exposed (here the F0 mothers) as well as behavioural changes in offspring 
(here the F1 offspring) (Muneoka et al. 1997, Brown 2009). In rats, maternal 
behaviour has been shown to affect the behaviour of female offspring, potentially 
through alterations in DNA methylation (Meaney 2001, Weaver et al. 2004). Thus, it 
is possible that the F0 mothers treated with Dex had altered maternal behaviour 
toward their F1 offspring postnatally, leading to a similarly altered maternal 




previous study using a cross fostering paradigm has shown that in the glucocorticoid 
programmed rat, Dex exposed fetuses do not escape the fate of developing metabolic 
phenotypes despite postnatal rearing by an unexposed mother. Similarly, pups 
exposed to Veh in utero do not develop metabolic phenotypes even if reared by a 
Dex exposed mother postnatally (Nyirenda et al. 2001), suggesting that the 
programming effects are determined in utero rather than by maternal behaviour 
postnatally. 
 
In conclusion, prenatal Dex overexposure during the last week of gestation in rats is 

















Programming effects in first generation 






Epidemiological studies in humans have shown that an increased maternal body mass 
index during pregnancy is linked to offspring obesity and metabolic illnesses 
(Eriksson et al. 2003, Whitaker 2004, Gale et al. 2007, Catalano et al. 2009). In 
animal studies, maintenance of females on a high fat and/or high sugar diet during 
and after pregnancy has also been associated with effects on hypertension, metabolic 
syndrome, muscle development, reproduction, and obesity in their offspring (Khan et 
al. 2005, Samuelsson et al. 2008, Bayol et al. 2009, Jungheim et al. 2010).  
 
Various approaches have been developed to determine the underlying mechanisms 
linking maternal obesity with programming effects in the offspring. These studies 
have included varying the content of the maternal diet, for example using lard to 
induce maternal obesity (Khan et al. 2003, Chechi et al. 2010); using ‘junk food’ 
including chocolate biscuits, marshmallow and cheese (Bayol et al. 2007, Akyol et al. 
2009, Bayol et al. 2009) or using commercially manufactured high fat diets with or 
without additional ingredients such as vegetable oil and sweetened condensed milk 
(Guo and Jen 1995, Samuelsson et al. 2008, Elahi et al. 2009). In addition to the 
dietary differences between studies, the age of introduction of dietary interventions 
and the duration of exposure prior to pregnancy differs between studies. In some 
studies dietary changes were introduced shortly after weaning (Jungheim et al. 2010, 
Massiera et al. 2010), whilst in others the experimental diets were introduced 55 
weeks before mating (Sumiyoshi et al. 2006), 4 weeks before mating (Samuelsson et 
al. 2008, Nivoit et al. 2009), a week before mating (Guo and Jen 1995, Taylor et al. 
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2005), or at day of conception (Bayol et al. 2007). In this study, we set out to 
characterise a model of maternal obesity and the effects on offspring by using a high 
fat, high sugar, balanced protein diet. There were two primary intentions for this 
study. Firstly, we wished to generate a model of maternal obesity in pregnancy which 
mimics the human state by inducing obesity prior to and during pregnancy and then 
to examine the programming effects on offspring. Second, we used a diet matched in 
terms of protein, micro and macronutrient content in order to exclude an altered 
protein content as a cause of programming effects in the offspring. 
 
5.1.2 Hypothesis 
I hypothesised that maternal obesity induced by exposure to a high fat and high sugar 
diet would lead to programming effects on metabolism in the offspring. 
 
5.1.3 Aims 
The aim of this study was to generate a mouse model of maternal obesity and to 
characterise the phenotype of the offspring by studying effects on glucose/insulin 
homeostasis and gene expression in offspring liver and adipose tissue at different 
postnatal ages. This study was part of a larger study performed with another PhD 
student Ms. Rachel S. Dakin, and a post-doctoral researcher Dr. Vicky King. I 
focused mainly on the F1 female offspring at 3 months and 6 months of age but also 
undertook studies in both genders at 12 months of age. I also collected body weights 
in both genders at all time points of development. Here I show only my own 




5.2.1 Animal maintenance and diet 
Female C57bl/6 mice were bred in-house and mated with a stud C57bl/6 male to 
produce an F0 generation. The presence of vaginal plug was checked daily in the 
morning and females were singly housed after a vaginal plug was found (denoted as 
E0) and were left undisturbed with ad libitum access to food and water. Pregnant 
female mice were allowed to litter and pups (F0) were sexed, culled back to five 
pups per litter and weaned at three weeks of age. The pups were then randomly 
assigned to house with pups from different litters at a maximum of five per cage and 
were assigned a standard laboratory chow (RM1) (Special diet services, Witham, UK) 
for two weeks. 
 
At five weeks of age, F0 females were either assigned to a diet-induced obesity (DIO) 
diet or a control (CON) diet that was matched in all macro- and micronutrients 
except fat and carbohydrate. After 12 weeks of exposure to the experimental diet, 
females were singly housed with a stud male for mating, remaining on their assigned 
experimental diet. Cages were checked for the presence of a vaginal plug daily and 
when found, males were removed from the cage. Throughout pregnancy, intake of 
diet was weighed and recorded although to avoid stress in the pregnant mother this 
procedure was not performed in metabolic cages. At birth, F1 pups were weighed, 
sexed and culled back to five per litter. F1 pups were reared by their biological 
mother (which remained on their respective experimental diets) until weaning at 
three weeks of age. At weaning, the pups were then randomly assigned to be group 
housed with other same sexed littermates from the same treatment group and were 
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put on to standard laboratory chow. Dr. Vicky King (Centre for Reproductive Health, 
University of Edinburgh) helped with the production of F1 offspring in two of the 
cohorts in this study. 
 
Groups of F1 offspring underwent intra-peritoneal glucose tolerance testing (IPGTT), 
and diurnal tail tip blood collections at 3 months, 6 months or 1 year of age and were 
killed after the experimental procedures by carbon dioxide asphyxiation at each of 
the three time points. Organs were dissected, weighed and snap frozen on dry ice and 
stored at -80°C. Organ weights were normalised to body weight before statistical 
analysis. 
 
5.2.2 Metabolic experiments 
Plasma from IPGTT was measured by using an enzymatic (hexokinase) method 
(Thermo Fisher Scientific) for glucose; enzymatic colourimetric tests were used for 
triglyceride (Thermo Fisher Scientific) and cholesterol (Thermo Fisher Scientific) 
measurements; plasma insulin was measured by using an ELISA kit (Crystal Chem 
Inc.). 
 
5.2.3 Molecular experiments 
Liver and adipose total RNA was extracted using the RNeasy® mini kit (Qiagen) and 
reverse transcribed (Promega) to produce cDNA. Quantitative real-time PCR was 
used to examine gene expression using TaqMan™ (Applied Biosystems) or self 
designed UPL (Roche) primers with the addition of MasterMix (Roche). Expression 
of all genes examined were normalised to the reference gene: Cyclophilin-A. 
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5.2.4 Statistical analysis 
Data were analysed by using SPSS® and GraphPad®. Statistical significance was 
calculated by Student’s t-tests, Mann-Whitney u-tests when the distribution of data 
was non-parametric or area under curve (AUC) analysis. Data are expressed as mean 




5.3.1 F0 maternal physiology and F1 offspring 
F0 females assigned to DIO diet were heavier than controls at 12 weeks of age 
(Figure 5.1a). There was no difference between the groups in terms of time taken to 
plug (CON = 3.00±0.43, DIO = 3.05±0.34 days; p=0.92), however F0 DIO females 
lost more weight between the time of introduction of a male and the identification of 
a vaginal plug (Figure 5.2). During pregnancy, F0 DIO females gained less weight 
(Figure 5.1b) and consumed less diet (Table 5.1) compared to F0 CON females. 
Although less diet in grams was consumed by the F0 DIO females, they consumed 
more fat than controls. There was no difference in either total calorie or protein 
intake between groups (Table 5.1). 
 
At birth, both male and female F1 DIO offspring were lighter than F1 CON offspring 
(Table 5.2). There was no difference in litter size between groups (Table 5.2). At 
weaning, both F1 DIO males and females were heavier than F1 CON offspring; this 
difference between weights disappeared by 2 months of age (Table 5.2) and no 
weight difference was seen at three months (Table 5.2). At six months of age, F1 DIO 
females were lighter than F1 CON females although no difference was seen in the 
males (Table 5.2). At one year of age, F1 DIO females were lighter than F1 CON 






















































Figure 5.1 Weight of F0 pregnant females before and during pregnancy 
A) F0 females on DIO had increased weight gain and were heavier before mating, 
however, B) F0 DIO females gained less weight throughout pregnancy compared to 
F0 CON females 
Data are mean ± SEM, analysed by Student’s t-test 
n = F0 CON: 22, F0 DIO: 23 litters 






















Figure 5.2 Maternal weight change following introduction of male to cage 
Females were mated after 12 weeks on experimental diet. F0 DIO females lost more 
weight than controls following the introduction of a male to the cage 
Data are mean ± SEM, analysed by Student’s t-test 
n = F0 CON: 19, F0 DIO: 19 litters 




Table 5.1 F0 maternal diet consumption during pregnancy from E1 – E18 
n = F0 CON: 22, F0 DIO: 22 litters 
 F0 CON F0 DIO p value 
Diet consumed (g) 51.01 ± 0.88 38.45 ± 2.19 < 0.0001 
Fat intake (%gm) 2.45 ± 0.04 13.77 ± 0.78 < 0.0001 
Protein intake (%gm) 8.57 ± 0.14 8.84 ± 0.50 0.60 




 F1 CON F1 DIO p value 
Birth weight (g)    
     Male 1.33 ± 0.02 (67) 1.22 ± 0.02 (48) < 0.0001 
     Female 1.27 ± 0.02 (58) 1.19 ± 0.02 (52) < 0.001 
Wean weight (g)    
     Male 8.14 ± 0.15 (48) 10.39 ± 0.2 (39) < 0.0001 
     Female 7.87 ± 0.15 (41) 10.01 ± 0.17 (42) < 0.0001 
Weight at 2 months (g)    
     Male 25.39 ± 0.25 (47) 25.16 ± 0.32 (30) 0.57 
     Female 19.29 ± 0.25 (31) 18.79 ± 0.21 (39) 0.13 
Weight at 3 months (g)    
     Male 30.39 ± 0.67 (12) 28.69 ± 0.73 (9) 0.11 
     Female 20.80 ± 0.45 (15) 21.55 ± 0.63 (16) 0.34 
Weight at 6 months (g)    
     Male 38.33 ± 0.99 (12) 36.48 ± 1.02 (9) 0.21 
     Female 26.06 ± 0.58 (14) 24.11 ± 0.57 (16) < 0.05 
Weight at 12 months (g)    
     Male 44.35 ± 1.36 (12) 44.76 ± 0.83 (9) 0.82 
     Female 28.10 ± 1.17 (8) 25.67 ± 0.54 (11) = 0.05 
 
Table 5.2 F1 offspring weights at birth, weaning, 2, 3, 6 and 12 months 
Numbers in brackets indicates number of animals at each time point 




5.3.2 F1 offspring plasma analysis and hepatic triglyceride 
At three months of age, there were no differences in plasma glucose or insulin levels 
during IPGTT between F1 CON and DIO female offspring (Figure 5.3). There was 
no difference in plasma triglyceride levels between the groups, but a trend to 
increased plasma cholesterol level was seen in F1 DIO females (Table 5.3). 
 
At six months of age, there was a trend for F1 DIO females to have lower plasma 
glucose levels than F1 CON females during the IPGTT (Figure 5.4). No differences 
were seen in plasma triglyceride and cholesterol levels (Table 5.3). 
 
At one year of age, no differences were seen in glucose or insulin levels in F1 
females (Figure 5.5) however there was a trend for F1 DIO males to have higher 
glucose levels during IPGTT (Figure 5.6). No differences were seen in plasma 
triglyceride and cholesterol levels between F1 control and F1 DIO females however 
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Figure 5.3 Plasma insulin and glucose levels at 3 months of age in F1 females 
There were no differences in plasma A) insulin or B) glucose between the groups at 3 
months of age 
Data are mean ± SEM, analysed by AUC 
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Figure 5.4 Plasma insulin and glucose levels at 6 months of age in F1 females 
There were no differences in A) plasma insulin levels following an intraperitoneal 
glucose load; however F1 DIO females had a trend towards a decrease in B) plasma 
glucose levels at 6 months of age 
Data are mean ± SEM, analysed by AUC 
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Figure 5.5 Plasma insulin and glucose levels at one year of age in F1 females 
There were no differences in A) plasma insulin and B) glucose levels following an 
intraperitoneal glucose load in F1 females at one year of age 
Data are mean ± SEM, analysed by AUC 
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Figure 5.6 Plasma insulin and glucose levels at one year of age in F1 males 
There were A) no differences in plasma insulin levels following an intraperitoneal 
glucose load; however B) F1 DIO males had a trend towards an increase in plasma 
glucose levels at one year of age 
Data are mean ± SEM, analysed by AUC 




 F1 CON F1 DIO p value
3 month female    
     Plasma TG (mmol/L) 0.65 ± 0.02 0.72 ± 0.05 0.18 
     Plasma chol (mmol/L) 0.87 ± 0.15 1.47 ± 0.26 0.06 
6 month female    
     Plasma TG (mmol/L) 0.61 ± 0.09 0.38 ± 0.06 0.07 
     Plasma chol (mmol/L) 2.16 ± 0.27 2.03 ± 0.16 0.70 
1 year female    
     Plasma TG (mmol/L) 0.72 ± 0.03 0.67 ± 0.02 0.12 
     Plasma chol (mmol/L) 0.95 ± 0.20 1.21 ± 0.08 0.19 
1 year male    
     Plasma TG (mmol/L) 0.64 ± 0.02 0.71 ± 0.03 < 0.05 
     Plasma chol (mmol/L) 2.13 ± 0.25 2.80 ± 0.23 < 0.05 
 
Table 5.3 F1 plasma triglyceride, plasma cholesterol, and hepatic triglyceride levels 
Data are mean ± SEM, analysed by Student’s t-test and Mann-Whitney u-test 
n = 3 month F1 CON: 5, F1 DIO: 4 
 6 month F1 CON: 6, F1 DIO: 5 
 1 year female F1 CON: 8, F1 DIO: 11 
 1 year male F1 CON: 12, F1 DIO: 10 




5.3.3 F1 offspring organ weight 
In F1 females, no difference was seen between groups in the weight of liver, kidney, 
mesenteric adipose, subcutaneous adipose, and retroperitoneal adipose tissue weight at 
3 months, 6 months or one year of age (Table 5.4). 
 
There was increased weight of mesenteric and gonadal adipose tissue in F1 DIO male 
offspring at one year of age; although no differences were seen in liver, kidney, 





 F1 CON F1 DIO p value
3 month female organ weights (mg/g)    
     Liver 4.64 ± 0.09 4.92 ± 0.17 0.15 
     Kidney 0.61 ± 0.02 0.61 ± 0.01 0.89 
     Mesenteric ad. 0.66 ± 0.14 0.58 ± 0.24 0.78 
     Subcutaneous ad. 0.95 ± 0.13 1.18 ± 0.14 0.25 
     Retroperitoneal ad. 0.49 ± 0.12 0.41 ± 0.17 0.70 
6 month female organ weights (mg/g)    
     Liver 4.32 ± 0.18 4.51 ± 0.06 0.39 
     Kidney 0.50 ± 0.10 0.59 ± 0.04 0.08 
     Mesenteric ad. 1.24 ± 0.38 1.02 ± 0.33 0.33 
     Subcutaneous ad. 1.04 ± 0.15 1.02 ± 0.10 0.92 
     Retroperitoneal ad. 1.15 ± 0.17 0.73 ± 0.09 0.07 
1 year female organ weights (mg/g)    
     Liver 3.91 ± 0.21 4.16 ± 0.16 0.35 
     Kidney 0.54 ± 0.02 0.55 ± 0.02 0.74 
     Mesenteric ad. 0.88 ± 0.12 0.81 ± 0.04 0.53 
     Subcutaneous ad. 1.47 ± 0.15 1.30 ± 0.08 0.31 
     Retroperitoneal ad. 0.22 ± 0.04 0.18 ± 0.01 0.35 
 
Table 5.4 F1 female offspring organ weights  
Data are normalised to the body weight of animal 
Data are mean ± SEM, analysed by Student’s t-test 
n = 3 month F1 CON: 5, F1 DIO: 4 
 6 month F1 CON: 6, F1 DIO: 5 
 1 year F1 CON: 8, F1 DIO: 11 




 F1 CON F1 DIO p value
1 year male organ weights (mg/g)    
     Liver 4.11 ± 0.15 4.33 ± 0.20 0.37 
     Kidney 0.47 ± 0.01 0.44 ± 0.01 0.07 
     Mesenteric ad. 1.53 ± 0.09 1.88 ± 0.10 < 0.05 
     Subcutaneous ad. 2.19 ± 0.13 2.24 ± 0.15 0.79 
     Retroperitoneal ad. 0.36 ± 0.03 0.42 ± 0.02 0.15 
     Gonadal ad. 1.63 ± 0.08 1.98 ± 0.11 < 0.05 
 
Table 5.5 F1 male offspring organ weights at one year of age 
Data are normalised to the body weight of animal 
Data are mean ± SEM, analysed by Student’s t-test 
n = CON: 12, DIO: 9 






5.3.4 F1 female offspring hepatic gene expression 
In the female liver, there was an increase in the expression of fatty acid synthase (Fas) 
and a trend towards an increase in lipoprotein lipase (LPL) expression (p=0.058) at 
three months of age (Figure 5.7). There were no differences in the expression of 
hormone sensitive lipase (HSL), peroxisome proliferator-activated receptor α (PPARα), 
PPARγ, phosphoenolpyruvate carboxykinase (PEPCK), glucocorticoid receptor (GR), 
11βHSD1, 5-α reductase (5αR), or 5-β reductase (5βR) (Figure 5.7). At six months of 
age, no differences were seen in the expression of: LPL, PPARα, PEPCK, GR, 
11βHSD1, 5αR, or 5βR in female offspring (Figure 5.8). 
 
5.3.5 F1 female offspring adipose tissue gene expression 
At six months of age, no differences were seen in the expression of LPL, HSL, FTO, 
GR or 11βHSD1 in mesenteric adipose tissue (Figure 5.9a). In the subcutaneous adipose 
tissue, no differences were seen in the expression of LPL, Fas, HSL, PEPCK, FTO, GR, 































































Figure 5.7 Hepatic gene expression in three months old F1 females 
At three months of age there was increased expression of Fas and a trend towards an 
increase in the expression of LPL in F1 DIO liver but no differences were seen in the 
expression of a number of other genes important in glucose, lipid and glucocorticoid 
metabolism. 
Data are mean ± SEM, analysed by Student’s t-test 
n = F1 CON: 6, F1 DIO: 5 

















































Figure 5.8 Hepatic gene expression in six months old F1 females 
There were no differences in gene expression in liver from F1 females at six months of 
age   
Data are mean ± SEM, analysed by Student’s t-test 


















































































Figure 5.9 Gene expression in adipose depots from six month old F1 females 
There were no differences in the expression of genes important in glucose, lipid and 
glucocorticoid metabolism in A) mesenteric or B) subcutaneous adipose at 6 months of 
age 
Data are mean ± SEM, analysed by Student’s t-test 







These results demonstrate that in this model, maternal obesity does not result in 
major effects on female offspring health at least until one year of age. This finding is 
in disagreement with a number of published studies which reported programming 
effects in both genders (Guo and Jen 1995, Khan et al. 2003, Bayol et al. 2008, 
Samuelsson et al. 2008). In male offspring of obese mothers, there was a trend to 
decreased insulin sensitivity at one year of age. This suggests possible effects of 
aging in male animals exposed to maternal obesity prenatally. Females that were 
assigned DIO diets gained more weight and were heavier than animals on CON at 
the time of mating. Throughout pregnancy, DIO females gained less weight 
compared to CON. This reduced weight gain was not due to alterations in litter size. 
This inverse relationship between maternal size and weight gain during pregnancy 
has also been shown in humans (CMACE 2010, Park et al. 2011). At birth, both male 
and female F1 offspring of DIO females were lighter in weight, but by weaning, both 
male and female F1 DIO offspring were heavier than F1 CON offspring. A recent 
study which analysed the contents of the milk from mothers maintained on a high fat 
diet showed a higher fat content in milk (Purcell et al. 2011), so that the ‘catch-up’ 
growth observed in the F1 DIO offspring in this study may be due to the ingestion of 
milk that is higher in fat content from their mothers, as the mothers remained on their 
assigned experimental diet during lactation. At two months of age, this difference in 
weight between the two groups was no longer present. 
 
No differences were seen in plasma triglyceride and cholesterol levels in F1 females 




in plasma triglyceride levels at 3 months of age and increased cholesterol at 6 months 
of age (Samuelsson et al. 2008) in offspring of obese mothers, but in agreement with 
other reports showing no difference in plasma lipid levels in female offspring of high 
fat and high protein fed mothers (Zhang et al. 2005). In males, there was an increase 
in plasma triglyceride and cholesterol levels in DIO offspring at 12 months of age. 
There were no differences in glucose homeostasis in F1 female offspring at 3, 6 and 
12 months of age although in DIO F1 males, we found a trend towards insulin 
insensitivity at 12 months of age. Gene expression was not analysed in the adipose 
tissue of three months old females because of the relatively minor changes seen in 
six month old females. 
 
One possible explanation for our finding of minimal effects of maternal obesity on 
F1 female offspring is the diets used in this model in comparison to others. In this 
study, the DIO diet was completely matched with CON diet in terms of the micro- 
and macronutrients and protein and only differed in fat and carbohydrate content. 
This is important as low protein intake during pregnancy has been associated with 
programming effects in the offspring, including programming of hypertension 
(Langley-Evans 1997) and glucose intolerance and homeostasis (Langley et al. 1994, 
Ozanne et al. 1996, Ozanne and Hales 2002). In some of the other studies of 
maternal obesity, dietary constituents were not matched between the experimental 
and control groups; diets included lard (Khan et al. 2003, Taylor et al. 2005), cheese, 
biscuits, marshmallow, pork pie and other human foods (Bayol et al. 2005, Bayol et 
al. 2007, Bayol et al. 2008, Akyol et al. 2009), or a supplementation of sweet 




manufactured DIO diets in the experimental group, but used a standard laboratory 
chow as control (Zhang et al. 2005, Liang et al. 2010), therefore also potentially not 
matching protein intake. Other than a protein imbalance leading to programming 
effects, differences in micronutrient levels, such as folate may also induce 
programming effects (Ashworth and Antipatis 2001). In my study, the F0 DIO 
females consumed less diet during gestation but the actual protein (per gram) 
consumed was the same between the two groups. This recording of dietary intake 
was not performed in metabolic cages, since although this is the ideal way to 
accurately measure dietary intake, solitary housing and novel cage environments 
cause a significant amount of stress to the pregnant animals which has its own 
programming effects. A second explanation for the differences between studies may 
be due to differences in the species and strains of animals used (Surwit et al. 1988). 
Some studies have used rats: either Wistar (Guo and Jen 1995, Bayol et al. 2005, 
Akyol et al. 2009, Nivoit et al. 2009) or Sprague-Dawley (Levin and Govek 1998, 
Khan et al. 2003, Shankar et al. 2008); while others have used mice: C57bl/6 
(Sumiyoshi et al. 2006, Samuelsson et al. 2008, Bruce et al. 2009, Elahi et al. 2009, 
Liang et al. 2009, Chechi et al. 2010, Gregorio et al. 2010) or BALB/c (Zhang et al. 
2005). It is known that some strains of mice are resistant to the development of 
obesity on a high fat diet (Surwit et al. 1988, Surwit et al. 1995b) so that the effects 
induced in females and their offspring may differ between animal strains. 
 
The duration and timing of exposure to the experimental diets may be of importance 
in inducing programming effects. Some studies have introduced experimental diets a 




introduced experimental diets for as long as a year before mating (Sumiyoshi et al. 
2006). This difference in the duration of exposure to diets may induce variable 
maternal phenotypes; as one week of high fat feeding may not be sufficient to 
generate ‘maternal obesity’ in comparison to months of high fat feeding. In this study, 
we introduced the experimental diets two weeks after weaning and maintained the 
animals on their assigned diets for a duration of 12 weeks. This was sufficient to 
induce obesity in the animals prior to mating, thus allowing us to look more 
specifically at the programming effects of maternal obesity. 
 
Catch-up growth has been shown to be important in a number of studies. In humans, 
catch-up growth has been associated with increased risk of coronary heart diseases 
(Eriksson et al. 1999), increased insulin secretion (Soto et al. 2003b) and childhood 
obesity (Ong et al. 2000). In animals, it has also been associated with a shorter 
lifespan (Ozanne and Hales 2004). In this study, F1 DIO offspring had a lighter birth 
weight compared to F1 CON offspring. This is in agreement with a previous study in 
cafeteria diet fed rats which showed a reduction in fetal weight at E20 of pregnancy 
(Akyol et al. 2009), however F1 DIO offspring were heavier than F1 CON at 
weaning. Despite this ‘catch up growth’ in F1 DIO female offspring, very minor 
programming effects were seen in F1 DIO females, although in F1 DIO males there 
was a trend to decreased insulin sensitivity at one year of age suggesting that 
programming effects may become more apparent with ageing. This could be due to 
the time point at which the catch up growth occurred, as studies in humans suggest 
that catch up growth at different time points and for different durations is important 




reports on catch up growth have examined offspring that were exposed to an 
environment of undernutrition in utero, whereas in this study the lower birth weight 
was seen in the over- nourished group. 
 
From an evolutionary point of view, the minimal programming effects seen in DIO 
offspring may reflect a protective effect of maternal obesity. Since nutrition was 
plentiful for the developing fetus(es) in this model, there may have been no need for 
them to ‘adapt’ to a potentially difficult environment in the postnatal period. The 
consequences of early life programming have been considered to reflect the 
adaptation of the fetus(es) to an expected poor or altered environment postnatally, 
resulting in some organs that are less important in survival to be less developed than 
other organs which may be critical for survival (Hales and Barker 1992). Thus in the 
setting of maternal obesity and relative fetal overnutrition, perhaps minimal 
programming effects are necessary in the next generation. Whether a programmed 
phenotype in the DIO offspring would be more apparent with exposure to the 
obesogenic diet after weaning is the subject of ongoing studies. 
 
This finding of minimal programming effects from maternal obesity may have public 
health implications. Many previous studies in humans have suggested that maternal 
obesity is linked to childhood obesity (Whitaker 2004, Gale et al. 2007). However, it 
is uncertain to what extent this link is due to programming effects of maternal obesity, 
shared genes or the effects of exposure to a poor diet / lack of exercises postnatally. 
In this study, I have shown that programming effects are not an inevitable 














Programming effects in second generation 





As discussed in chapter four, programming effects may be transmissible to a second 
generation although the mechanisms by which effects are transmitted remains unclear. 
In humans the offspring of obese mothers are at increased risk of developing 
childhood obesity (Whitaker 2004, Gale et al. 2007), so that maternal obesity in 
pregnancy may lead to the establishment of a cycle of obesity which continues across 
a number of generations. Maternal effects may be one mechanism underlying the 
transmission of programmed effects across generations. Additionally, studies in other 
programmed models of overnutrition suggest that programmed effects may also be 
transmitted through the paternal line (Pentinat et al. 2010) so that an alternative 
mechanism for the transmission of programming effects as a consequence of 
overnutrition may be through effects which are transmissible through the germline. 
 
Thus, although minimal programming effects were seen in F1 DIO female offspring 
in our mouse model as described in chapter five, we hypothesised that there may still 






We hypothesise that the programming effects may be found in the second generation 
in a mouse model of maternal obesity and that these effects may differ from that in 
the first generation. Secondly, we hypothesise that the programming effects in the F2 
generation will be both parental exposure status specific and gender specific. 
 
6.1.3 Aims 
The aim of this study was to determine whether the programming effects of maternal 
obesity differ in the F1 and F2 generations. In this initial study, this will involve 





6.2.1 Animal maintenance, diet induction, and offspring production 
Female C57bl/6 mice were bred in-house and mated with a stud C57bl/6 male to 
produce an F0 generation. The presence of a vaginal plug was checked for daily in 
the morning. The females were singly housed when vaginal plug was found (denoted 
as E0) and were left undisturbed with ad libitum access to food and water. Pregnant 
female mice were allowed to litter and pups (F0) were sexed, culled back to five 
pups per litter and weaned at three weeks of age. The pups were then randomly 
assigned to house with pups from different litters at a maximum of five per cage and 
were assigned a standard laboratory chow (RM1) (Special diet services, Witham, UK) 
for two weeks. 
 
At five weeks of age, F0 females were either assigned to a diet-induced obesity (DIO) 
diet or a control (CON) diet that was matched in all macro- and micronutrients 
except fat and carbohydrate. After 12 weeks of exposure to the experimental diet, 
females were singly housed with a stud male for mating, remaining on their assigned 
experimental diet. Cages were checked for the presence of a vaginal plug daily and 
when found, males were removed from the cage.  
 
Litters (F1 CON and F1 DIO) were weighed at birth and culled back to five per 
group. Pups were reared by their biological mother until three weeks of age and were 
then weaned and housed with animals from same treatment group. At three months 
of age, F1 females were housed singly with an F1 male from a different litter of 
either the same or a different treatment group. This lead to the production of four 
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different groups: F1 CON female x F1 CON male (CC), F1 CON female x F1 DIO 
male (CD), F1 DIO female x F1 CON male (DC), and F1 DIO female x F1 DIO male 
(DD). 
 
At six months of age, all four groups of F2 animals underwent IPGTT and were 
killed after the experimental procedures by carbon dioxide asphyxiation. Organs 
were dissected, weighed, snap frozen on dry ice and stored at -80°C. Organ weights 
were normalised to body weight before statistical analysis. 
 
6.2.2 Metabolic experiments 
Plasma from IPGTT was measured by using an enzymatic (hexokinase) method 
(Thermo Fisher Scientific) for glucose; plasma insulin was measured using an ELISA 
kit (Crystal Chem Inc.). 
 
6.2.3 Statistical analysis 
Data were analysed using SPSS® and GraphPad®. Statistical significance was 
calculated by two-way ANOVA or area under curve (AUC) analysis and is expressed 





6.3.1 F2 weights 
At birth, analysis by two-way ANOVA showed an effect of both paternal (p<0.001, 
F=10.3) and maternal (p<0.05, F=4.9) prenatal DIO exposure to decrease birth 
weight (Figure 6.1a). In F2 male pups, there was an effect of maternal prenatal DIO 
exposure (p<0.05, F=4.30) to decrease birth weight (Figure 6.1b) whereas in F2 
female pups, there was an effect of paternal prenatal DIO exposure (p<0.01, F=8.77) 
to decrease birth weight (Figure 6.1c). There were no differences between litter sizes 
in all four groups (Figure 6.2). At weaning, the differences between weights had 
disappeared in both male (Figure 6.3a) and female (Figure 6.3b) offspring and by six 
months of age, no differences in weights were seen in F2 males (Figure 6.4a) or 
females (Figure 6.4b). 
 
In F2 males, at six months, there was an effect of maternal prenatal DIO exposure to 
increase the weight of mesenteric adipose (p<0.05, F=4.93), subcutaneous adipose 
(p<0.01, F=9.87) and retroperitoneal adipose tissue (p<0.05, F=6.73); as well as a 
trend to increase gonadal adipose tissue weight (p=0.07, F=3.35) (Figure 6.5). No 
differences were seen between groups in the weight of liver and kidney (Figure 6.5). 
 
In F2 females at six months, there was a trend for maternal prenatal DIO exposure to 
increase the weight of liver (p=0.06, F=3.97) (Figure 6.6). No differences were seen 
between groups in the weight of kidney, mesenteric adipose, subcutaneous adipose 
and retroperitoneal adipose tissue (Figure 6.6). 
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Figure 6.1 F2 birth weights 
There was A) an effect of both paternal and maternal prenatal DIO exposure to 
decrease birth weight with both offspring sexes combined. B) In males, there was an 
effect of maternal prenatal DIO diet exposure to decrease birth weight and C) in 
females there was an effect of paternal prenatal DIO exposure to decrease birth 
weight 
Data are mean ± SEM, analysed by two-way ANOVA 
n = CC: 11, DD: 9, DC: 9, CD: 8 litters per group 
a = Effect of paternal prenatal DIO exposure to decrease, b = effect of maternal 



















Figure 6.2 F2 litter size 
There were no differences between the litter size in all four groups 
Data are mean ± SEM, analysed by two-way ANOVA 
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Figure 6.3 F2 weaning weights 
There were no differences in the weights of A) male and B) female offspring at 
weaning in all four groups 
Data are mean ± SEM, analysed by two-way ANOVA 
n = Male CC: 25, DD: 22, DC: 23, CD: 20 






































































Figure 6.4 F2 male and female offspring growth trajectory 
There were no differences in weight gain in all four groups in A) male or B) female 
offspring till six months of age 
Data are mean ± SEM, analysed by AUC 
n = Males CC: 15, DD: 11, DC: 14, CD: 10 




































































Figure 6.5 Organ weights of F2 male offspring at six months of age 
There was an effect of maternal prenatal DIO exposure to increase the weight of 
mesenteric adipose, subcutaneous adipose and retroperitoneal adipose tissue. There 
was also a trend for maternal prenatal DIO exposure to increase the weight of 
gonadal adipose tissue  
Data are mean ± SEM, analysed by two-way ANOVA 
n = CC: 7, DD: 8, DC: 9, CD: 9 litters per group 
c = Maternal prenatal DIO exposure effect to increase, # = trend (p=0.07) to 
significance for maternal prenatal DIO exposure effect to increase 



























































Figure 6.6 Organ weights of F2 female offspring at six months of age 
There was a trend for maternal prenatal DIO exposure to increase the weight of liver  
Data are mean ± SEM, analysed by two-way ANOVA 
n = 8 per group 
# = trend (p=0.06) to significance for maternal prenatal DIO diet exposure effect to 
increase 




6.3.2 F2 offspring plasma analysis 
At six months of age, there was an effect of maternal prenatal DIO exposure (p<0.01, 
F=9.36) to increase insulin levels during IPGTT in F2 male offspring (Figure 6.7a). 
There were no differences in glucose levels (Figure 6.7b). 
 
In F2 female offspring, there was an interaction between maternal and paternal 
prenatal diet exposure (p<0.05, F=5.47) to reduce insulin levels during IPGTT 
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Figure 6.7 Plasma insulin and glucose levels at six months of age in F2 males 
There was A) an effect of maternal prenatal DIO exposure effect to increase insulin 
secretion, but B) no difference in glucose levels following an intraperitoneal glucose 
load 
Data are mean ± SEM, analysed by AUC 
n = CC: 8, DD: 9, DC: 9, CD: 10 
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Figure 6.8 Plasma insulin and glucose levels at six months of age in F2 females 
There was A) an interaction between maternal and paternal prenatal DIO exposure to 
decrease insulin levels, but B) no differences in glucose levels following an 
intraperitoneal glucose load 
Data are mean ± SEM, analysed by AUC 
n = CC: 8, DD: 9, DC: 9, CD: 8 





Although minimal programming effects were seen in the F1 generation directly 
exposed to maternal obesity, there were both gender- and parent-of-origin specific 
programming effects on birth weight, fat distribution and glucose homeostasis in the 
second generation. At birth, there were parent-of-origin effects on male and female 
pup birth weights. There was an effect of maternal prenatal DIO exposure to decrease 
birth weight in male pups and an effect of paternal prenatal DIO exposure to decrease 
birth weight in female pups. At six months of age, no differences were seen in the 
body weights of F2 males, but there was an effect of maternal prenatal DIO exposure 
to increase the weight of adipose tissue. Interestingly, the character of this fat 
distribution suggests central fat deposition. In human males, central obesity has been 
linked to metabolic illnesses such as diabetes and dyslipidaemia as well as an 
increased risk of cardiovascular disease (Björntorp 1991, Bujalska et al. 1997). In 
this study, mice with an increase in adipose tissue, groups DD and DC, also 
displayed insulin insensitivity. 
 
In F2 females at six months of age, there were no differences in body weight or in the 
weight or distribution of adipose depots. However, there was an interaction between 
maternal and paternal prenatal DIO exposure effect to decrease the insulin response 
to an intraperitoneal glucose load, suggesting increased insulin sensitivity in these 
animals. 
 
Previous studies using high fat diets (Ng et al. 2010, Dunn and Bale 2011) and other 
programming models (Dahlgren et al. 2001, Sugden and Holness 2002, O'Regan et al. 
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2004, Zambrano et al. 2006, Kaati et al. 2007) have shown gender specific 
programming effects. A study of the effects of paternal obesity showed effects mainly 
in daughters (Ng et al. 2010) and using a similar model of maternal obesity, Dunn et 
al. showed programming effects of increased body size and reduced insulin 
sensitivity in both F1 and F2 offspring (Dunn and Bale 2009) and an increased body 
size in F3 only in females (Dunn and Bale 2011). Notably, these effects in F3 appear 
to be passed down through the paternal lineage to the daughters only (Dunn and Bale 
2011). These findings are similar to the findings in my study showing gender specific 
programming effects of mother to son or father to daughter transmission of 
programmed effects (Figure 6.9).  
 
Although the mechanisms of such gender specific transmission are unknown, there 
are a number of possibilities. Firstly, maternal investment in the offspring may play a 
role in such gender specific programming (Haig 1990). F1 DIO mothers could have 
‘invested’ more in their male offspring postnatally, either through preferential feeding 
or increased maternal caring behaviour to increase the chances of survival; thus 
leading to a mother to son transmission pattern. This explanation is supported by 
previous reports showing maternal retrieval of pups being influenced by pup gender 
so that mothers retrieve male pups before females (Deviterne and Desor 1990) and 
additionally retrieve pups that are less developed and perhaps less likely to survive 
(Bolivar and Brown 1995). Secondly, these gender specific changes could be due to 
in utero hormonal exposure leading to different programming effects in male and 
female offspring. For example, maternal obesity leads to increased oestrogen 
exposure of the fetus (Pettigrew and Hamilton-Fairley 1997), such effects might 
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plausibly affect one sex but not the other. One previous report in mice has shown that 
male fetuses positioned in between two female fetuses are exposed to higher level of 
oestrogen than those position between male fetus(es), as the amniotic fluid of female 
fetuses contains higher oestrogen levels. This increased in utero exposure of 
oestrogen in the male fetus(es) was associated with less aggressive behaviour in 
adulthood and an increased sexual activity (Vom Saal et al. 1983). Lastly, the 
placenta may have played a role in gender specific programming effects. Previous 
studies have shown that gene expression, protein levels, hormone levels and 
immunological function in the placenta differ according to the gender of the 
developing fetus (Mueller and Bale 2008b, Clifton 2010). However, none of these 
mechanisms explain the transmission of effects from father to daughter. As the father 
was removed from the cage after mating and only contributes sperm to the next 
generation, this suggests an epigenetic mode of transmission leading to the 
transmission of effects. How this might affect daughters but not sons is unclear 
although it has been proposed that effects on the X chromosome might mediate 
father-to-daughter transmission (Pembrey et al. 2006). However, I am not aware of 
any reports providing clear evidence of such transmission.  
 
As mentioned previously, in addition to the gender specific programming effects in 
the F2, there were also generation specific programming effects in this model of 
maternal obesity. There are a few possibilities which might explain such generation 
specific programming effects. Firstly, as discussed in chapter four, epigenetic effects 
in the germline as a consequence of disrupted epigenetic reprogramming may impact 
on the next generation. In the germline of both sexes, epigenetic marks are erased 
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during early development. In males, the re-establishment of epigenetic marks in the 
developing germline occurs during late fetal development whereas in females, this 
occurs mainly after birth (Reik et al. 2001, Sasaki and Matsui 2008). Although the 
developing F1 generation offspring were exposed to the abnormal maternal 
environment throughout gestation and lactation, they were also potentially exposed at 
the level of the germ cell. We maintained F0 mothers on obesogenic diets from 5 
weeks of age, so that the germ cells which would form the F1 generation were also 
potentially exposed to, and may have been influenced by this environment both 
during the period of re-establishment of methylation marks which occurs at ovulation 
and during the period of epigenetic reprogramming post-fertilisation. In contrast, the 
F2 were first exposed at the level of the developing germ cell (Figure 6.10). These 
germ cells were exposed throughout development, during the time at which 
epigenetic marks are both erased and re-established (at least in the male germline). 
Thus, the difference in timing and extent to which the F1 and F2 germ cells and 
offspring were exposed to the insult may lead to different programming effects in the 
two generations.  
 
Alterations in F1 maternal or paternal physiology may also play a role. In other 
programming models, altered maternal physiology such as a smaller maternal size 
has been shown to have programming effects (Walton and Hammond 1938, Cowley 
et al. 1989). In my model, although there were minimal programming effects seen in 
the directly exposed F1 females, however this was assessed in the non-pregnant state. 
Normal pregnancy is a state of physiological insulin resistance (Spellacy and Goetz 
1963), and it is possible that there was decompensation during pregnancy in F1 DIO 
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females, leading to programming effects in the F2 generation. This is supported by 
previous studies using a model of undernutrition in rats in which a reduction in β cell 
mass was associated with alterations in glucose homeostasis during pregnancy 
(Blondeau et al. 1999). Additionally, alterations in the F1 males, such as changes in 
sperm may be of importance. Studies in both humans (Fejes et al. 2005, Hammoud et 
al. 2008) and animals (Ghanayem et al. 2010, Bakos et al. 2011) have shown effects 
of obesity on sperm count, motility, sperm function and DNA damage, suggesting 
that sperm may be a target for programming effects. Emerging evidence suggests that 
effects on histones (Hammoud et al. 2009) and siRNA (Rassoulzadegan et al. 2006, 
Lalancette et al. 2008) in sperm may be associated with the transmission of effects to 
subsequent generations. Although I am not aware of reports suggesting epigenetic 
changes in histones and siRNA in sperm in models of paternal or maternal obesity, 
this may be an important direction in future work. 
 
In summary, maternal obesity induced by a high fat and high sugar diet in mice is 
associated with minimal programming effects in the F1 offspring, but leads to gender 








Figure 6.9 Summary of findings in F2 mice 








Figure 6.10 Schematic of F1 and F2 exposure to experimental diets 
The F1 generation was initially exposed to the experimental diets as a germ cell in 
the gonad of the F0 mother as diets were commenced at 5 weeks of age. This 
exposure was also present during fertilisation, throughout the period of in utero 
development and also postnatally during lactation. In contrast, the F2 was only 
exposed to the experimental diets as a germ cell in the developing gonad of the F1 




















The aim of this thesis was to explore the possible mechanisms of multigenerational 
programming in two different animal models: i) the glucocorticoid programmed rat 
model, and ii) a mouse model of maternal obesity. In the rat model of glucocorticoid 
overexposure, I have explored changes in placental and fetal hepatic gene expression 
in both generations and protein levels in the first generation. In the mouse model of 
maternal obesity, I studied body weight, metabolic changes and gene expression 
changes in the first generation and body weight and glucose homeostasis in the 
second generation. A summary of the main findings in the glucocorticoid 
programmed rat and the maternal obesity programmed mice is presented in figure 7.1 
and 7.2 respectively. 
 
7.2 Multigenerational programming in the glucocorticoid programmed rat 
Previous reports from our laboratory have shown that programming effects on 
glucose homeostasis and hypertension may be induced by administering a synthetic 
glucocorticoid, dexamethasone, during the last week of gestation in rats 
(Benediktsson et al. 1993, Nyirenda et al. 1998, Drake et al. 2005). Such 
programming effects have also been shown to be passed down to the ‘not directly 
exposed’ second generation (Drake et al. 2005). I have continued to use this model to 
explore the underlying mechanisms of multigenerational programming. In this study, 
I have found that Dex lowers fetal and placental weight at E20 and increases the 
expression of several placental nutrient transporters important in fetal growth. This 
enhancement of the nutrient transporters may be a result of a ‘call for help’ signal 
from the fetus mediated through increased expression of Igf2 (Constância et al. 2005). 
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However, despite the increased expression of Igf2 in the fetal liver and the increased 
expression of important nutrient transporters in the placenta, Dex exposed fetuses 
remained small at E20 and at birth. This may be due to a variety of reasons such as: i) 
a smaller maternal weight gain during the period of Dex administration, ii) reduced 
fetal insulin secretion and / or signalling, and iii) the increased expression of several 
other growth restricting genes (e.g. CDKn1c, Grb10) in the fetal liver. Our recent 
study has also shown DNA methylation changes in the offspring that were exposed to 
Dex prenatally (Drake et al. 2011).  
 
Previous reports have shown that Dex exposure in rats during the last week of 
gestation alters the expression of vascular endothelial growth factor and placental 
vascularity (Hewitt et al. 2006) as well as changes in the secretion of hormones by 
the placenta that are important in maintaining pregnancy in rats (Ain et al. 2005). 
These changes, although not explored in my study, may potentially lead to an altered 
in utero environment for the developing fetus leading to programming effects.  
 
In addition to the molecular changes in the placenta and fetal liver, maternal 
physiology and behaviour may also play a role in programming of the fetus. Previous 
reports have shown that Dex exposure can lead to an anorexic behaviour in rats 
(Simpson et al. 1974) resulting in decreased weight gain. In my study, at E20, F0 
Dex mothers are lighter in comparison to F0 Veh mothers. Reduced maternal weight 
and size has been shown to be linked to reduced birth weight in a variety of species 
such as horses (Allen et al. 2002), sheep (Hunter 1956), pigs (Gama and Johnson 
1993), mice (Cowley et al. 1989), and humans (Ibanez et al. 2000). Thus, the 
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underlying mechanism(s) that lead to the final phenotype in the F1 offspring of 
glucocorticoid programmed rat may reflect an interaction between gene expression, 
placental morphology, altered hormone secretion, and altered maternal behaviour. 
 
Although previous reports have suggested that the programmed phenotype in F2 
offspring is similar to that in the F1 (Drake et al. 2005, Harrison and Langley-Evans 
2009, Jimenez-Chillaron et al. 2009), the mechanisms by which programming effects 
are transmitted across generations remain to be determined. In my study, despite the 
similarity in metabolic phenotypes in the two generations, the underlying 
mechanisms appear to be different. In the F2 fetuses, I found parent-of-origin effects 
on both placental and fetal weight at E20 and on birth weight. These results suggest 
that the growth of the F2 fetuses and placentas are closely related to their parental 
Dex exposure status and that the programming effects may be passed down through 
either the maternal or paternal lineage. One of the explanations for the differences in 
results seen as a consequence of Dex exposure in either the mother or the father is 
the parental conflict hypothesis. This hypothesis suggests that the influence of the 
father promotes growth enhancement, whereas the influence of the mother is to 
restrict the growth of the developing fetus (Moore and Haig 1991).  
 
The generation specific programming effects seen in this model may be explained by 
the timing of exposure to the Dex insult at different time points of development. F1 
offspring were directly exposed to Dex during the last week of in utero development. 
In the F2, the exposure to Dex was at the level of the germ cell within the gonads of 
the developing F1 during a crucial time of epigenetic reprogramming. The fact that 
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epigenetic reprogramming differs in timing between male and female germ cells - 
occurring predominantly during late fetal development in males (Kafri et al. 1992, 
Tada et al. 1998, Reik and Walter 2001) but predominantly after birth in females 
(Tada et al. 1998, Reik et al. 2001) may underlie some of the parent-of-origin 









Figure 7.1 Summary of main findings in the glucocorticoid programmed rat model 
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7.3 Multigenerational programming as a consequence of maternal obesity 
Obesity has become an increasing issue worldwide (WHO 2011). In the second part 
of this thesis, I described a model of maternal obesity by feeding a high fat and high 
sugar diet to mice after weaning to induce a phenotype of obesity prior to pregnancy; 
mimicking the human state of maternal dietary obesity. In this study, we found 
relatively minimal programming effects in our F1 offspring. This finding is in 
contrast to previous reports showing programming effects by maternal obesity on 
offspring glucose homeostasis, adipose deposition, metabolic disorders, and 
cardiovascular disease (Guo and Jen 1995, Bayol et al. 2005, Samuelsson et al. 2008, 
Elahi et al. 2009). There are several possible reasons for this difference in findings. 
As discussed in chapter five, the differences in diets used to induce obesity in our 
model compared to others may be an important factor. In our model, we used a diet 
that is high fat and high sugar but identical in other micro- and macronutrient 
contents including protein. Secondly, the duration of exposure to the experimental 
diets may be an important factor. In our model, we aimed to induce maternal obesity 
prior to pregnancy thus mimicking human maternal obesity. In other models, the 
duration of experimental diets ranges from a week (Guo and Jen 1995) to 55 weeks 
(Sumiyoshi et al. 2006) prior to pregnancy, potentially leading to different 
programming results. 
 
Despite the lack of changes in the F1 offspring, I found changes in the F2 offspring. 
The findings are similar to those in the glucocorticoid programmed rat which also 
showed generation specific and parent-of-origin specific programming effects. 
Additionally, there were gender specific effects in the F2 offspring with mother to 
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son and father to daughter transmission effects. Possible mechanisms of such specific 
parental transmission effects include: i) epigenetic effects on the germline which may 
be transmitted to subsequent generations, ii) maternal investment on the offspring in 
response to the environment the mother was exposed to, iii) in utero exposure to 
hormones which may affect one gender but not the other. The mechanisms which 












7.4 Public health implications 
In the past two decades, numerous large scale human epidemiological studies from 
different geographical areas and in different ethnicities have suggested that exposure 
to an adverse environment during specific time points in development is associated 
with adult disease risk. Such adverse environments may include direct physiological 
alterations such as starvation, malnutrition, or over nutrition as well as psychological 
stress such as the 9/11 event. Interestingly, it has been shown that some of these 
programming effects are reproduced in subsequent generations. Programming of the 
offspring has been viewed as a consequence of fetal adaptation to a poor 
environment, resulting in lower investment in organs that are less important in 
survival compared with organs which may be critical for survival (Hales and Barker 
1992). The exact underlying mechanisms of such programming and 
multigenerational transmission effects remain largely unknown and animal models 
have been developed in which to explore potential mechanisms. The advantages of 
using animal models for programming studies are the i) controlled environment and 
ii) genetic background to minimise bias as well as iii) the shorter life cycle which 
allows rapid reproduction of subsequent generations.  
 
In the glucocorticoid programmed rat model, I have shown programming effects in 
the placenta including changes in placental size, structure, and gene expression. If 
such findings can be translated into human studies, they may be useful in the early 
detection and prevention of future health risks in the offspring. 
 
Previous studies in humans have suggested that maternal obesity is linked to 
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childhood obesity (Whitaker 2004, Gale et al. 2007). However, it is uncertain to what 
extent this link is due to programming effects of maternal obesity, shared genes or 
the effects of exposure to a poor diet / lack of exercise postnatally. In this study, I 
have shown that programming effects are perhaps not an inevitable consequence of 
exposure to maternal obesity in utero. However, despite this, there are programming 
effects in the F2. This model will allow future exploration of how maternal 
overnutrition may lead to programming effects in the grand-offspring and potentially 
in subsequent generations. 
 
In conclusion, the two animal models presented in this thesis have confirmed that an 
adverse environment during early life may lead to programming effects in the 
offspring and grand-offspring. Along with the numerous large scale human 
epidemiological studies, this indicates a link between early life exposure to ‘insults’ 





7.5 Future work 
As presented in this thesis, and from reports in the literature, epigenetic 
modifications may play an important role in early life programming and in the 
transmission of effects to subsequent generations. Future studies should be directed 
at exploring epigenetic changes, such as DNA methylation changes and histone 
modifications, in both models as mediators of programming effects. Reports have 
suggested possible transmission of programming effects via sperm (Anway et al. 
2005, Stouder and Paoloni-Giacobino 2010) and further studies aimed at exploring 
whether epigenetic effects may be transmissible through the germline will be 
important in increasing our understanding of the mechanisms by which effects are 
transmitted across generations. In order to explore the full effect of obesity in 
programming, I would also like to generate a model of paternal obesity and 
determine its effect on offspring and grand-offspring. Additionally, as previously 
discussed, dietary constituents may be important in different programming effects. 
Future studies aimed at teasing out programming effects of different micro- and 
macronutrients will be important. Lastly, although minimal programming effects 
were seen in F1 females of the maternal obese mice, this does not exclude possible 
decompensation during pregnancy therefore studies should also be aimed at 
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